NCT00000102	Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets
NCT00000104	Does Lead Burden Alter Neuropsychological Development?
NCT00000105	Vaccination With Tetanus and KLH to Assess Immune Responses.
NCT00000106	41.8 Degree Centigrade Whole Body Hyperthermia for the Treatment of Rheumatoid Diseases
NCT00000107	Body Water Content in Cyanotic Congenital Heart Disease
NCT00000108	Effects of Training Intensity on the CHD Risk Factors in Postmenopausal Women
NCT00000110	Influence of Diet and Endurance Running on Intramuscular Lipids Measured at 4.1 TESLA
NCT00000111	Intraoral Grafting of Ex Vivo Produced Oral Mucosal Composites
NCT00000112	Prevalence of Carbohydrate Intolerance in Lean and Obese Children
NCT00000113	Correction of Myopia Evaluation Trial (COMET)
NCT00000114	Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa
NCT00000115	Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema
NCT00000116	Randomized Trial for Retinitis Pigmentosa
NCT00000117	Intravenous Immunoglobulin Therapy in Optic Neuritis
NCT00000118	Ganciclovir Implant Study for Cytomegalovirus Retinitis
NCT00000119	Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis
NCT00000120	Clinical Trial of Eye Prophylaxis in the Newborn
NCT00000121	The Prism Adaptation Study (PAS)
NCT00000122	Fluorouracil Filtering Surgery Study (FFSS)
NCT00000123	The Berkeley Orthokeratology Study
NCT00000124	Collaborative Ocular Melanoma Study (COMS)
NCT00000125	Ocular Hypertension Treatment Study (OHTS)
NCT00000126	Ischemic Optic Neuropathy Decompression Trial Followup (IONDT Followup)
NCT00000127	Ischemic Optic Neuropathy Decompression Trial (IONDT)
NCT00000128	A Trial of Bifocals in Myopic Children With Esophoria
NCT00000129	Prospective Evaluation of Radial Keratotomy (PERK) Study
NCT00000130	Endophthalmitis Vitrectomy Study (EVS)
NCT00000131	Central Vein Occlusion Study (CVOS)
NCT00000132	Early Manifest Glaucoma Trial (EMGT)
NCT00000133	Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for Retinopathy of Prematurity
NCT00000134	Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)
NCT00000135	Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)
NCT00000136	Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)
NCT00000137	Collaborative Corneal Transplantation Studies (CCTS)
NCT00000138	Herpetic Eye Disease Study (HEDS) I
NCT00000139	Herpetic Eye Disease Study (HEDS) II
NCT00000140	The Silicone Study
NCT00000142	Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)
NCT00000143	Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
NCT00000144	Glaucoma Laser Trial (GLT) Glaucoma Laser Trial Followup Study (GLTFS)
NCT00000145	Age-Related Eye Disease Study (AREDS)
NCT00000146	Optic Neuritis Treatment Trial (ONTT)
NCT00000147	Longitudinal Optic Neuritis Study (LONS)
NCT00000148	Advanced Glaucoma Intervention Study (AGIS)
NCT00000149	Collaborative Initial Glaucoma Treatment Study (CIGTS)
NCT00000150	Submacular Surgery Trials (SST)
NCT00000151	Early Treatment Diabetic Retinopathy Study (ETDRS)
NCT00000152	Randomized Trial of Beta-Carotene and Macular Degeneration
NCT00000153	Krypton-Argon Regression of Neovascularization Study (KARNS)
NCT00000154	Diabetic Retinopathy Vitrectomy Study (DRVS)
NCT00000155	The Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study
NCT00000156	The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP)
NCT00000157	Randomized Trial of Aspirin and Cataracts in U.S. Physicians
NCT00000158	Macular Photocoagulation Study (MPS)
NCT00000159	Sorbinil Retinopathy Trial (SRT)
NCT00000160	Diabetic Retinopathy Study (DRS)
NCT00000161	Randomized Trials of Vitamin Supplements and Eye Disease
NCT00000162	Branch Vein Occlusion Study
NCT00000163	Congenital Esotropia Observational Study (CEOS)
NCT00000167	Complications of Age-Related Macular Degeneration Prevention Trial
NCT00000168	Longitudinal Study of Ocular Complications of AIDS (LSOCA)
NCT00000169	The Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study
NCT00000170	Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia
NCT00000171	Study of Melatonin: Sleep Problems in Alzheimer's Disease
NCT00000172	Evaluation of Galantamine in the Treatment of Alzheimer's Disease
NCT00000173	Memory Impairment Study (Mild Cognitive Impairment Study)
NCT00000174	Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx)
NCT00000175	The Effects of Sex Hormones on Cognition and Mood in Older Adults
NCT00000176	Alzheimer's Disease Prevention Trial
NCT00000177	Estrogen Hormone Protocol
NCT00000178	Multicenter Trial of Prednisone in Alzheimer's Disease
NCT00000179	Agitation in Alzheimer's Disease
NCT00000180	AIT-082 Phase 1B Study
NCT00000187	Ritanserin in Treatment of Cocaine Dependence - 1
NCT00000188	Selegiline in Treatment of Cocaine Dependence - 2
NCT00000189	Gepirone vs Placebo in Treatment of Cocaine Dependence - 3
NCT00000190	Cocaine in Parotid Saliva, Blood and Urine - 4
NCT00000191	Carbamazepine Treatment for Cocaine Dependence - 5
NCT00000192	Neurobiology of Opioid Dependence: 1 - 1
NCT00000193	Neurobiology of Opioid Dependence: 2 - 2
NCT00000194	Neurobiology of Opioid Dependence: 3 - 3
NCT00000195	Neurobiology of Opioid Dependence: 4 - 4
NCT00000196	Neurobiology of Opioid Dependence: 5 - 5
NCT00000197	Propranolol for Treatment of Cocaine Addiction - 2
NCT00000198	Piracetam for Treatment of Cocaine Addiction - 3
NCT00000199	Piracetam for Treatment of Cocaine Addiction, Phase II - 4
NCT00000200	Cocaine Effects in Humans: Physiology and Behavior - 1
NCT00000201	Pharmacological Modulation of Cocaine Effects - 1
NCT00000202	Buprenorphine Maintenance for Opioid Addicts - 1
NCT00000203	Buprenorphine Maintenance for Opioid Addicts - 2
NCT00000204	Buprenorphine Maintenance for Opioid Addicts - 3
NCT00000205	Buprenorphine Maintenance Protocol - 1
NCT00000206	Clinical Rescue Protocol - 2
NCT00000207	Multicenter Clinical Trial of Buprenorphine - 3
NCT00000208	Methadone/Buprenorphine Cross-Over Study - 4
NCT00000209	Buprenorphine Dosing Interval - 5
NCT00000210	Treatment Efficacy for Drug Abuse and AIDS Prevention - 1
NCT00000211	Treatment Efficacy for Drug Abuse and AIDS Prevention - 2
NCT00000212	IV Cocaine Abuse: A Laboratory Model - 1
NCT00000213	IV Cocaine Abuse: A Laboratory Model - 2
NCT00000214	IV Cocaine Abuse: A Laboratory Model - 3
NCT00000215	IV Cocaine Abuse: A Laboratory Model - 4
NCT00000216	Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
NCT00000217	Pharmacotherapy and Intensive Treatment of Drug Abuse - 1
NCT00000218	Pharmacotherapy and Intensive Treatment - 2
NCT00000219	Buprenorphine Dose Alteration Study - 1
NCT00000220	Gradual Vs. Rapid Buprenorphine Detoxification - 2
NCT00000221	Alternate-Day Buprenorphine Administration. Phase I - 3
NCT00000222	Alternate-Day Buprenorphine Administration. Phase II - 4
NCT00000223	Alternate-Day Buprenorphine Administration. Phase IV - 5
NCT00000224	Alternate-Day Buprenorphine. Phase V - 6
NCT00000225	Alternate-Day Buprenorphine Administration. Phase VI - 7
NCT00000226	Alternate-Day Buprenorphine Administration. Phase VII - 8
NCT00000227	Alternate-Day Buprenorphine Administration. Phase VIII - 9
NCT00000228	Buprenorphine Detox With Two Types of Treatment. BBD I - 10
NCT00000229	Buprenorphine Detox With Two Types of Treatment. BBD II - 11
NCT00000230	Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12
NCT00000231	Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13
NCT00000232	Alternate Day Buprenorphine Administration, Phase IX - 14
NCT00000233	Alternate Day Buprenorphine Administration, Phase X - 15
NCT00000234	Alternate Day Buprenorphine Administration, Phase XI - 16
NCT00000235	Alternate Day Buprenorphine Administration, Phase XII - 17
NCT00000236	Buprenorphine Pharmacology Related to Addiction Treatment - 18
NCT00000237	Buprenorphine Detoxification - BBDVI - 19
NCT00000238	Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20
NCT00000239	Buprenorphine Pharmacology Related to Addiction Treatment - 21
NCT00000240	Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22
NCT00000241	Flupenthixol Decanoate in Methamphetamine Smoking - 1
NCT00000242	Carbamazepine Treatment of Cocaine Dependence - 1
NCT00000243	Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone
NCT00000244	Effects of Dynorphin 1-13 on Heroin Addiction - 1
NCT00000245	Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1
NCT00000246	Rapid Benzodiazepine Detoxification Using Flumazenil - 1
NCT00000248	Dose Response Trial of Pergolide for Cocaine Dependence - 1
NCT00000249	Effects of Subanesthetic Concentrations of Nitrous Oxide - 1
NCT00000250	Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2
NCT00000251	Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3
NCT00000252	Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4
NCT00000253	Effects of Nitrous Oxide: A Dose-Response Analysis - 5
NCT00000254	Isoflurane at Subanesthetic Concentrations - 6
NCT00000255	Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7
NCT00000256	Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8
NCT00000257	Effects of Alcohol History on Effects of Nitrous Oxide - 9
NCT00000258	Role of Instructions in Nitrous Oxide Effects and Choice - 10
NCT00000259	Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11
NCT00000260	Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12
NCT00000261	Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13
NCT00000262	Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14
NCT00000263	Effects of Combined Alcohol and Nitrous Oxide Intake - 15
NCT00000264	Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16
NCT00000265	Subjective Effects of Nitrous Oxide in Dental Patients - 17
NCT00000266	Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1
NCT00000267	Risperidone Treatment in Dually-Diagnosed Individuals - 2
NCT00000268	Cocaine Abuse and Attention Deficit Disorder - 3
NCT00000269	Pergolide Treatment for Substance Abusers - 4
NCT00000270	Brain Imaging: Cocaine Effects & Medication Development - 5
NCT00000271	New Approaches to Cocaine Abuse Medications (A) - 6
NCT00000273	A Laboratory Model for Heroin Abuse Medications - 8
NCT00000274	Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
NCT00000275	Cocaine Abuse and ADHD - 10
NCT00000276	Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
NCT00000277	Mazindol for Cocaine Abuse - 2
NCT00000278	Disulfiram for Cocaine-Alcohol Abuse - 3
NCT00000279	Novel Medications for Opiate Detoxification - 4
NCT00000280	Glutaminergic Agents for Cocaine Abuse - 5
NCT00000281	Pharmacotherapy for Schizophrenic Drug Users - 6
NCT00000282	Pemoline for Cocaine Abuse - 7
NCT00000284	Role of Metabolites in Nicotine Dependence (1) - 1
NCT00000285	Effects of Phenytoin on Cocaine Use in Humans - 2
NCT00000286	Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3
NCT00000287	Relapse Patterns in Female Cocaine Users - 4
NCT00000288	Role of Metabolites in Nicotine Dependence (2) - 5
NCT00000289	Role of Metabolites in Nicotine Dependence (3) - 6
NCT00000290	Stress Hormones and Human Cocaine Use - 7
NCT00000291	Effects of Labetalol on Human Cocaine Use - 8
NCT00000292	Acute Withdrawal From Smoked Cocaine - 9
NCT00000293	Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10
NCT00000294	Effects of Carvedilol on Cocaine Use in Humans - 11
NCT00000295	Progesterone Treatment in Female Smokers - 12
NCT00000296	Role of Metabolites in Nicotine Dependence (4) - 13
NCT00000297	Effects of Labetalol on Nicotine Administration in Humans - 14
NCT00000298	Buprenorphine Combination Tablet Feasibility - 1
NCT00000299	Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
NCT00000300	Feasibility Study of Take-Home LAAM Medication - 3
NCT00000301	Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4
NCT00000302	Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
NCT00000303	Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6
NCT00000304	Dextroamphetamine as an Adjunct in Cocaine Treatment - 1
NCT00000305	Amphetamine Cocaine Interaction Study - 2
NCT00000306	Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3
NCT00000307	Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4
NCT00000308	Dextroamphetamine-Cocaine Behavioral Intervention - 5
NCT00000309	Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1
NCT00000310	Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2
NCT00000311	Combining Behavioral Treatment With Agonist Maintenance - 1
NCT00000312	Alterations in Serotonergic Functions in Cocaine Addicts - 1
NCT00000313	Predictive Values of Serotonergic Alterations for Outcome - 2
NCT00000314	M-CPP and Fenfluramine in Cocaine Addicts - 3
NCT00000315	Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1
NCT00000316	Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2
NCT00000317	Early Phase II Trials for Cocaine Medication Development - 1
NCT00000318	Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
NCT00000319	Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2
NCT00000320	Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1
NCT00000321	Methamphetamine Abuse Treatment in Patients With AIDS - 1
NCT00000322	Tyrosine for Methamphetamine Dependence - 1
NCT00000323	Therapeutic Potential of Kappa-Opioids Against Cocaine - 1
NCT00000324	Tryptophan and Behavior Therapy for Cocaine Abuse - 1
NCT00000325	Psychostimulant Abuse - Novel Treatment Approaches - 1
NCT00000326	Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1
NCT00000327	Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2
NCT00000328	Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
NCT00000329	Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4
NCT00000330	Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
NCT00000331	Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
NCT00000332	High Dose Nimodipine Treatment Adjunct - 1
NCT00000333	Evaluation of Benztropine for Cocaine Craving - 2
NCT00000334	Comparison of Buprenorphine and Methadone - 3
NCT00000335	Activity Monitoring Assessment of Opiate Withdrawal - 4
NCT00000336	Selegiline in Outpatient Treatment for Cocaine Dependence - 1
NCT00000337	Infusion Laboratory: Protocol 1 - Selegeline - 2
NCT00000338	Infusion Laboratory: Protocol 2 (Lisuride) - 3
NCT00000339	Infusion Laboratory: Protocol 3 (Risperidone) - 4
NCT00000340	Pemoline in the Treatment of Stimulant Dependence - 5
NCT00000341	Evaluation of Liquid vs. Tablet Buprenorphine - 6
NCT00000342	Risperidone for the Treatment of Cocaine Dependence - 7
NCT00000343	Brain Changes in Stimulant Dependent Subjects - 8
NCT00000344	Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
NCT00000345	Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10
NCT00000346	Cognitive Correlates of Substance Abuse - 11
NCT00000347	Risperidone for Treatment of Cocaine Dependence in Outpatients - 12
NCT00000348	Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13
NCT00000349	Infusion Laboratory: Protocol 5 (Flupenthixol) - 14
NCT00000350	Effects of Stimulant Dependence on Human Striatal Dopamine System - 15
NCT00000351	Cognitive Correlates of Substance Abuse, Part 2 - 16
NCT00000352	Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1
NCT00000353	Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
NCT00000354	Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3
NCT00000355	Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
NCT00000356	Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5
NCT00000357	Buprenorphine Maintenance for Opiate Dependence - 6
NCT00000358	Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
NCT00000359	Treatments for Benign Paroxysmal Positional Vertigo (BPPV)
NCT00000361	Autoimmunity in Inner Ear Disease
NCT00000362	Randomized Study of Two Interventions for Liquid Aspiration: Short-Term and Long-Term Effects
NCT00000363	Acute Otitis Media: Adjuvant Therapy to Improve Outcome
NCT00000367	Prevention of Suicide in the Elderly
NCT00000368	Treatment of Panic Disorder: Long Term Strategies
NCT00000369	Maintenance Therapies in Bipolar Disorders
NCT00000370	Treatment of Social Phobia
NCT00000371	Trial of D-Cycloserine in Schizophrenia
NCT00000372	Glycine and D-Cycloserine in Schizophrenia
NCT00000373	Treatment of Obsessive-Compulsive Disorder
NCT00000374	Treatment for First-Episode Schizophrenia
NCT00000375	Continuation Electroconvulsive Therapy Vs Medication to Prevent Relapses in Patients With Major Depressive Disorder
NCT00000376	Cognitive and Drug Therapy for Drug-Resistant Depression
NCT00000377	Preventing the Return of Depression in Elderly Patients
NCT00000378	Antidepressant Treatment of Melancholia in Late Life
NCT00000379	Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder (PTSD)
NCT00000380	Growth Hormone Releasing Hormone (GHRH) Treatment for Age-Related Sleep Disturbances
NCT00000381	Fluoxetine for Anxious Children
NCT00000382	Preventing Child Abuse in Infants
NCT00000383	Treatment of Post-Traumatic Stress Disorder (PTSD) in Sexually Abused Children
NCT00000384	Treatment of Obsessive-Compulsive Disorder (OCD) in Children
NCT00000385	Long-Term Lithium Treatment for Aggressive Conduct Disorder
NCT00000386	Behavior Therapy for Children and Adolescents With Obsessive-Compulsive Disorder (OCD)
NCT00000387	Self-Management Therapy for Youth With Schizophrenia
NCT00000388	Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA)
NCT00000389	Treatment for Anxiety in Children
NCT00000390	Antidepressant Treatment of AIDS Related Depression.
NCT00000391	A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human Immunodeficiency Virus-1 (HIV-1) Infected Patients.
NCT00000392	Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.
NCT00000393	A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).
NCT00000394	Acupuncture for Carpal Tunnel Syndrome
NCT00000395	Antifolate Effectiveness in Arthritis
NCT00000396	Arthritis Patient Education for Urban African Americans
NCT00000397	Behavioral Insomnia Therapy for Fibromyalgia
NCT00000398	Behavioral Treatment of Fibromyalgia
NCT00000399	Bone Estrogen Strength Training
NCT00000400	Alendronate and/or Parathyroid Hormone for Osteoporosis
NCT00000401	Oral Collagen for Rheumatoid Arthritis
NCT00000402	Calcium and Bone Mass in Young Females
NCT00000403	Doxycycline and OA Progression
NCT00000404	Effects of Comprehensive Care for Knee OA
NCT00000405	Effects of Jumping on Growing Bones
NCT00000406	Effects of Strength Training on Knee Osteoarthritis
NCT00000407	Improving Vocational Outcomes in Arthritis
NCT00000408	Low Back Pain Patient Education Evaluation
NCT00000409	Spine Patient Outcomes Research Trial (SPORT): Degenerative Spondylolisthesis With Spinal Stenosis
NCT00000410	Spine Patient Outcomes Research Trial (SPORT) - Intervertebral Disc Herniation
NCT00000411	Spine Patient Outcomes Research Trial (SPORT): Spinal Stenosis
NCT00000412	Osteoporosis Prevention After Heart Transplant
NCT00000413	Osteoporosis Prevention in Preadolescent Girls
NCT00000414	Patient Education in Rheumatoid Arthritis and Osteoarthritis
NCT00000415	Physical Activity, Calcium, and Bone in Children
NCT00000416	Prevention of Arthritis-Related Work Disability
NCT00000417	Psychoeducational Approach to Improve Health in Lupus
NCT00000418	Psychosocial Treatment for Acute Low Back Pain
NCT00000419	Safety of Estrogens in Lupus: Hormone Replacement Therapy
NCT00000420	Safety of Estrogens in Lupus: Birth Control Pills
NCT00000421	Serologically Active, Clinically Stable Systemic Lupus Erythematosus
NCT00000422	Tailored Treatments of Fibromyalgia
NCT00000423	Support, Health, and Fibromyalgia
NCT00000424	Tidal Lavage in Knee Osteoarthritis
NCT00000425	Toward Better Outcomes in Osteoarthritis
NCT00000426	Treatment of Calcium Deficiency in Young Women
NCT00000427	Effects of Parathyroid Hormone in Men With Osteoporosis
NCT00000428	Combining N-of-1 Trials to Assess Fibromyalgia Treatments
NCT00000429	Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis
NCT00000430	Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis
NCT00000431	Preliminary Testing of New Treatment for Chronic Leg Wounds
NCT00000432	Lyme Disease Prevention Program
NCT00000433	Blocking Tumor Necrosis Factor in Ankylosing Spondylitis
NCT00000434	Impact of Exercise on Older Persons With Osteoarthritis
NCT00000435	dnaJ Peptide for Relieving Rheumatoid Arthritis
NCT00000436	Improving Functional Recovery After Hip Fracture
NCT00000437	Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)
NCT00000438	Naltrexone Treatment for Alcoholism
NCT00000439	Drug Treatment for Alcoholics With Bipolar Disorder
NCT00000440	Sertraline and Naltrexone for Alcohol Dependence
NCT00000441	Drug Therapy for Alcohol Detoxification
NCT00000442	Naltrexone for Relapse Prevention
NCT00000443	Ondansetron Treatment for Alcoholism
NCT00000444	Timing of Smoking Intervention in Alcohol Treatment (Nicotine Patch)
NCT00000445	Use of Naltrexone in a Clinical Setting
NCT00000446	Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder
NCT00000447	Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (Naltrexone/Nicotine Patch)
NCT00000448	Naltrexone Treatment for Alcoholic Women
NCT00000449	Behavior and Naltrexone Treatment for Alcoholics
NCT00000450	Naltrexone Maintenance Treatment of Alcoholism
NCT00000451	Drug Therapy for Alcohol Dependence in Alaska Natives (Naltrexone/Sertraline)
NCT00000452	Naltrexone Treatment of Alcohol Dependence
NCT00000454	Smoking Cessation in Alcoholism Treatment
NCT00000455	Naltrexone for Early Problem Drinkers
NCT00000456	Behavioral Therapy Plus Naltrexone for Alcoholism
NCT00000457	Pharmacologic Relapse Prevention for Alcoholic Smokers
NCT00000458	Sertraline and Cognitive Therapy in Depressed Alcoholics
NCT00000459	Dietary Intervention Study in Children (DISC)
NCT00000460	Training Levels Comparison Trial
NCT00000461	Harvard Atherosclerosis Reversibility Project (HARP)
NCT00000462	Bypass Angioplasty Revascularization Investigation (BARI)
NCT00000463	Post Coronary Artery Bypass Graft (CABG) Study
NCT00000464	Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
NCT00000465	Emory Angioplasty Versus Surgery Trial (EAST)
NCT00000466	Postmenopausal Estrogen/Progestin Interventions (PEPI)
NCT00000467	Child and Adolescent Trial for Cardiovascular Health (CATCH)
NCT00000468	Myocardial Infarction Triage and Intervention Project (MITI)
NCT00000469	Asymptomatic Carotid Artery Plaque Study (ACAPS)
NCT00000470	Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest
NCT00000471	Lifestyle Heart Trial
NCT00000472	Thrombolysis in Myocardial Ischemia Trial (TIMI III)
NCT00000473	Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?
NCT00000474	Prevention and Treatment of Hypertension Study (PATHS)
NCT00000475	Prevention of Early Readmission in Elderly Congestive Heart Failure Patients
NCT00000476	Digitalis Investigation Group (DIG)
NCT00000477	Cholesterol Reduction in Seniors Program (CRISP)
NCT00000478	Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
NCT00000479	Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
NCT00000480	Multicenter Unsustained Tachycardia Trial (MUSTT)
NCT00000481	Women's Health Trial: Feasibility Study in Minority Populations
NCT00000482	Coronary Drug Project
NCT00000483	Coronary Drug Project Mortality Surveillance
NCT00000484	Treatment of Hypertension
NCT00000485	Hypertension Detection and Follow-up Program (HDFP)
NCT00000486	Unstable Angina Pectoris Trial
NCT00000487	Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease (MRFIT)
NCT00000488	Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)
NCT00000489	Coronary Artery Surgery Study (CASS)
NCT00000490	Program on Surgical Control of Hyperlipidemias (POSCH)
NCT00000491	Aspirin-Myocardial Infarction Study (AMIS)
NCT00000492	Beta-Blocker Heart Attack Trial (BHAT)
NCT00000493	Multicenter Investigation of Limitation of Infarct Size (MILIS)
NCT00000494	Management of Patent Ductus in Premature Infants
NCT00000495	Prevention of Hypertension: A Randomized Trial
NCT00000496	Platelet Drug Trial in Coronary Disease Progression
NCT00000497	Dietary Intervention Study for Hypertension (DISH)
NCT00000498	Control of Hypertension by Non-Pharmacologic Means
NCT00000499	Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)
NCT00000500	Physicians' Health Study
NCT00000501	Hypertension Prevention Trial (HPT) Feasibility Study
NCT00000502	Evaluation of SC-V Versus Conventional CPR
NCT00000503	Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary Arteries
NCT00000504	Cardiac Arrhythmia Pilot Study (CAPS)
NCT00000505	Thrombolysis in Myocardial Infarction (TIMI)
NCT00000506	Cardiovascular System in Obesity: Effect of Treatment
NCT00000507	Intravenous Streptokinase in Acute Myocardial Infarction
NCT00000508	Stanford Coronary Risk Intervention Project (SCRIP)
NCT00000509	Potassium and Sodium to Control Blood Pressure in Hypertensives
NCT00000510	Platelet-Inhibitor Drug Trial in Coronary Angioplasty
NCT00000511	Polyunsaturates and KCL to Control Mild Hypertension
NCT00000512	Familial Atherosclerosis Treatment Study
NCT00000513	Trial of Antihypertensive Intervention Management
NCT00000514	Systolic Hypertension in the Elderly Program (SHEP)
NCT00000515	Randomized Trial of Dietary Intervention Therapy in Obese Hypertensives (DITOH)
NCT00000516	Studies of Left Ventricular Dysfunction (SOLVD)
NCT00000517	Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)
NCT00000518	Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)
NCT00000519	Exercise Training and Plasma Lipoproteins in Man
NCT00000520	Prevention of Coronary Aneurysms in Kawasaki Syndrome
NCT00000521	Sodium-Potassium Blood Pressure Trial in Children
NCT00000522	Treatment of Mild Hypertension Study (TOMHS)
NCT00000523	Optimal Exercise Regimens for Persons at Increased Risk
NCT00000524	Myocarditis Treatment Trial
NCT00000525	Diuretics, Hypertension, and Arrhythmias Clinical Trial
NCT00000526	Cardiac Arrhythmia Suppression Trial (CAST)
NCT00000527	Recurrent Carotid Stenosis
NCT00000528	Trials of Hypertension Prevention (TOHP)
NCT00000529	Tamoxifen Study
NCT00000530	Raynaud's Treatment Study (RTS)
NCT00000531	Antiarrhythmics Versus Implantable Defibrillators (AVID)
NCT00000532	Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause
NCT00000533	Montreal Heart Attack Readjustment Trial (M-HART)
NCT00000534	Calcium for Pre-Eclampsia Prevention (CPEP)
NCT00000535	Trial of Nonpharmacologic Interventions in Elderly (TONE)
NCT00000536	Sodium Sensitivity in African Americans
NCT00000537	Stress Reduction & CVD Morbidity and Mortality in Blacks
NCT00000538	Dietary Effects on Lipoproteins and Thrombogenic Activity (DELTA)
NCT00000539	Arterial Disease Multifactorial Intervention Trial (ADMIT)
NCT00000540	Coronary Artery Bypass Graft (CABG) Patch Trial
NCT00000541	Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)
NCT00000542	Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
NCT00000543	Oral Calcium in Pregnant Women With Hypertension
NCT00000544	Dietary Approaches to Stop Hypertension (DASH)
NCT00000545	PATHWAYS--FULL SCALE STUDY
NCT00000546	Stress Reduction and Atherosclerotic CVD in Blacks
NCT00000547	Enalapril After Anthracycline Cardiotoxicity
NCT00000548	Inhaled NO in Prevention of Chronic Lung Disease
NCT00000549	Estrogen Replacement and Atherosclerosis (ERA) in Older Women
NCT00000550	Rapid Early Action for Coronary Treatment (REACT)
NCT00000551	Activity Counseling Trial (ACT)
NCT00000552	Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
NCT00000553	HDL-Atherosclerosis Treatment Study (HATS)
NCT00000554	Women's Ischemia Syndrome Evaluation (WISE)
NCT00000555	Women's Angiographic Vitamin and Estrogen Trial (WAVE)
NCT00000556	Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
NCT00000557	Enhancing Recovery in Coronary Heart Disease (ENRICHD) Patients
NCT00000558	Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)
NCT00000559	Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
NCT00000560	Beta-Blocker Evaluation in Survival Trial (BEST)
NCT00000561	Mode Selection Trial in Sinus Node Dysfunction (MOST)
NCT00000562	Extracorporeal Support for Respiratory Insufficiency (ECMO)
NCT00000563	Prevention of Neonatal Respiratory Distress Syndrome With Antenatal Steroid Administration
NCT00000564	Nocturnal Oxygen Therapy
NCT00000565	Clinical Study of Intermittent Positive Pressure Breathing (IPPB)
NCT00000566	Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)
NCT00000567	High Frequency Ventilation in Premature Infants (HIFI)
NCT00000568	Lung Health Study (LHS) I and III
NCT00000569	Lung Health Study II
NCT00000570	Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial
NCT00000571	Trial of Inspiratory Muscle Rest and Exercise in Chronic Obstructive Lung Disease
NCT00000572	Extracorporeal Carbon Dioxide Removal for Acute Respiratory Distress Syndrome
NCT00000573	Emphysema: Physiologic Effects of Nutritional Support
NCT00000574	Ibuprofen in Sepsis Study
NCT00000575	Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)
NCT00000576	Inhaled Beclomethasone to Prevent Chronic Lung Disease
NCT00000577	Asthma Clinical Research Network (ACRN)
NCT00000578	NHLBI/NICHD Collaborative Studies of Asthma in Pregnancy
NCT00000579	Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
NCT00000580	Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin
NCT00000581	Granulocyte Transfusion Study
NCT00000582	Cooperative Study of Factor VIII Inhibitors
NCT00000583	Hepatitis B Vaccine Clinical Trial
NCT00000584	Transfusion-Transmitted Cytomegalovirus Prevention in Neonates
NCT00000585	Penicillin Prophylaxis in Sickle Cell Disease (PROPS)
NCT00000586	Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)
NCT00000587	Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection
NCT00000588	Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone
NCT00000589	Trial to Reduce Alloimmunization to Platelets (TRAP)
NCT00000590	Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185)
NCT00000591	T-Cell Depletion in Unrelated Donor Marrow Transplantation
NCT00000592	Stroke Prevention in Sickle Cell Anemia (STOP 1)
NCT00000593	Viral Activation Transfusion Study (VATS)
NCT00000594	NHLBI Type II Coronary Intervention Study
NCT00000595	Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis
NCT00000596	Diffuse Fibrotic Lung Disease
NCT00000597	Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders
NCT00000598	Diet and Exercise for Elevated Risk (DEER)
NCT00000599	Cholesterol-Lowering Atherosclerosis Study (CLAS)
NCT00000600	Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up
NCT00000601	Postmenopausal Hormone Therapy in Unstable Angina
NCT00000602	Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)
NCT00000603	Cord Blood Stem Cell Transplantation Study (COBLT)
NCT00000604	Influence of CPB Temperature on CABG Morbidity
NCT00000605	Estrogen and Graft Atherosclerosis Research Trial (EAGER)
NCT00000606	National Emphysema Treatment Trial (NETT)
NCT00000607	Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH)
NCT00000608	Dietary Patterns, Sodium Intake and Blood Pressure (DASH - Sodium)
NCT00000609	Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
NCT00000610	Magnesium in Coronaries (MAGIC)
NCT00000611	Women's Health Initiative (WHI)
NCT00000612	Soy Estrogen Alternative Study (SEA)
NCT00000613	CVD Risk and Health in Postmenopausal Phytoestrogen Users
NCT00000614	Prevention of Recurrent Venous Thromboembolism (PREVENT)
NCT00000615	Girls Health Enrichment Multi-Site Studies (GEMS)
NCT00000616	PREMIER: Lifestyle Interventions for Blood Pressure Control
NCT00000617	Azithromycin and Coronary Events Study (ACES)
NCT00000619	Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE)
NCT00000620	Action to Control Cardiovascular Risk in Diabetes (ACCORD)
NCT00000621	Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)
NCT00000623	Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)
NCT00000625	A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3
NCT00000626	Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease
NCT00000627	Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome
NCT00000628	A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine
NCT00000629	The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients.
NCT00000630	Phase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (gp160; VaxSyn)
NCT00000631	A Phase I Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (VaxSyn)
NCT00000632	A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59
NCT00000633	A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals
NCT00000634	A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children
NCT00000635	Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine
NCT00000636	Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
NCT00000637	A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children
NCT00000638	Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
NCT00000639	A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis
NCT00000640	A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS
NCT00000641	A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.
NCT00000642	A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns
NCT00000643	Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients
NCT00000644	A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS
NCT00000645	A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 Lymphocytes
NCT00000646	Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS
NCT00000647	An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection
NCT00000648	A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals
NCT00000649	An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)
NCT00000650	An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in HIV-Infected Patients
NCT00000651	A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy
NCT00000652	A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection
NCT00000653	A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT
NCT00000654	The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU
NCT00000655	A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients
NCT00000656	A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease
NCT00000657	Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex
NCT00000658	A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma
NCT00000659	A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC)
NCT00000660	Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma
NCT00000661	The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient
NCT00000662	A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease
NCT00000663	A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection
NCT00000664	Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals
NCT00000665	Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component
NCT00000666	A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection
NCT00000667	A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells
NCT00000668	A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir
NCT00000669	A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection
NCT00000670	Safety and Tolerance of Zidovudine With Probenecid and the Effect of Probenecid on Zidovudine Pharmacokinetics Over Four Weeks
NCT00000671	A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment
NCT00000672	An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex
NCT00000673	A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy
NCT00000674	A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS
NCT00000675	A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex
NCT00000676	Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)
NCT00000677	SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy
NCT00000678	Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.
NCT00000679	(Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC
NCT00000680	A Phase I Study of Autologous, Activated CD8(+) Lymphocytes Expanded In Vitro and Infused With or Without Recombinant Interleukin-2 to Patients With AIDS or Severe ARC
NCT00000681	A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma
NCT00000682	A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002
NCT00000683	A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus
NCT00000684	Continuous High-Dose Intravenous Dextran Sulfate in Human Immunodeficiency Virus-Infected Individuals
NCT00000685	A Study of Zidovudine in HIV-Infected Patients With Kidney Problems
NCT00000686	A Study of d4T in Patients With AIDS or AIDS-Related Complex Who Cannot Take AZT
NCT00000687	Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma
NCT00000688	A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS
NCT00000689	Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma
NCT00000690	Single Dose Pharmacokinetics of Oral Dextran Sulfate (UA001) and Intravenous Dextran Sulfate in Healthy Volunteers
NCT00000691	A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure
NCT00000692	Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex
NCT00000693	Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS
NCT00000694	A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma
NCT00000695	Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma
NCT00000696	A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease
NCT00000697	A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir
NCT00000698	A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis
NCT00000699	A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients
NCT00000700	A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP
NCT00000701	A Phase I Evaluation of Azidothymidine (AZT) in Children With Acquired Immune Deficiency Syndrome (AIDS) or AIDS Related Complex (ARC)
NCT00000702	A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection
NCT00000703	Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members
NCT00000704	A Multicenter Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC.
NCT00000705	Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia
NCT00000706	Influence of Probenecid and Quinine on the Pharmacokinetics of Azidothymidine
NCT00000707	Aerosols in the Treatment of Asymptomatic Pneumocystis Pneumonia: A Pilot Study Assessing the Effectiveness of Aerosolized Pentamidine as Treatment of Subclinical Pneumocystis Infection in Patients With No Clinical Symptoms
NCT00000708	Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
NCT00000709	An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts
NCT00000710	A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related Complex
NCT00000711	Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC
NCT00000712	A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3
NCT00000713	A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects
NCT00000714	An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved Therapies
NCT00000715	A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia in AIDS
NCT00000716	A Multicenter Trial To Evaluate Oral Retrovir in the Treatment of Children With Symptomatic HIV Infection
NCT00000717	The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii Pneumonia in Patients With AIDS
NCT00000718	A Clinical Trial of Alternating and Intermittent Regimens of 2',3'-Dideoxycytidine and 3'-Azido-3'-Deoxythymidine in the Treatment of Patients With AIDS and Advanced ARC
NCT00000719	A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease
NCT00000720	A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine
NCT00000721	An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive
NCT00000722	Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine Therapy
NCT00000723	The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer
NCT00000724	A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia
NCT00000725	A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma
NCT00000726	Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome
NCT00000727	A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)
NCT00000728	Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy
NCT00000729	A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease
NCT00000730	Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients
NCT00000731	Evaluation of the Interaction Between Acetaminophen and Zidovudine
NCT00000732	Evaluation of the Interaction Between Low Dose Sulfamethoxazole-Trimethoprim and Zidovudine
NCT00000733	Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients
NCT00000734	Evaluation of the Interaction Between High Dose Sulfamethoxazole/Trimethoprim and Zidovudine
NCT00000735	A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC
NCT00000736	Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals
NCT00000737	A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome
NCT00000738	Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1
NCT00000739	Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection
NCT00000740	Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected Subjects
NCT00000741	The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDS
NCT00000742	A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)
NCT00000743	A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons
NCT00000744	A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women
NCT00000745	A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160
NCT00000746	A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines
NCT00000747	An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3
NCT00000748	A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients
NCT00000749	A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 Mcg of gp120 (CHO) BIOCINE in MF59 Emulsion Versus the Emulsion Control: Three Injections at 0, 1, and 6 Months
NCT00000750	A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection
NCT00000751	A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
NCT00000752	Preventing Frequent Sinus Infections in HIV-Infected Patients
NCT00000753	A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC
NCT00000754	A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3
NCT00000755	A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3
NCT00000756	Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3
NCT00000757	A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160
NCT00000758	A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women
NCT00000759	Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and AIDS in Clinical Trials
NCT00000760	A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection
NCT00000761	Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children
NCT00000762	A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection
NCT00000763	A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma
NCT00000764	Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.
NCT00000765	Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo)
NCT00000766	CMV Retinitis Retreatment Trial
NCT00000767	A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)
NCT00000768	A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients
NCT00000769	A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma
NCT00000770	A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine
NCT00000771	A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3
NCT00000772	A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals
NCT00000773	Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children
NCT00000774	A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers
NCT00000775	A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide Vaccine)
NCT00000776	Dexamethasone in Cryptococcal Meningitis
NCT00000777	Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)
NCT00000778	A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin
NCT00000779	A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3
NCT00000780	"""A Pre-Enrollment Protocol for HIV-Infected Adolescents"""
NCT00000781	A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)
NCT00000782	A Phase I/II Study of Delayed-Type Hypersensitivity (DTH) Reactions to Intradermal HIV Envelope Antigen
NCT00000783	Heterosexual HIV Transmission Study (HATS)
NCT00000784	A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols
NCT00000785	A Registry of Tuberculosis Cases in the CPCRA
NCT00000787	Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study
NCT00000788	A Study to Assess the Effect of Concomitant Administration of Fluconazole on the Clinical Pharmacokinetics of Methadone
NCT00000789	A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection
NCT00000790	Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection
NCT00000791	A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV
NCT00000792	A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects
NCT00000793	A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection
NCT00000794	Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis
NCT00000795	A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects
NCT00000796	A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.
NCT00000797	Women's Interagency HIV Study (WIHS)
NCT00000798	A Phase I Safety and Immunogenicity Trial of UBI Microparticulate Monovalent HIV-1 MN Peptide Immunogen in HIV-1 Seronegative Human Subjects
NCT00000799	HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol
NCT00000800	Methadone Effects on Zidovudine (ZDV, AZT) Disposition
NCT00000801	Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma
NCT00000802	A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides
NCT00000803	A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy
NCT00000804	A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)
NCT00000805	A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease
NCT00000806	A Phase I Randomized Dose/Formulation Comparison Study of SC-52151
NCT00000807	Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy
NCT00000808	A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers
NCT00000809	Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women
NCT00000810	Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)
NCT00000811	A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
NCT00000812	A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection
NCT00000813	A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox-gp160 MN (ALVAC vCP125, HIV-1 gp160 MN) in HIV-1 Uninfected Adult Volunteers
NCT00000814	A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease
NCT00000815	A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group
NCT00000816	Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis
NCT00000817	The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients
NCT00000818	Evaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue Following Zidovudine ( AZT ) Treatment in HIV-1-Infected Patients With CD4+ Cells Between 100 and 500 Cells/mm3.
NCT00000819	A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy of Prednisone Therapy in HIV-Associated Nephropathy (HIVAN)
NCT00000820	A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy
NCT00000821	Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected Patients
NCT00000822	A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells
NCT00000823	A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection
NCT00000824	A Study of Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients
NCT00000825	The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
NCT00000826	Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites
NCT00000827	A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children
NCT00000828	Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine
NCT00000829	A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants
NCT00000830	Intracellular Pharmacokinetics of Zidovudine Triphosphate in Maternal and Infant Cord Blood Mononuclear Cells.
NCT00000831	Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy
NCT00000832	A Randomized, Placebo-Controlled, Double-Blinded Phase I Safety and Immunogenicity Trial of Recombinant Envelope Protein, HIV-1 SF-2 rgp120 (BIOCINE), Combined With MF59 in HIV-1 Uninfected Adult Volunteers
NCT00000833	A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.
NCT00000834	A Phase I Study of Methotrexate for HIV Infection
NCT00000835	A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Pseudovirion Vaccine
NCT00000836	A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT)
NCT00000837	A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children
NCT00000838	Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine
NCT00000839	A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women
NCT00000840	A Multicenter, Exploratory Study to Evaluate the Effects of Antiretroviral Cessation on Plasma Associated HIV-1 RNA
NCT00000841	A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months
NCT00000842	A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy
NCT00000843	The Safety and Effectiveness of Adefovir Dipivoxil in HIV-Infected Children
NCT00000844	A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3
NCT00000845	A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b in HIV-1 Seronegative Human Subjects
NCT00000846	A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.
NCT00000847	A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers
NCT00000848	The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year
NCT00000849	A Study to Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected Children
NCT00000850	The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy
NCT00000851	Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children
NCT00000852	A Pilot Study of Allogeneic Lymphocyte Transfer in HIV Infection
NCT00000853	A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of Low Dose MN rsgp120/HIV-1 (Genentech) in Combination With QS21 Adjuvant or Alum in Healthy Adults
NCT00000854	A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss
NCT00000855	A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women.
NCT00000856	A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.
NCT00000857	A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3
NCT00000858	Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation With Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other Infections
NCT00000859	A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3
NCT00000860	The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients
NCT00000861	The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients
NCT00000862	A Study of Zidovudine During Labor and Delivery in HIV-Infected Pregnant Women
NCT00000863	A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients
NCT00000864	A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women
NCT00000865	The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children
NCT00000866	A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.
NCT00000867	A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)
NCT00000868	A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers
NCT00000869	A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies
NCT00000870	A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone
NCT00000871	A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult Volunteers
NCT00000872	Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection
NCT00000873	A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants
NCT00000874	A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GART
NCT00000875	Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection
NCT00000876	Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children
NCT00000877	Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults
NCT00000878	A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants
NCT00000879	A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers
NCT00000880	A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease
NCT00000881	A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease
NCT00000882	Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects
NCT00000883	Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy
NCT00000884	A Randomized Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult Volunteers
NCT00000885	Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320
NCT00000886	A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)
NCT00000887	A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants
NCT00000888	Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies
NCT00000889	A Study to Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
NCT00000890	A Study to Evaluate the Effect of Anti-HIV Therapy on Lean Tissue (Muscle) in HIV-Positive Patients
NCT00000891	Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315
NCT00000892	A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir
NCT00000893	Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children
NCT00000894	Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis
NCT00000895	A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection
NCT00000896	A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients
NCT00000897	A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women
NCT00000898	The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir
NCT00000899	A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients
NCT00000900	The Effects of Illnesses on HIV Levels in the Body
NCT00000901	Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children
NCT00000902	A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment
NCT00000903	Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen
NCT00000904	Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults
NCT00000905	A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV Therapy
NCT00000906	Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected Patients
NCT00000907	A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients
NCT00000908	A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts
NCT00000909	A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy
NCT00000910	A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies
NCT00000911	A Study to Monitor Patients With Primary or Early HIV Infection
NCT00000912	A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients
NCT00000913	A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children
NCT00000914	A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks
NCT00000915	An HIV Vaccine Preparedness Study
NCT00000916	A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood
NCT00000917	Setting up a Blood Bank for Gene Therapy in HIV-Infected Infants
NCT00000918	A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure
NCT00000919	A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection
NCT00000920	Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns
NCT00000921	The Effects of Prednisone on HIV Levels and the Immune System
NCT00000922	A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)
NCT00000923	Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328
NCT00000924	A Study to Compare Two Different Anti-HIV Drug Regimens
NCT00000925	A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss
NCT00000926	A Study of Nonoxynol-9 (N-9) and HIV Infection
NCT00000927	A Study of BufferGel in Women
NCT00000928	Phase I Trial of an Intervention to Increase Condom Use by HIV-Discordant Couples
NCT00000929	A Study of the Effects of Advantage 24 on the Rectum
NCT00000930	A Study of HIV in Newly Infected Individuals
NCT00000931	HIV Prevention Counseling for Men Who Have Sex With Men
NCT00000932	A Study of the Long-Term Outcomes of HIV-Positive Patients
NCT00000933	Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048
NCT00000935	An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens
NCT00000936	A Study To Test An Anti-Rejection Therapy After Kidney Transplantation
NCT00000937	Study and Treatment of Post Lyme Disease (STOP-LD)
NCT00000938	A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease
NCT00000939	A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible
NCT00000940	Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
NCT00000941	A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood
NCT00000942	A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies
NCT00000943	A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328
NCT00000944	A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants
NCT00000945	A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS Patients
NCT00000946	A Study to Test the Safety of Three Experimental HIV Vaccines
NCT00000947	A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients
NCT00000948	Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
NCT00000949	A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3
NCT00000950	Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis
NCT00000951	A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush
NCT00000952	A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children
NCT00000953	Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients
NCT00000954	A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma
NCT00000955	Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection
NCT00000956	A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160
NCT00000957	A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules
NCT00000958	A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)
NCT00000959	Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection
NCT00000960	The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants
NCT00000961	The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants
NCT00000962	The Safety and Effectiveness of BI-RG-587 in HIV-Infected Patients
NCT00000963	A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine
NCT00000964	The Effect of Stomach Acid on Foscarnet
NCT00000965	The Effects of Zidovudine on the Blood of HIV-Infected Patients
NCT00000966	A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS
NCT00000967	The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected Children
NCT00000968	A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived HIV-1 Recombinant Envelope Glycoprotein (gp160)
NCT00000969	A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) Therapy
NCT00000970	A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir
NCT00000971	The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS
NCT00000972	A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59
NCT00000973	A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients
NCT00000974	A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii Pneumonia
NCT00000975	A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDS
NCT00000976	A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex
NCT00000977	Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity
NCT00000978	A Study of Dideoxycytidine Plus Zidovudine in the Treatment of AIDS or Advanced AIDS Related Complex (ARC)
NCT00000979	Comparison of ddI Versus Zidovudine in HIV-Infected Patients
NCT00000980	A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea
NCT00000981	The Safety and Effectiveness of FIAC in the Treatment of Cytomegalovirus (CMV) in Patients With AIDS
NCT00000982	A Study of Azidothymidine in HIV-Infected Children
NCT00000983	The Safety of Different Dose Levels of Zidovudine in HIV-Infected Children
NCT00000984	A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection
NCT00000985	Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With Acyclovir
NCT00000986	The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex
NCT00000987	A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
NCT00000988	A Study of BMY-27857 in Patients With AIDS or AIDS Related Complex
NCT00000989	The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS
NCT00000990	The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate Symptoms
NCT00000991	A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients
NCT00000992	A Study of Itraconazole in Preventing the Return of Histoplasmosis, a Fungal Infection, in Patients With AIDS
NCT00000993	A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus
NCT00000994	A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma
NCT00000995	A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection
NCT00000996	A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma
NCT00000997	A Study of Dideoxycytidine in HIV-Infected Patients
NCT00000998	A Study of Trimetrexate in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Not Previously Treated for PCP
NCT00000999	The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC
NCT00001000	A Study of Atvogen in Healthy Volunteers and HIV-Infected Patients Who Have No Symptoms of Infection
NCT00001001	A Study of Zidovudine in HIV-Infected Patients With Liver Disease
NCT00001002	A Study of Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long Time
NCT00001003	A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia
NCT00001004	A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex
NCT00001005	A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes
NCT00001006	A Study of AS-101 in Patients With AIDS or AIDS Related Complex (ARC)
NCT00001007	A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After Birth
NCT00001008	A Study of Azidothymidine Plus Methadone in Patients With AIDS and AIDS Related Complex (ARC)
NCT00001009	A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC)
NCT00001010	A Study of Zidovudine Plus Acyclovir in HIV-Infected Patients
NCT00001011	The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related Complex
NCT00001012	A Study of AL721 in HIV-Infected Patients With Swollen Lymph Nodes
NCT00001013	Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS
NCT00001014	Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS
NCT00001015	A Study of Ribavirin in the Treatment of Patients With AIDS and AIDS-Related Problems
NCT00001016	A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies
NCT00001017	Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS
NCT00001018	A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea
NCT00001019	Safety of and Immune Response to an HIV Vaccine (SF-2 gp120) With or Without MTP-PE/MF59 Adjuvant
NCT00001020	A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)
NCT00001021	A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)
NCT00001022	A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients
NCT00001023	The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients
NCT00001024	The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDS
NCT00001025	Evaluation of Patients Who Have Not Had Success With Zidovudine
NCT00001026	A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals
NCT00001027	A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Children Who Cannot Take Trimethoprim-Sulfamethoxazole
NCT00001028	A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides
NCT00001029	A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past
NCT00001030	The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients
NCT00001031	A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults
NCT00001032	A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT
NCT00001033	The Treatment of Tuberculosis in HIV-Infected Patients
NCT00001034	The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV
NCT00001035	The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections
NCT00001036	The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection
NCT00001037	A Phase I, Multicenter, Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules
NCT00001038	A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients
NCT00001039	Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients
NCT00001040	Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddC
NCT00001041	Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
NCT00001042	A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals
NCT00001043	A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules
NCT00001044	A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.
NCT00001045	Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease
NCT00001046	Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
NCT00001047	Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS
NCT00001048	Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients
NCT00001049	A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIV
NCT00001050	Study of Women Who Have AIDS
NCT00001052	A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults
NCT00001053	A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects
NCT00001054	The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children
NCT00001055	A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult Volunteers
NCT00001056	A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose
NCT00001057	The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients
NCT00001058	A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS
NCT00001059	Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
NCT00001060	A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons
NCT00001061	Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS
NCT00001062	A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes
NCT00001063	The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks
NCT00001064	A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3
NCT00001065	A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole
NCT00001066	A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children
NCT00001067	The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs
NCT00001068	A Study of Disease Progression and Anti-HIV Treatments
NCT00001069	A Study of Two Methods of Determining When to Begin or Change Anti-HIV Treatment
NCT00001070	The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients
NCT00001071	A Study of Stem Cells and Filgrastim
NCT00001072	A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300 and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers
NCT00001073	Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors
NCT00001074	The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients
NCT00001075	The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients
NCT00001076	A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Volunteers to Evaluate Accelerated Vaccine Schedules
NCT00001077	A Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients With AIDS Who Take Daily Multivitamin and Mineral Supplements
NCT00001078	A Study on the Rate of Opportunistic (AIDS-Related) Infections Among HIV-Positive Children Who Have Stopped Taking Their OI Preventive Medications
NCT00001079	A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss
NCT00001080	Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals
NCT00001081	A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium
NCT00001082	The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients
NCT00001083	Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs
NCT00001084	A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients
NCT00001085	A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients
NCT00001086	A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients
NCT00001087	The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs
NCT00001088	A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult Volunteers
NCT00001089	A Study of HIV and Cytomegalovirus (CMV) in HIV-Infected Patients
NCT00001090	A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected Volunteers
NCT00001091	Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens
NCT00001092	The Biology of HIV Transmission
NCT00001093	Outcomes of Anti-HIV Therapy During Early HIV Infection
NCT00001094	A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients
NCT00001095	A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir
NCT00001096	A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults
NCT00001097	Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune Systems
NCT00001100	A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.
NCT00001101	A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease
NCT00001102	The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive Patients
NCT00001103	HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs
NCT00001104	A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia
NCT00001105	The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV
NCT00001106	A Study of Zidovudine in HIV-Infected Pregnant Women and Their Children
NCT00001107	Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver Transplants
NCT00001108	A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses
NCT00001109	A Blood Test to Look at Cells of the Immune System in Healthy Children
NCT00001110	Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients
NCT00001111	A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected Children
NCT00001112	The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken Zidovudine
NCT00001113	A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma
NCT00001114	The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma
NCT00001115	The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood
NCT00001116	A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected Patients
NCT00001117	A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection
NCT00001118	Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children
NCT00001119	Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV
NCT00001120	A Study of Patients With AIDS Syndrome
NCT00001121	A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1
NCT00001122	A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly
NCT00001123	A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome
NCT00001125	Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox
NCT00001126	Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat)
NCT00001127	Study of a Flu Vaccine in Children
NCT00001128	Treatment of Chronic Cryptosporidiosis in AIDS Patients
NCT00001129	A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly
NCT00001130	Identifying Emergency Room Patients Who Have Recently Been Infected With HIV
NCT00001131	Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients
NCT00001132	Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination
NCT00001133	Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir
NCT00001135	A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants
NCT00001136	A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine
NCT00001137	Long-Term Data Collection From Participants in Adult AIDS Clinical Trials
NCT00001142	Metabolism and Body Shape of Healthy Children and Children With Chronic Infections
NCT00001143	Development of the Eye Motor System During the First 7 Months of Life in Infants With and Without a Family History of Cross-Eye
NCT00001144	Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia
NCT00001145	Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM Syndrome
NCT00001146	Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial
NCT00001147	Blood Sampling for Neurochemical and Genetic Testing
NCT00001148	Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor
NCT00001149	Monitoring Patients With Uncontrolled Epilepsy
NCT00001150	Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers
NCT00001151	Studies With 1,25-Dihydroxycholecalciferol
NCT00001152	Pigment Dispersion Syndrome With and Without Glaucoma
NCT00001153	Visual Function and Ocular Pigmentation in Albinism
NCT00001154	Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
NCT00001155	Treatment of Wegener's Granulomatosis With Cyclophosphamide
NCT00001156	Assessment of Patients With Multiple Sclerosis (MS)
NCT00001158	Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
NCT00001159	Evaluation of Patients With Thyroid Disorders
NCT00001160	Studies on Tumors of the Thyroid
NCT00001161	Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens
NCT00001162	Parasitic Infections of the Gastrointestinal Tract
NCT00001163	Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
NCT00001164	Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
NCT00001165	Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas
NCT00001166	Gyrate Atrophy of the Choroid and Retina
NCT00001167	Ultrasound Evaluation of Tongue Movements in Speech and Swallowing
NCT00001168	Evaluation of Lipoproteins
NCT00001169	Clinical Investigation of Infections Due to Leishmanial Parasites
NCT00001170	Study of the Psychological Development of Children of Parents With and Without Affective Disorders
NCT00001171	Evaluation of Factors in Human Brain Tumors
NCT00001172	Visual Stimulus and Eye Movement
NCT00001173	Studies of In Vitro B Lymphocyte Responses in Subjects Receiving Tetanus Toxoid Booster Immunization
NCT00001174	Evaluation of the Genetics of Bipolar Disorder
NCT00001176	Effects of Salt Intake on the Nervous Systems of Patients With Salt-Sensitive High Blood Pressure
NCT00001177	Study of Premenstrual Syndrome and Premenstrual Dysphoria
NCT00001178	Brain Study of Patients With Frontal Lobe Dementia and Parkinsonian Disorders
NCT00001180	Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients With Adrenal Insufficiency
NCT00001181	Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty
NCT00001182	Evaluation of Patients With Unusual Diagnostic or Treatment Considerations
NCT00001183	Evaluation of the Causes and Disease Processes of Chronic Lung Disease
NCT00001184	Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001185	"""Study of Post-Polio Syndrome"""
NCT00001186	Psychological Benefits of a Normalized Camping Experience for Children With Cancer
NCT00001188	The Role of Multi-Modality Therapy for the Treatment of High-Grade Soft Tissue Sarcomas of the Extremities
NCT00001189	The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors
NCT00001190	Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature
NCT00001191	The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid
NCT00001192	Neuropsychological Evaluation of Psychiatric and Neurological Patients
NCT00001193	A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer
NCT00001194	NMR Scanning on Patients
NCT00001195	Endocrine Studies of Healthy Children
NCT00001196	Evaluation of Salivary Gland Dysfunction
NCT00001197	Hydroxyurea for the Treatment of Patients With Sickle Cell Anemia
NCT00001198	Evaluating Genetic Risk Factors for Childhood-Onset Schizophrenia
NCT00001201	Evaluation of Neuromuscular Disease
NCT00001202	Treatment of Boys With Precocious Puberty
NCT00001203	Deferoxamine for the Treatment of Hemochromatosis
NCT00001204	Cardiovascular Evaluation of Patients With High Cholesterol and Normal Volunteers
NCT00001205	Treatment of Patients With Cysticercosis With Praziquantel or Albendazole
NCT00001206	Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD)
NCT00001208	Botulinum Toxin for the Treatment of Involuntary Movement Disorders
NCT00001209	A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors
NCT00001210	Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines
NCT00001211	Clinical Study of Oral Endosseous Titanium Implants in Edentulous Subjects
NCT00001212	Drug Therapy in Lupus Nephropathy
NCT00001213	Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis
NCT00001214	Collection of Blood From Patients With Pancytopenia
NCT00001215	Genetic Studies of Lysosomal Storage Disorders
NCT00001216	Non-Invasive Electrical Stimulation of the Human Brain
NCT00001217	Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study
NCT00001218	Development of Normative Ultrasound Databases of Tongue Surface Configuration
NCT00001219	Comparing Magnetic Resonance Imaging/Spectroscopy Techniques
NCT00001220	Ultrasound and Videofluoroscopy for Diagnosing Swallowing Disorders
NCT00001221	Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients With Turner Syndrome
NCT00001223	Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders
NCT00001224	Analysis of Eye Tissue
NCT00001225	Family Studies of Inherited Heart Disease
NCT00001226	Lipoprotein Metabolism in Normal Volunteers and Patients With Abnormal Levels of Lipoproteins
NCT00001228	Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer
NCT00001229	Diagnosis and Treatment of Pheochromocytoma
NCT00001230	Host Response to Infection and Treatment in Filarial Diseases
NCT00001231	Perimenopause-Related Mood and Behavioral Disorders
NCT00001232	The Effect of GnRH on Pitutitary Hormones in Menstrual-Cycle Mood Related Disorders
NCT00001233	Study of Children at Risk for Disruptive Behavior Disorders
NCT00001234	Gene Therapy for Gaucher's and Fabry Disease Using Viruses and Blood-Forming Cells
NCT00001235	Genetic Studies in Alzheimer's Disease
NCT00001237	Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas
NCT00001238	Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders
NCT00001239	Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer
NCT00001240	Evaluating Patients With Abnormal Levels of Gastric Acid
NCT00001241	Treatment of Zollinger-Ellison Syndrome
NCT00001242	Resistance to Vitamin D or Parathyroid Hormone
NCT00001243	Effects of HIV on the Development and Function of Bone Marrow Cells
NCT00001244	Immune Regulation in Patients With Common Variable Immunodeficiency and Related Syndromes
NCT00001245	Study of Patients With Strongyloides Stercoralis Infection
NCT00001246	Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers
NCT00001247	Inpatient Evaluation of Adults With Schizophrenia
NCT00001248	Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
NCT00001249	Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac
NCT00001250	Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial
NCT00001251	Phase I Study of Intrathecal Mafosfamide
NCT00001252	Human Movement Database
NCT00001253	The Effects of Estrogen on Cognition in Girls With Turner Syndrome
NCT00001254	Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome
NCT00001255	Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency: A Natural History Study
NCT00001256	Steroids and Methotrexate to Treat Systemic Vasculitis
NCT00001257	Inflammatory Responses in Normal Volunteers and Patients With Abnormal Immune Responses
NCT00001258	Studies of Frontal Lobe Brain Functioning in Schizophrenia
NCT00001259	A Treatment Study for Premenstrual Syndrome (PMS)
NCT00001260	Brain Tissue Collection for Neuropathological Studies
NCT00001261	Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies
NCT00001262	Copper Histidine Therapy for Menkes Diseases
NCT00001265	Study and Treatment of Inflammatory Muscle Diseases
NCT00001266	A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma
NCT00001267	A Randomized Pilot Study for the Treatment of AIDS or AIDS Related Complex With an Alternating or Simultaneous Combination Regimen of AZT and 2',3'-Dideoxyinosine
NCT00001269	Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer
NCT00001270	Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma
NCT00001271	A Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive B-Cell Lymphoma
NCT00001272	A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients
NCT00001275	Ovarian Follicle Function in Patients With Primary Ovarian Failure
NCT00001276	Diagnosing and Treating Low Blood Sugar Levels
NCT00001277	Studies of Elevated Parathyroid Activity
NCT00001278	Study of Eye Tissue for Sarcoidosis
NCT00001280	Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease
NCT00001281	Studies of Blood and Reproductive Fluids in HIV-Infected and Non-HIV-Infected Persons
NCT00001282	A Phase I/II Study of the Combination of Azidothymidine and Interleukin-2 (IL-2) in the Treatment of HIV-Infected Patients
NCT00001284	Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers
NCT00001285	Effects of Sex Hormones on Circadian Rhythm in Men and Women
NCT00001287	Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT00001288	Brain Blood Flow Studies of Language and Memory
NCT00001289	Effects of Enzyme Replacement in Gaucher's Disease
NCT00001291	Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
NCT00001292	Study of Scaling Disorders and Other Inherited Skin Diseases
NCT00001294	Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens
NCT00001295	Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease
NCT00001296	A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma
NCT00001298	A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal Dysfunction
NCT00001300	A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma
NCT00001301	Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors
NCT00001302	A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833
NCT00001303	Effects of Endotoxin in Normal Human Volunteers
NCT00001304	Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34
NCT00001305	Growth Hormone Therapy in Osteogenesis Imperfecta
NCT00001306	Steroid Therapy in Autoimmune Premature Ovarian Failure
NCT00001307	Positron Emission Tomography to Measure Pain and Pain Control
NCT00001308	Central Mechanisms in Speech Motor Control Studied With H215O PET
NCT00001309	The Body's Affect on Vitamin C
NCT00001310	Tissue Studies of Human Eye Diseases
NCT00001311	Modified Intraocular Lens to Reduce Eye Inflammation After Cataract Surgery in Uveitis Patients
NCT00001313	Evaluation of Patients With Known or Suspected Heart Disease
NCT00001314	Investigation of Heart Function in Patients With Heart Valve Defects
NCT00001316	Viral Load in Blood and Lymph Tissues of HIV-Infected Individuals
NCT00001317	A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood
NCT00001318	Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma
NCT00001319	Evaluation of HIV-Negative Patients With Low CD4+ T Lymphocyte Counts
NCT00001320	Neuroimaging of Dopamine Metabolism in Normal and Psychiatric Patients
NCT00001322	The Effects of Reproductive Hormones on Mood and Behavior
NCT00001323	Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia
NCT00001324	PET Scan to Study Brain Control of Human Movement
NCT00001325	Metabolic Abnormalities in Children With Epilepsy
NCT00001327	Establishing the Physiology of Syringomyelia
NCT00001328	Gene Therapy for the Treatment of Brain Tumors
NCT00001329	Study of Norepinephrine Levels and Sympathetic Nervous System Activity
NCT00001330	Study of Silicone-Associated Connective Tissue Diseases
NCT00001331	Genetic and Family Studies of Inherited Muscle Diseases
NCT00001332	Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis
NCT00001333	Phase I Study of Intrathecal Topotecan
NCT00001335	New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma
NCT00001336	In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
NCT00001337	Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
NCT00001338	A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer
NCT00001339	A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection
NCT00001341	A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease
NCT00001342	Study of Glycogen Storage Disease and Associated Disorders
NCT00001343	The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome
NCT00001344	Dextromethorphan Versus Placebo for Neuropathic Pain
NCT00001345	Studies of Inherited Diseases of Metabolism
NCT00001346	Diabetic Retinopathy and Visual Function Study
NCT00001347	Study of Usher Syndromes, Type 1 and Type 2
NCT00001349	Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
NCT00001350	Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
NCT00001351	Evaluation and Long-Term Follow-up of Patients With Inflammatory Disorders
NCT00001352	Evaluation and Follow-up of Patients With Cryptococcosis
NCT00001353	Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs
NCT00001354	Interleukin-2 Therapy for HIV Infection - Supplemental Procedures
NCT00001355	Detection and Characterization of Host Defense Defects
NCT00001356	Characteristics of Mast Cells in Mastocytosis
NCT00001357	Subcutaneously Administered Interleukin-2 Therapy in HIV-Infected Patients
NCT00001359	Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup)
NCT00001360	Studies of Blood Flow to the Brain During Thought
NCT00001361	Magnetic Resonance Imaging Studies of Motor and Thought Processes
NCT00001362	Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders
NCT00001363	PET Scan to Map the Areas of the Brain Involved in Planning
NCT00001364	Evaluation and Treatment of Patients Spinal Blood Vessel Abnormalities
NCT00001365	Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System
NCT00001366	Mapping the Areas of the Brain Associated With Language in Children With Epilepsy
NCT00001367	Diagnosis and History Study of Patients With Different Neurological Conditions
NCT00001368	Potential Risk Factors for Stroke
NCT00001371	A Pilot Study of Topical Antiflammin-2 for Psoriasis
NCT00001372	Study of Systemic Lupus Erythematosus
NCT00001373	Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
NCT00001375	The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis
NCT00001376	Steroid Hormones, TH1/TH2 Cytokines and Reproductive Status
NCT00001377	Familial Prostate Cancer
NCT00001378	A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer
NCT00001379	Treatment and Natural History Study of Lymphomatoid Granulomatosis
NCT00001381	A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder
NCT00001382	A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate
NCT00001383	A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833
NCT00001384	A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients
NCT00001385	Positron Emission Tomography in Patients With Breast Cancer
NCT00001386	Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection
NCT00001387	Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy
NCT00001390	Salivary Evaluation in Healthy Volunteers
NCT00001391	Bone Regeneration Using Bone Marrow Stromal Cells
NCT00001392	Pathogenesis of Glomerulosclerosis
NCT00001393	Genetic Markers for Focal Segmental Glomerulosclerosis
NCT00001394	Using X-Ray Dye to Locate Hidden Parathyroid Tumors
NCT00001395	Long Term Follow-Up of Diabetic Retinopathy
NCT00001396	Natural History and Results of Dual Chamber (DDD) Pacemaker Therapy of Children With Obstructive Hypertrophic Cardiomyop...
NCT00001397	Evaluation, Treatment, and Training for Patients With Blood Disorders
NCT00001398	Stem Cell Factor Medication for Aplastic Anemia
NCT00001399	Gene Therapy for the Treatment of Fanconi's Anemia Type C
NCT00001400	Outpatient Evaluation of Patients With Known or Suspected Heart Disease
NCT00001402	PET Scan to Determine Areas of Blood Flow and Activity in the Hearts of Patients With Heart Disease Taking Beta-Blockers
NCT00001403	Study of Proteus Syndrome and Related Congenital Disorders
NCT00001404	Phenotype and Etiology of Pallister-Hall Syndrome
NCT00001405	Use of G-CSF to Obtain Blood Cell Precursors
NCT00001406	Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
NCT00001407	Interferon Gamma for Drug Resistant Tuberculosis
NCT00001408	Role of T-Cells in Asthma
NCT00001409	Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications
NCT00001410	PEG-Glucocerebrosidase for the Treatment of Gaucher Disease
NCT00001412	Effects on the Brain of Lupron Induced Hypogonadotropic Hypogonadism With and Without Testosterone Replacement
NCT00001413	Bone Mineral Density in Women With Major Depression
NCT00001414	Mapping Personality Traits to Genes
NCT00001415	Glucocorticoid Effects on Cellular Cytokine Release
NCT00001416	Bone Response to Enzyme Replacement in Gaucher's Disease
NCT00001417	Direct Injection of Alcohol for the Treatment of Spinal Tumors
NCT00001418	PET Scan in Patients With Neurocardiologic Disorders
NCT00001420	Study of Psoriatic Arthritis
NCT00001421	Methimazole to Treat Polymyositis and Dermatomyositis
NCT00001422	A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis
NCT00001424	Evaluation and Natural History of Children With Cancer and AIDS
NCT00001426	A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer
NCT00001427	A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin
NCT00001428	A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer
NCT00001430	A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas
NCT00001431	A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas
NCT00001432	The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies
NCT00001435	Psychosocial Correlates and Coping Strategies Associated With Long-Term Survival of HIV-Infected Children
NCT00001436	A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma
NCT00001437	Trial of Pentoxifylline in Patients With Functional Disability Caused by Radiation-Induced Advanced Regional Fibrosis
NCT00001438	A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes
NCT00001439	A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant
NCT00001440	Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy
NCT00001442	A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer
NCT00001443	A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection
NCT00001444	A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms
NCT00001445	Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection
NCT00001446	A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer
NCT00001448	The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection
NCT00001449	A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients
NCT00001450	Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC
NCT00001451	Evaluation of Healthy Volunteer Marrow Donors Participating in the National Marrow Donor Program (NMDP)
NCT00001452	Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
NCT00001453	Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome
NCT00001454	Hormonal Effects on the Uterus and Endometrium
NCT00001455	Iron Overload in African Americans
NCT00001456	Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
NCT00001457	Lamivudine for Chronic Hepatitis B
NCT00001458	Evaluation of Patients With Heart Disease Not Eligible for Research Protocols
NCT00001459	Analysis of Heart Muscle Function in Patients With Heart Disease and Normal Volunteers
NCT00001460	Evaluation and Treatment of Heart Disease in Patients Not Participating in Research
NCT00001461	Study of the Interaction Between the Cells Lining Blood Vessels and Angiotensin-Converting Enzyme
NCT00001462	Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals
NCT00001464	Effect of High Levels of Oxygen and Smoking on the Lungs in Human Volunteers
NCT00001465	Study of the Disease Process of Lymphangioleiomyomatosis
NCT00001466	Study of Clinical and Molecular Manifestations of Genetic Disorders
NCT00001467	Genetic Analysis of Immune Disorders
NCT00001468	Outcomes of Education and Counseling for BRCA1 Testing
NCT00001469	Genetic Analysis of Hereditary Prostate Cancer
NCT00001471	Tissue Biopsy and Imaging Studies in HIV-Infected Patients
NCT00001473	Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides
NCT00001474	Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients
NCT00001475	Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist
NCT00001476	Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up
NCT00001477	Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy
NCT00001478	Effects of Drugs on Cerebral Blood Flow in Patients With Mood Disorders
NCT00001479	Study of the Hypothalmic-Pituitary-Adrenal (HPA) Axis and Its Role in Major Depression
NCT00001480	The Evaluation and Follow-up of Individuals With Memory Disorder
NCT00001481	The Role of Hormones in Postpartum Mood Disorders
NCT00001482	New Drugs in the Treatment of Mood Disorders
NCT00001483	Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression
NCT00001485	Effects of Season on Melatonin Secretion in Healthy Men and Women and Patients With Seasonal Affective Disorder
NCT00001486	Genetic Study of Schizophrenia
NCT00001487	Treatment of Mid-Life-Related Mood Disorders
NCT00001489	Effect of Vigabatrin on Brain Blood Flow and Glucose Metabolism
NCT00001491	Analysis of the Nervous System in Patients With Fabry's Disease
NCT00001493	Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer
NCT00001495	A Phase I Study of Irinotecan (CPT-11) Administered as a Prolonged Infusion in Adult Patients With Solid Tumors
NCT00001496	Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer
NCT00001497	Assessment of Attentional Functioning in Children With HIV-1 Infection
NCT00001498	A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer
NCT00001499	Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer
NCT00001500	Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits
NCT00001502	A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors
NCT00001503	Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
NCT00001504	A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients
NCT00001505	The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic Diseases
NCT00001506	Evaluation and Treatment of Patients With Dermatologic Diseases
NCT00001507	Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer
NCT00001509	A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor
NCT00001512	Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines
NCT00001515	Diagnostic Effectiveness of Virtual Bronchoscopy
NCT00001516	Evaluating the Personal Computer as a Treatment Activity in Occupational Therapy
NCT00001518	A Randomized Evaluation of the Effect of Routine Normal Saline Flush Versus Heparinized Saline Solution in Groshong and Groshong PICC Catheters
NCT00001519	Oxygen Uptake Kinetics During Recovery From Maximal and Submaximal Exercise
NCT00001520	The Early Reversibility of Rocuronium After Different Doses of Neostigmine
NCT00001521	Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia
NCT00001522	Metabolic Differences of Overweight Children and Children of Overweight Parents
NCT00001523	Structure and Functional Status of Parotid Glands Exposed to Therapeutic Irradiation
NCT00001524	Thalidomide to Treat Oral Lesions in HIV-Infected Patients
NCT00001526	ANTI-TAC THERAPY FOR UVEITIS
NCT00001527	Role of Endothelin in the Regulation of Vascular Tone in Patients With Essential Hypertension
NCT00001528	Analysis of Heart Muscle Function Following Exercise in Patients With Heart Disease
NCT00001529	Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
NCT00001530	Long-Term Results of DDD Pacing in Obstructive Hypertrophic Cardiomyopathy
NCT00001531	Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction
NCT00001532	Role of Genetic Factors in the Development of Lung Disease
NCT00001533	Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine
NCT00001534	Long Term Effects of Enalapril and Losartan on Genetic Heart Disease
NCT00001535	Twins Study of Gene Therapy for HIV Infection
NCT00001536	Issues Surrounding Prenatal Genetic Testing for Achondroplasia
NCT00001538	Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers
NCT00001539	A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations
NCT00001540	The Use of Bacteriophage Phi X174 to Assess the Immune Competence of HIV-Infected Patients In Vivo
NCT00001541	Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis
NCT00001542	Fluconazole Prophylaxis of Thrush in AIDS
NCT00001543	Dynamics of Leptin and Endocrine Function
NCT00001544	Genetic Aspects of Neurologic and Psychiatric Disorders
NCT00001545	Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders
NCT00001546	Circadian Regulation of Sleep in Habitual Short Sleepers and Long Sleepers
NCT00001547	Neuropsychiatric Effects of Interferon-Alpha and Ribavirin
NCT00001548	Genetics of Obsessive-Compulsive Disorder
NCT00001549	Diagnosis and Natural History Study of Patients With Neurological Conditions
NCT00001550	Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)
NCT00001551	Characteristics of Idiopathic Familial Speech Disorders
NCT00001552	Characteristics of Idiopathic Familial Voice Disorders
NCT00001553	Motor Changes Associated With Recovery From Stroke After Therapy
NCT00001554	Infrared Camera for Brain Mapping During Surgery
NCT00001560	Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers
NCT00001561	Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation
NCT00001563	EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma
NCT00001564	A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas
NCT00001565	Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy
NCT00001566	A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas
NCT00001567	A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia
NCT00001568	Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modalities
NCT00001569	Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis
NCT00001570	A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer
NCT00001571	A Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of Organochlorines
NCT00001572	Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype
NCT00001573	A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancy
NCT00001574	A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors
NCT00001575	Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia
NCT00001576	A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver
NCT00001577	Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity
NCT00001579	A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors
NCT00001580	Tissue Acquisition for Molecular Diagnostics
NCT00001582	Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer
NCT00001584	Determination of HIV-1 Production by the Prostate
NCT00001586	Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis
NCT00001587	A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver
NCT00001589	Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors
NCT00001591	Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy
NCT00001594	Evaluation and Intervention for the Effects of Osteogenesis Imperfecta
NCT00001595	An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
NCT00001596	Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome
NCT00001597	Pain Measurement in Healthy Volunteers
NCT00001598	DHEA Treatment for Sjogren's Syndrome
NCT00001599	Pilot Study of Thalidomide to Treat Sjogren's Syndrome
NCT00001600	Diagnosis and Evaluation of Patients Needing Third Molar (Wisdom Tooth) Extraction and Patients With Chronic Facial Pain
NCT00001601	Evaluation and Treatment of Oral Soft Tissue Diseases
NCT00001602	Genetic Factors Related to Stuttering
NCT00001603	The Effects of Upper Airway and Digestive Tract Tumors on the Immune System
NCT00001604	Genetic Linkage Studies of Stuttering
NCT00001605	Vaccination for Middle Ear Infection
NCT00001606	Genetic Analysis of Human Hereditary Hearing Impairment
NCT00001609	Studies of Families With Hereditary Cataracts
NCT00001610	Normal Human Electro-Oculogram
NCT00001611	Immune Activity Against CVM Retinitis
NCT00001612	Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS)
NCT00001613	Cataract Surgery to Obtain Human Lens Material for the Study of Nuclear Cataracts
NCT00001614	The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis
NCT00001615	Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration
NCT00001617	Test of QLS Device to Detect Early Cataracts
NCT00001618	Segmental Bronchoalveolar Lavage
NCT00001619	Magnetic Resonance Imaging at Different Levels of Magnetic Intensity
NCT00001620	Screening for Hematology Branch Protocols
NCT00001621	Evaluation and Treatment of Patients With Lung Disease Not Participating in Research
NCT00001622	Study of the Response of Human Small Blood Vessels
NCT00001623	Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
NCT00001624	Effect of Insulin on Endothelin-Dependent Vascular Tone in the Forearm Circulation
NCT00001625	Methods for Measuring Insulin Sensitivity
NCT00001626	Comparing Therapies for the Treatment of Severe Aplastic Anemia
NCT00001627	Collection of Blood and Bone Marrow From Healthy Volunteers and Patients for Research Purposes
NCT00001628	The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular Function
NCT00001629	The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function
NCT00001630	Treatment of Autoimmune Thrombocytopenia (AITP)
NCT00001631	Study of Blood Flow in Heart Muscle
NCT00001632	Investigation Into the Use of Ultrasound Technique in the Evaluation of Heart Disease
NCT00001633	Safety and Effectiveness of Coronary Magnetic Resonance Angiography (CMRA) Imaging
NCT00001637	Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults
NCT00001638	Magnetic Resonance Imaging of the Blood Vessels of the Heart
NCT00001639	Evaluation of Patients With Unresolved Chromosome Abnormalities
NCT00001640	Genetic Analysis of Parkinson's Disease
NCT00001641	Study of Heritable Connective Tissue Disorders
NCT00001642	Positional Cloning of the Gene(s) Responsible for Alagille Syndrome
NCT00001643	Gene Analysis of Parkinson's Disease
NCT00001644	Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection
NCT00001645	Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
NCT00001646	Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis
NCT00001647	White Blood Cell Infusions to Treat HIV Infection
NCT00001648	Structure of the Herpes Simplex Virus Receptor
NCT00001649	Valaciclovir to Prevent Transmission of Herpes Simplex Virus
NCT00001650	Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients
NCT00001651	Use of Labeled Glucose to Study Lymphocyte Replication and Survival in HIV-Infected Patients
NCT00001652	The Evaluation and Follow-up of Patients With Bipolar Disorder
NCT00001654	The Role of Emotion in the Development of Psychopathology
NCT00001656	Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders
NCT00001657	Use of Repetitive Transcranial Magnetic Stimulation (rTMS) in Chronic Posttraumatic Stress Disorder (PTSD)
NCT00001658	Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections
NCT00001659	Consequences of Conjugal Bereavement in Adults
NCT00001661	Mechanisms of Human Plasticity in the Human System
NCT00001662	Treatment of Alzheimer's Disease With CX516 (Ampalex)
NCT00001663	Treatment of Cortical Myoclonus With Repetitive Transcranial Magnetic Stimulation
NCT00001664	Sleep Disorders of Patients With Diseases of the Nervous System
NCT00001665	Transcranial Magnetic Stimulation for the Treatment of Parkinson's Disease
NCT00001666	Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy
NCT00001667	Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases
NCT00001668	Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors
NCT00001669	A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients
NCT00001671	The Classification and Cause of Leukodystrophies of Unknown Cause
NCT00001672	Language Localization Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients With Epilepsy
NCT00001673	Screening Evaluation for Studies of the National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NCT00001675	The Effect of Positive and Negative Emotions on Brain Activity in Alcoholics and Nonalcoholics
NCT00001676	Cyclophosphamide and Fludarabine to Treat Lupus Nephritis
NCT00001677	Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and Efficacy
NCT00001678	Genetics of Rheumatoid Arthritis
NCT00001679	Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients
NCT00001680	A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus
NCT00001681	A Pilot Study of the Patterns of Cellular Gene Expression in HIV-1 Patients Following Clinical Events Which Increase Plasma Virus Concentrations
NCT00001683	A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer
NCT00001685	Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase
NCT00001686	Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases
NCT00001688	A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine
NCT00001689	A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia
NCT00001693	Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers
NCT00001695	Survey of the Use of Alternative Medical Therapies in Adult Cancer Patients Enrolled in Phase I Clinical Trials
NCT00001696	A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor
NCT00001698	Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR
NCT00001699	A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their Mothers
NCT00001701	Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection
NCT00001702	Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection
NCT00001703	Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell Carcinoma
NCT00001705	Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence
NCT00001711	Magnetic Resonance Imaging (MRI) Ofl Volunteers
NCT00001712	Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan
NCT00001713	Treatment for Blood Clots in the Veins of the Legs
NCT00001714	Magnetization Transfer Quantitation and Characterization for Clinical Scanners
NCT00001715	Evaluation of Patients With Blood Disorders
NCT00001716	Effects of Nitric Oxide and Nitroglycerin in Patients With Sickle Cell Anemia
NCT00001717	Influences on HIV Infected Subjects' Willingness to Participate in Research and Ability to Give Informed Consent
NCT00001718	Facilitation of Oral Bolus Propulsion Using Electropalatography in Patients With Dysphagia
NCT00001719	Magnetic Resonance Imaging of Blood Flow in the Liver and Abdomen
NCT00001720	Treatment of Childhood Osteoporosis With Alendronate (Fosamax)
NCT00001721	Study of Smith-Lemli-Opitz Syndrome
NCT00001722	Fat Tissue Microperfusion to Measure Leptin Secretion and Its Relations With Fat Breakdown in Humans
NCT00001723	Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases
NCT00001724	Local Flurbiprofen to Treat Pain Following Wisdom Tooth Extraction
NCT00001725	Studies of Dextromethorphan and Topiramate to Treat Oral and Facial Pain
NCT00001726	Study of the Composition of Dental Plaque
NCT00001727	Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
NCT00001728	Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
NCT00001729	Combination Drug Therapy for Patients With Hepatitis C
NCT00001730	Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.
NCT00001731	Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops
NCT00001732	Screening for Studies on Inherited Eye Diseases
NCT00001733	Screening for Studies on Retinovascular Diseases
NCT00001734	Screening for NEI Clinical Studies
NCT00001735	Gene Therapy for Gyrate Atrophy
NCT00001736	New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis
NCT00001737	Cyclosporin Implant to Treat Uveitis
NCT00001738	Vascular Endothelial Growth Factor (VEGF) in Uveitis
NCT00001740	Evaluation of Left Ventricular Volumes by Real-Time 3-Dimensional Echocardiography
NCT00001741	Study of Inherited Changes of Receptors Located on Blood Vessels
NCT00001742	The Role of Cyclooxygenase Activity in the Endothelial Function of Hypertensive and Hypercholesterolemic Patients
NCT00001746	Screening for Inherited Heart Disease
NCT00001747	Racial Differences in Control of Blood Vessel Tone and Blood Flow
NCT00001748	HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies
NCT00001749	Medical Treatment for Diamond Blackfan Anemia
NCT00001750	Comparing Treatments for Multiple Myeloma
NCT00001752	Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women
NCT00001753	Study of the Effects of Temperature on Metabolism in Human Muscle
NCT00001754	Study of Skeletal Disorders and Short Stature
NCT00001756	Study of Mast Cell Precursors
NCT00001757	An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
NCT00001758	Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz
NCT00001759	Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography
NCT00001760	Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals
NCT00001761	Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis
NCT00001762	Magnetic Resonance Imaging of the Face and Bones
NCT00001763	Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection
NCT00001764	Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions
NCT00001765	Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease
NCT00001766	Drug Interactions Among Anti-HIV Agents
NCT00001768	Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg)
NCT00001770	Progestin (Progesterone-Like Hormones) Induced Dysphoria (Depressed Mood, Irritability, Anxiety)
NCT00001771	I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers
NCT00001772	Evaluation of Patients With Rapid Cycling Bipolar Disorder (RCBD)
NCT00001774	Vasodilation in Patients With Fabry's Disease
NCT00001776	Effects of Brain Stimulation on Learning and Reasoning
NCT00001777	Sertraline for the Treatment of Patients With Frontal Lobe Dementia (FLD)
NCT00001778	Evaluation of Patients With HAM/TSP
NCT00001780	Magnetic Stimulation of the Human Nervous System
NCT00001781	Safety, Tolerability, and Effectiveness of CGP77116 in Patients With Multiple Sclerosis (MS)
NCT00001782	Areas of Brain Responsible for Understanding American Sign Language
NCT00001783	Motor Recovery in Recent Stroke Patients Treated With Amphetamine and Physical Therapy
NCT00001784	Mexiletine for the Treatment of Focal Dystonia
NCT00001785	Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)
NCT00001788	Genetic Basis of Primary Immunodeficiencies
NCT00001789	BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis
NCT00001790	Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia
NCT00001797	Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis
NCT00001803	Von Hippel-Lindau Disease Genetic Epidemiology Study
NCT00001805	A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab
NCT00001806	Methods in Education for Breast Cancer Genetics
NCT00001807	(1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic Therapy
NCT00001810	An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
NCT00001812	A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2
NCT00001813	Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
NCT00001814	Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of Samples
NCT00001816	The Impact of Starbright World on Children Being Treated at the NIH
NCT00001818	Combination Drug Treatment of Pediatric HIV Infection
NCT00001823	Evaluation for NCI Surgery Branch Clinical Research Protocols
NCT00001826	Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor
NCT00001827	p53 Vaccine for Ovarian Cancer
NCT00001830	Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants
NCT00001832	Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma
NCT00001835	Oxaliplatin in Cancer Patients With Impaired Kidney Function
NCT00001836	Detection of Coronary Artery Calcification: Comparison of Volumetric and Electron Beam Computed Tomography
NCT00001837	Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients
NCT00001839	A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome
NCT00001840	Evaluation of Treated and Untreated Stroke
NCT00001841	Magnetic Resonance Angiography (MRA) for the Diagnosis of Atherosclerosis
NCT00001842	G-CSF for Granulocyte Donation
NCT00001844	Study of New Magnetic Resonance Methods
NCT00001845	Study of Brain Blood Flow During Induced Hypercapnia (Excess Blood Carbon Dioxide)
NCT00001846	Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
NCT00001848	The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by Endometriosis
NCT00001849	New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
NCT00001850	Evaluation of Women With Endocrine and Reproductive-Related Conditions
NCT00001851	Bone Marrow Injection to Replace Diseased Bone in Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
NCT00001852	Natural History of Salivary Gland Dysfunction and Sjogren's Syndrome
NCT00001853	Diabetes and Heart Disease Risk in Blacks
NCT00001854	Long-Term Therapy With Ribavirin for Chronic Hepatitis C
NCT00001856	Live Donors for Kidney Transplants
NCT00001857	Study Comparing the Safety of BG9588 (Anti-CD40L Antibody) Against Standard Treatment in Kidney Transplantation
NCT00001858	Monitoring for Tolerance to Kidney or Combined Kidney-Pancreas Transplants
NCT00001859	Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant
NCT00001860	Sandostatin LAR Depot vs. Surgery for Treating Acromegaly
NCT00001861	Screening for Studies on Nystagmus and Strabismus
NCT00001862	TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis
NCT00001863	Leflunomide to Treat Uveitis
NCT00001864	Amblyopia (Lazy Eye) Treatment Study
NCT00001865	HAT in Eye Complications of Behcet's Disease
NCT00001866	Eye Muscle Surgery to Treat Congenital Nystagmus
NCT00001867	Effect of Pregnancy on Uveitis
NCT00001869	Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)
NCT00001870	Study of the Effects of Vitamin C on Patients With Type 2 Diabetes
NCT00001871	Study of Muscle Abnormalities in Patients With Specific Genetic Mutations
NCT00001872	Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease
NCT00001873	The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers
NCT00001874	Technical Evaluation of Cardiovascular Magnetic Resonance Imaging and Spectroscopy
NCT00001876	Lung Disease Associated With Rheumatoid Arthritis
NCT00001877	Treatment of Pulmonary Sarcoidosis With Pentoxifylline
NCT00001878	Factors Contributing to Increased Left Ventricle Size in Patients With Abnormally Enlarged Hearts
NCT00001879	Collections of Blood and Stool Samples in Patients With Acute Hepatitis
NCT00001880	Stem Cell Transplantation for Metastatic Solid Tumors
NCT00001881	Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease
NCT00001883	Quality Control of Cardiopulmonary Exercise Equipment
NCT00001884	Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis
NCT00001885	Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis
NCT00001886	Real Time 3-Dimensional Stress Echocardiography
NCT00001887	Factors Involved in Asthma and Airway Inflammation
NCT00001888	Sample Collections From the Airways of Asthmatic Patients
NCT00001889	Comparison of Echocardiographic Techniques in Diagnosis of Coronary Artery Disease
NCT00001890	Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
NCT00001891	Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle
NCT00001893	Study of TNFR:Fc (Enbrel) in the Treatment of Asthma
NCT00001894	A Comparison of Two Treatments: Pacemaker and Percutaneous Transluminal Septal Ablation for Hypertrophic Cardiomyopathy
NCT00001895	Electromechanical Mapping to Evaluate Heart Muscle
NCT00001898	Microarray Analysis for Human Genetic Disease
NCT00001899	Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy
NCT00001901	Etanercept to Treat Wegener's Granulomatosis
NCT00001903	Prevention of RSV Infections in Bone Marrow Transplant Recipients
NCT00001904	Assessment of a B-Mode Ultrasound Technique for the Measurement of Carotid Artery Intima-Media Thickness
NCT00001905	Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I
NCT00001906	Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants
NCT00001908	T Cell Cytokine Changes During IL-4 Receptor Treatment for Asthma
NCT00001909	Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma
NCT00001910	Mechanisms of Allergen Immunotherapy
NCT00001911	Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections
NCT00001912	Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis
NCT00001913	The Impact of Familiarity and Emotional Attachment on the Visual Processing of Faces
NCT00001915	Study of Attention Deficit/Hyperactivity Disorder Using Transcranial Magnetic Stimulation
NCT00001916	Use of Bone Biopsy to Better Understand the Causes of Decreased Bone Mineral Density in Depression
NCT00001917	Brain Imaging in Elderly People and Individuals With Alzheimer's Disease
NCT00001918	L-5-HTP-Related EMS
NCT00001919	Neuroimaging of St. John's Wort-Induced Changes of Serotonin Metabolism in Normal Subjects
NCT00001920	Eye Blink Response in Healthy Volunteers and Adults With Schizophrenia
NCT00001921	Electrophysiology and Blood Flow in Patients With Schizophrenia and Their Siblings
NCT00001922	Sensory Function in Idiopathic Voice Disorders
NCT00001923	Transcranial Magnetic Stimulation for the Treatment of Phantom Pain
NCT00001925	Effect of Alcohol on Tremors
NCT00001926	The Connection Between Areas in the Brain of Blind Patients
NCT00001927	Study of Abnormal Blood Clotting in Children With Stroke
NCT00001928	Intravenous Levodopa for the Diagnosis of Parkinson's Disease
NCT00001929	Treatment of Parkinson's Disease With Eliprodil
NCT00001930	Treatment of Huntington's Chorea With Amantadine
NCT00001931	Treatment of Parkinson's Disease With a Transdermal Skin Patch
NCT00001932	Serotonin Receptors in Seizure Disorders
NCT00001933	Nefiracetam in the Treatment of Alzheimer's Disease
NCT00001934	Zenapax to Treat Multiple Sclerosis
NCT00001936	Electrical Muscle Stimulation to Aid Swallowing in Dysphagia
NCT00001937	Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients
NCT00001938	A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)
NCT00001940	Voriconazole to Treat Fungal Infections
NCT00001941	Anti-Tac for Treatment of Leukemia
NCT00001944	Vinorelbine and XR9576 to Treat Cancer
NCT00001946	Comparison of Magnetic Resonance Angiography and Standard Angiography in Diagnosing Atherosclerosis
NCT00001948	A Study of Health-Related Quality of Life in HIV-Infected Patients Undergoing Structured Treatment Interruptions of Highly Active Antiretroviral Therapy
NCT00001950	The Development of Categorization
NCT00001951	Hormone Replacement in Young Women With Premature Ovarian Failure
NCT00001952	Using a Narcotic to Enhance the Numbing Effect of the Local Anesthetic Lidocaine on Inflamed Molar Teeth
NCT00001953	The Functioning of Immune and Hormonal Systems in Patients With Sjogren's Syndrome and in Healthy Volunteers
NCT00001954	Etanercept Therapy for Sjogren's Syndrome
NCT00001955	Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)
NCT00001956	Influence of Genetics in Pain Sensitivity
NCT00001957	Testing a Possible Cause of Reduced Ability of Children to Process Speech in Noise
NCT00001958	Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)
NCT00001959	Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)
NCT00001960	Studying the Effectiveness of Pacemaker Therapy in Children Who Have Thickened Heart Muscle
NCT00001961	MRI Evaluation of Chest Pain
NCT00001962	A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure
NCT00001963	Vascular Effects of Endothelium-Derived Versus Hemoglobin-Transported Nitric Oxide in Healthy Subjects
NCT00001964	Combination Therapy of Severe Aplastic Anemia
NCT00001965	Cyclosporine A to Treat Hypertrophic Cardiomyopathy (HCM)
NCT00001966	Mind-Body Therapy for Pain in Ehlers-Danlos Syndrome
NCT00001967	Intermittent Versus Continuous Medication in the Treatment of HIV
NCT00001968	Once-Daily Drug Regimen for HIV-Infected Patients
NCT00001969	Heart Disease Risk Factors in Major Depression
NCT00001971	Evaluation of Patients With Liver Disease
NCT00001972	PET Scan of Brain Metabolism in Relation to Age and Disease
NCT00001973	Studies on Abnormal Bone From Patients With Polyostotic Fibrous Dysplasia and McCune Albright Syndrome
NCT00001975	Study of Skin Tumors in Tuberous Sclerosis
NCT00001976	Comparison of Two Test Methods-NASBA and Antigenemia-for Detecting Cytomegalovirus Infection
NCT00001977	The Effect of Acetylcholine on Memory and Attention
NCT00001978	Determination of Kidney Function
NCT00001979	Immune System Related Kidney Disease
NCT00001981	The Treatment and Natural History of Acromegaly
NCT00001982	History of Hepatitis C in Volunteer Blood Donors
NCT00001983	Eligibility Screening for National Institute of Dental and Craniofacial Research Studies
NCT00001984	Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys
NCT00001985	Genetic Influence on Susceptibility to Type 1 Diabetes Mellitus
NCT00001986	1-Octanol to Treat Essential Tremor
NCT00001987	Genetic Studies of Insulin and Diabetes
NCT00001989	A Randomized Phase II Efficacy, Activity and Safety Study of GLQ223 Alone and in Combination With Zidovudine in Symptomatic HIV-Infected Patients Without Prior Treatment With GLQ223 or Trichosanthin
NCT00001990	An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine
NCT00001991	A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia
NCT00001992	A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volunteers
NCT00001993	Initial Phase II Efficacy and Safety Study of SC-48334 Administered in Combination With Low-Dose Zidovudine (AZT) to Symptomatic HIV-1 Infected Patients With = or > 200 to = or < 500 CD4+ Cells/mm3
NCT00001994	A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine
NCT00001995	A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS
NCT00001996	A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole
NCT00001997	Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals
NCT00001998	Pharmacokinetics of Nystatin LF I.V. in Patients With Acquired Immune Deficiency Syndrome-Related Complex (ARC)
NCT00001999	A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS
NCT00002000	A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients
NCT00002001	The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease
NCT00002002	A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency Syndrome
NCT00002003	Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas
NCT00002004	A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex
NCT00002005	A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex
NCT00002006	A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility
NCT00002007	A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and Leukopenia
NCT00002008	An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia
NCT00002009	A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia
NCT00002010	Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis
NCT00002011	The Therakos UVAR Photopheresis System in the Treatment of AIDS-Related Complex
NCT00002012	Double-Blind, Randomized, Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived) in ARC Patients
NCT00002013	A Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC Patients
NCT00002014	A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)
NCT00002015	An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children
NCT00002016	A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis
NCT00002017	Immunomodulation of HIV-1 Infected Individuals With PEG-Interleukin-2
NCT00002018	Double-Blind, Randomized, Dose Ranging Study of Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) in HIV+ Subjects
NCT00002019	Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome
NCT00002020	Trial of an Alternative Dosing Regimen of Oral Retrovir in Patients With AIDS or Advanced ARC
NCT00002021	An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies
NCT00002022	Treatment Program for Anemia in AIDS Patients
NCT00002023	An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2
NCT00002024	Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections
NCT00002025	Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient
NCT00002026	Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)
NCT00002027	Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)
NCT00002028	A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir)
NCT00002029	Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent
NCT00002030	An Open Label Study to Evaluate the Long-Term Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients
NCT00002031	Evaluation of the Epidermal Langerhans Cell Population in AIDS / ARC Patients by the Topical Application of a Potent Contact Allergen (1-Chloro-2,4-Dinitro-Chlorobenzene) (DNCB)
NCT00002032	Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
NCT00002033	A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease
NCT00002034	A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS
NCT00002035	Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine
NCT00002036	Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)
NCT00002037	Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study
NCT00002038	Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy
NCT00002039	An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients
NCT00002040	Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
NCT00002041	Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients
NCT00002042	A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS and Advanced ARC Patients With Anemia
NCT00002043	Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC)
NCT00002044	A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases
NCT00002045	A Prospective Double-Blind Study of Retrovir in Early HIV Infection
NCT00002046	A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARC
NCT00002047	Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure
NCT00002048	The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)
NCT00002049	Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients
NCT00002050	A Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients
NCT00002051	Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection
NCT00002052	Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients
NCT00002053	A Double-Blind Placebo-Controlled Group Comparative Study To Evaluate the Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With AIDS Post First Episode PCP
NCT00002054	A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients
NCT00002055	A Double-Blind Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients With Multiple Episodes of PCP
NCT00002056	A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral / Oral Trimethoprim - Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia in AIDS
NCT00002057	Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC
NCT00002058	A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease
NCT00002059	A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers
NCT00002060	A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Patients With AIDS Related Complex (ARC)
NCT00002061	A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy
NCT00002062	"""Open-Label Compassionate Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients"""
NCT00002063	Treatment of AIDS and AIDS Related Complex. Part-1- Treatment of Patients With ARC (AZT Vs. Placebo)
NCT00002064	Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse
NCT00002065	Depot Disulfiram for AIDS and ARC
NCT00002066	Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection
NCT00002067	A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia
NCT00002068	A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
NCT00002069	A Study of DTC in Patients With AIDS and AIDS Related Complex
NCT00002070	Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis
NCT00002071	A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy
NCT00002072	A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy
NCT00002073	A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy
NCT00002074	Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome
NCT00002075	Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
NCT00002076	Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
NCT00002077	An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
NCT00002078	Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection
NCT00002079	Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)
NCT00002080	Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study
NCT00002081	Open-Label Program of Dideoxycytidine ( ddC ) to Be Used in Combination With Zidovudine ( AZT ) for Treatment of Advanced HIV Disease
NCT00002082	Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study
NCT00002083	Intranasal Peptide T in the Treatment of Painful Peripheral Neuropathy of AIDS
NCT00002084	A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients
NCT00002085	A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy
NCT00002086	A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV Infection
NCT00002087	Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals
NCT00002088	Treatment of Patients With Human Immunodeficiency Virus (HIV)-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo: A Double Blind Trial
NCT00002089	An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy
NCT00002090	An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)
NCT00002091	An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score > 40 Percent and < 100 Percent
NCT00002092	A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection
NCT00002093	A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.
NCT00002094	Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E
NCT00002095	A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus
NCT00002096	A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine
NCT00002097	A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.
NCT00002098	Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients
NCT00002099	Phase II/III Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients
NCT00002100	Phase I/II Study of Curdlan Sulfate
NCT00002101	A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo
NCT00002102	A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia.
NCT00002103	A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate (Neutrexin) With Leucovorin Protection for European Adult Patients (>= 13 Years Old) With Pneumocystis Carinii Pneumonia
NCT00002104	Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV
NCT00002105	Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma
NCT00002106	A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3
NCT00002107	A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients
NCT00002108	3TC (Lamivudine; GR109714X) Open-Label Program
NCT00002109	Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy
NCT00002110	A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease
NCT00002111	A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.
NCT00002112	Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome
NCT00002113	A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.
NCT00002114	A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides
NCT00002115	A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)Adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease.
NCT00002116	A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS
NCT00002117	A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection
NCT00002118	An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical Studies
NCT00002119	A Phase I/II Clinical Study of WF 10 IV Solution ( TCDO ) in Patients With HIV Infection
NCT00002120	Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia
NCT00002121	Diethylhomospermine (DEHSPM) for Refractory AIDS-Related Diarrhea
NCT00002122	A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients
NCT00002123	A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3
NCT00002124	A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3
NCT00002125	A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium)
NCT00002126	A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.
NCT00002127	A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome
NCT00002128	Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients
NCT00002129	A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3
NCT00002130	A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons
NCT00002131	A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma
NCT00002132	Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.
NCT00002133	An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.
NCT00002134	A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis
NCT00002135	An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access
NCT00002136	A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days
NCT00002137	A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4
NCT00002138	A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.
NCT00002139	Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.
NCT00002140	A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients
NCT00002141	A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89
NCT00002142	An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS
NCT00002143	Treatment of Psoriasis Using Acitretin in HIV-Positive Patients
NCT00002144	The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment
NCT00002145	Phase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV Disease
NCT00002146	Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study
NCT00002147	Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.
NCT00002148	Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia
NCT00002149	Acupuncture and Herbal Treatment of Chronic HIV Sinusitis
NCT00002150	A Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients
NCT00002151	A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients
NCT00002152	A Study of WF 10 IV Solution in Patients With Advanced HIV Disease
NCT00002153	Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders
NCT00002154	A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia
NCT00002155	A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC
NCT00002156	A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )
NCT00002157	Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome
NCT00002158	A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis
NCT00002159	A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis
NCT00002160	A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain
NCT00002161	A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3
NCT00002162	A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs
NCT00002163	A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex
NCT00002164	Phase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed Infants
NCT00002165	Viracept Expanded Access Program
NCT00002166	An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease
NCT00002167	Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary.
NCT00002168	A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients
NCT00002169	A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis
NCT00002170	A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)
NCT00002171	A Study of Viracept in HIV-Positive Women
NCT00002172	An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml
NCT00002173	An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater.
NCT00002174	Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients
NCT00002175	Epicutaneous 1-Chloro-2, 4-Dinitrobenzene (DNCB) Patch in HIV Infection.
NCT00002176	A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection
NCT00002177	A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection
NCT00002178	A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients
NCT00002179	The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection
NCT00002180	A Study of PMPA in HIV-Infected Patients
NCT00002181	Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS
NCT00002182	A Study of Megestrol Acetate in HIV-Infected Children
NCT00002183	A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection
NCT00002184	A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient
NCT00002185	A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3
NCT00002186	Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)
NCT00002187	A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis
NCT00002188	A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma
NCT00002189	Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals
NCT00002190	A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients
NCT00002191	A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis
NCT00002192	Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.
NCT00002193	Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease Inhibitors
NCT00002194	An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.
NCT00002195	A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients
NCT00002196	A Study of CI-1012 in HIV-Infected Patients
NCT00002197	A Study of 1592U89 in HIV-Infected Children
NCT00002198	A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients
NCT00002199	A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.
NCT00002200	A Study of 1592U89 in HIV-Infected Adults
NCT00002201	A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients
NCT00002202	A Comparison of 141W94 and Indinavir in HIV-Infected Patients
NCT00002203	A Study of Two Anti-HIV Drug Combinations
NCT00002204	A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults
NCT00002205	An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen
NCT00002206	A Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated With Anti-HIV Drugs
NCT00002207	A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients
NCT00002208	A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC
NCT00002209	Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy
NCT00002210	A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies
NCT00002211	Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients
NCT00002212	A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma
NCT00002213	The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors
NCT00002214	Phase I Trial of S-1153 in Patients With HIV Infection
NCT00002215	A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive
NCT00002216	A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment
NCT00002217	A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs
NCT00002218	A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients
NCT00002219	Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children
NCT00002220	Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir
NCT00002221	Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma
NCT00002222	A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS
NCT00002223	A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients
NCT00002224	Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)
NCT00002225	A Study of Efavirenz in Combination With Stavudine and Didanosine
NCT00002226	Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma
NCT00002227	A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002228	A Study of T-20 in HIV-Positive Adults
NCT00002229	Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected Patients
NCT00002230	A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients
NCT00002231	Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers
NCT00002232	A Study of GENEVAX-HIV, a Possible Vaccine
NCT00002233	A Study of a Combination of Four Drugs in Patients With Recent HIV Infection
NCT00002234	Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients
NCT00002235	A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors
NCT00002236	A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients
NCT00002237	A Study of Peldesine (BCX-34) in HIV-Infected Patients
NCT00002238	Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen
NCT00002239	A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults
NCT00002240	Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs
NCT00002241	Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily
NCT00002243	A Study to Evaluate the Safety and Effectiveness of a New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), (+)-Calanolide A, in HIV-Positive Patients Who Have Never Received Anti-HIV Treatment
NCT00002244	A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease
NCT00002245	A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients
NCT00002246	A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex
NCT00002247	A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy
NCT00002248	A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients
NCT00002249	A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV Infection
NCT00002250	A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura
NCT00002251	A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir
NCT00002252	A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea
NCT00002253	"""A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either Responders or Non-Responders in a Prior Placebo-Controlled Double-Blind Sandostatin Study."""
NCT00002254	A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC)
NCT00002255	An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)
NCT00002256	Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine ( AZT ) Therapy.
NCT00002257	A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS
NCT00002258	A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With Cytopenia
NCT00002259	Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma
NCT00002260	An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects
NCT00002261	A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers
NCT00002262	A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma
NCT00002263	A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine
NCT00002264	The Effectiveness of Cow's Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea
NCT00002265	An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Previously Demonstrated Intolerance to Zidovudine (AZT) in Protocol N3300 or N3492
NCT00002266	An Open Parallel Study to Determine the Optimum Dosing Schedule for AS-101 in AIDS/ARC Patients
NCT00002267	Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
NCT00002268	A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria
NCT00002269	A Multicenter, Double-Blind, Controlled Study to Evaluate Ampligen
NCT00002270	A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection
NCT00002271	An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects
NCT00002272	An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies
NCT00002273	A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS
NCT00002274	A Study of ddI in Patients With AIDS Who Become Sicker While Taking Zidovudine
NCT00002275	A Comparison of Two Types of Injected Nutritional Supplements in Patients With AIDS and Pneumocystis Carinii Pneumonia (PCP)
NCT00002276	The Effects of AZT and Ibuprofen on HIV-Infected Patients With Hemophilia
NCT00002277	A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections
NCT00002278	A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS
NCT00002279	A Study of ddC in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Have Not Had Success With Zidovudine (AZT)
NCT00002280	A Study of ddI in Children With AIDS Who Have Not Had Success With Zidovudine
NCT00002281	A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex
NCT00002282	A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS
NCT00002283	A Comparison of Dapsone and Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS
NCT00002284	A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow Transplant
NCT00002285	A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDS
NCT00002286	A Study of Retrovir in the Treatment of Psoriasis in HIV-Positive Patients
NCT00002287	A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the Virus
NCT00002288	The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous System
NCT00002289	The Effects of Thymopentin on HIV Infectivity of Blood Cells and Semen in HIV-Infected Patients
NCT00002290	The Safety and Effectiveness of Zidovudine Plus Acyclovir in Patients With Early HIV Infection
NCT00002291	The Safety and Effectiveness of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Who Have Had PCP Before
NCT00002292	A Study of Two Forms of Pentamidine in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS
NCT00002293	A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes
NCT00002294	A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS
NCT00002295	A Study of Isoprinosine in Patients With Severe AIDS
NCT00002296	The Safety and Effectiveness of Isoprinosine in Patients With Weakened Immune Systems and Lymph Node Disease
NCT00002297	A Study of Isoprinosine in Patients With Lymph Node Disease
NCT00002298	The Safety and Effectiveness of Ribavirin in the Early Stages of HIV-Infection
NCT00002299	The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
NCT00002300	A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition
NCT00002301	A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir
NCT00002302	The Safety and Effectiveness of r-HuEPO in Patients With AIDS and Anemia Caused by AIDS and Treatment With AZT
NCT00002303	The Safety and Effectiveness of r-HuEPO in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Are Anemic
NCT00002304	A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
NCT00002305	A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis
NCT00002306	A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B
NCT00002307	A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients
NCT00002308	A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs
NCT00002309	A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected Patients
NCT00002310	SP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success With Acyclovir
NCT00002311	The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients
NCT00002312	The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine
NCT00002313	A Study of Nystatin in HIV-Infected Patients
NCT00002314	A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma
NCT00002315	A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems
NCT00002316	The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis
NCT00002317	A Study of Trimetrexate Plus Leucovorin in Children With Pneumocystis Carinii Pneumonia
NCT00002318	A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma
NCT00002319	A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma
NCT00002320	A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past
NCT00002321	A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis
NCT00002322	A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive Patients
NCT00002323	A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cell
NCT00002324	The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease
NCT00002325	A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
NCT00002326	The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected Patients
NCT00002327	The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients
NCT00002328	Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs
NCT00002329	A Study of MDL 28,574A in HIV-Infected Patients
NCT00002330	A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
NCT00002331	The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS
NCT00002332	A Study of Timunox (Thymopentin) in HIV-Infected Patients Receiving Other Anti-HIV Drugs
NCT00002333	A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take Zidovudine
NCT00002334	A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment
NCT00002335	The Safety and Effectiveness of 524W91
NCT00002336	The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients
NCT00002337	A Study of Multiple Doses of Vesnarinone in Advanced HIV Disease
NCT00002338	The Safety and Effectiveness of 935U83 in HIV-Infected Patients
NCT00002339	A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
NCT00002340	A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX
NCT00002341	A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole
NCT00002342	A Study of Tecogalan Sodium
NCT00002343	A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS
NCT00002344	A Study of Azithromycin in HIV-Infected Patients
NCT00002345	The Safety and Effectiveness of Megace in HIV-Infected Women
NCT00002346	The Safety and Effectiveness of Bis-POM PMEA in HIV-Infected Patients
NCT00002347	The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection
NCT00002348	A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's Lymphoma
NCT00002349	A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.
NCT00002350	A Phase I Trial of APL 400-003 Vaccine: Safety and Immune Response Evaluations of Multiple Injections at Escalating Doses in Asymptomatic HIV-Infected Patients
NCT00002351	A Study of L-735,524 in HIV-Positive Children and Adolescents
NCT00002352	A Study of Lobucavir in Patients With AIDS
NCT00002353	A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects
NCT00002354	A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients
NCT00002355	A Comparison of ISIS 2922 Used Immediately or Later in Patients With Cytomegalovirus (CMV) of the Eyes
NCT00002356	The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes
NCT00002357	The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms
NCT00002358	A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV
NCT00002359	A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega
NCT00002360	A Study Comparing Two Forms of Didanosine in HIV-infected Patients
NCT00002361	Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors
NCT00002362	A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002363	The Safety and Effectiveness of SPC3 in HIV-1 Infected Patients
NCT00002364	A Study of 1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs
NCT00002365	A Study of LXR015-1 in HIV-Infected Patients
NCT00002366	The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma
NCT00002367	A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002368	The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs
NCT00002369	A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002370	Study of Itraconazole in Patients With Advanced HIV Infection
NCT00002371	The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine
NCT00002372	A Study of 141W94 in Combination With Other Anti-HIV Drugs
NCT00002373	The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients
NCT00002374	A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients
NCT00002375	Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected Patients
NCT00002376	The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients
NCT00002377	A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes
NCT00002378	A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients
NCT00002379	The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
NCT00002380	The Safety and Effectiveness of Two Forms of Saquinavir Combined With Other Anti-HIV Drugs in HIV-Infected Infants and Children
NCT00002381	The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine
NCT00002382	A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients
NCT00002383	A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected Patients
NCT00002384	A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
NCT00002385	The Safety and Effectiveness of Fozivudine Tidoxil in HIV-1 Infected Patients
NCT00002386	Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia
NCT00002387	The Safety and Effectiveness of Indinavir Sulfate Plus Efavirenz
NCT00002388	A Study of 1592U89 in HIV-Infected Patients
NCT00002389	The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002390	A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients
NCT00002391	The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs
NCT00002392	A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART
NCT00002393	A Study of Indinavir Taken With or Without DMP 266
NCT00002394	Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment
NCT00002395	Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)
NCT00002396	The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients
NCT00002397	A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease
NCT00002398	Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations
NCT00002399	A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients
NCT00002400	A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients
NCT00002401	A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients
NCT00002402	A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines
NCT00002403	Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients
NCT00002404	The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected Patients
NCT00002405	A Study of Amprenavir in HIV-Infected Patients
NCT00002406	A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients
NCT00002407	A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs
NCT00002408	A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients
NCT00002409	The Effect of Teaching HIV-Infected Patients About HIV and Treatment
NCT00002410	A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected Patients
NCT00002411	A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs
NCT00002412	A Study of MKC-442 in Combination With Other Anti-HIV Drugs
NCT00002413	A Study of MKC-442 in HIV-Positive Patients
NCT00002414	Safety and Effectiveness of Giving CPI-1189 to HIV-Infected Patients With AIDS Dementia
NCT00002415	Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients
NCT00002416	Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination
NCT00002417	A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications
NCT00002418	The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
NCT00002419	Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment
NCT00002420	The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
NCT00002422	A Study on the Safety and Anti-HIV Activity of HE2000 in HIV-Infected Patients on Salvage Therapy
NCT00002423	A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir
NCT00002424	A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine
NCT00002425	The Safety and Effectiveness of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs
NCT00002426	A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive Patients
NCT00002427	Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults
NCT00002428	A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects
NCT00002429	Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen
NCT00002430	A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations
NCT00002431	The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients
NCT00002432	A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
NCT00002433	The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDS
NCT00002434	A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP)
NCT00002435	A Study of Thymic Humoral Factor (THF Gamma 2) in HIV-Infected Patients
NCT00002436	The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT
NCT00002437	The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
NCT00002438	A Study of Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected Patients
NCT00002439	A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma
NCT00002440	A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002441	Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection
NCT00002442	A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs
NCT00002443	The Safety and Effectiveness of MK-639 and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002444	A Study of Nitazoxanide in the Treatment of AIDS-Related Diarrhea
NCT00002445	Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients
NCT00002446	Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients
NCT00002447	A Study to Compare Two Anti-HIV Drug Combinations
NCT00002448	A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients
NCT00002449	Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy
NCT00002450	Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients
NCT00002451	Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
NCT00002452	A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir
NCT00002453	A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection
NCT00002454	Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx
NCT00002455	Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma
NCT00002456	Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation
NCT00002458	Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission
NCT00002459	Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus
NCT00002460	Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
NCT00002461	Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
NCT00002462	RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease
NCT00002463	Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors
NCT00002465	High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma
NCT00002466	Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer
NCT00002470	Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors
NCT00002471	Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
NCT00002472	Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors
NCT00002473	Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney Cancer
NCT00002474	Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer
NCT00002475	Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
NCT00002476	Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
NCT00002477	Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer
NCT00002478	Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer
NCT00002479	Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome
NCT00002480	Radiation Therapy in Treating Patients With Prostate Cancer
NCT00002481	Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT00002482	Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer
NCT00002484	Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung Cancer
NCT00002485	Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
NCT00002487	Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer
NCT00002488	Combination Chemotherapy in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy
NCT00002489	Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors
NCT00002490	Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer
NCT00002492	Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma
NCT00002493	Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
NCT00002494	Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
NCT00002495	SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease
NCT00002496	Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx
NCT00002498	Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer
NCT00002499	Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia
NCT00002501	Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma
NCT00002502	Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome
NCT00002503	Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases
NCT00002504	Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer
NCT00002505	Tumor Cell Vaccine in Treating Patients With Advanced Cancer
NCT00002506	Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
NCT00002507	Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer
NCT00002508	Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors
NCT00002509	High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer
NCT00002510	Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
NCT00002511	Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer
NCT00002514	Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
NCT00002515	Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
NCT00002516	Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma
NCT00002517	Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome
NCT00002519	Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer
NCT00002520	Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
NCT00002521	Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
NCT00002522	Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
NCT00002523	Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed
NCT00002524	Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
NCT00002525	Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed
NCT00002526	Chemotherapy in Treating Patients With Advanced Sarcoma
NCT00002527	Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
NCT00002528	Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer
NCT00002529	Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
NCT00002531	Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia
NCT00002532	Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia
NCT00002533	Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer
NCT00002534	Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission
NCT00002535	Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma
NCT00002536	Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer
NCT00002537	Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer
NCT00002538	Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers
NCT00002539	Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma
NCT00002540	Screening for Prostate Cancer in Older Patients (PLCO Screening Trial)
NCT00002542	Tamoxifen in Treating Women With High-Risk Breast Cancer
NCT00002543	Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors
NCT00002544	Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer
NCT00002545	Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
NCT00002546	Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
NCT00002547	Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome
NCT00002548	SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma
NCT00002549	Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
NCT00002550	Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
NCT00002551	SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed
NCT00002552	Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma
NCT00002553	Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer
NCT00002554	Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse
NCT00002555	High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer
NCT00002556	Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma
NCT00002557	Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides
NCT00002558	Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
NCT00002559	Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin
NCT00002560	Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma
NCT00002561	Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease
NCT00002562	Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer
NCT00002563	SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease
NCT00002564	Nutrition Intervention in Treating Women With Breast Cancer
NCT00002565	Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma
NCT00002566	Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors
NCT00002567	High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission
NCT00002568	Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer
NCT00002569	Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma
NCT00002570	Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease
NCT00002571	SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma
NCT00002572	Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors
NCT00002574	Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia
NCT00002575	Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer
NCT00002576	Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma
NCT00002577	Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
NCT00002578	Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
NCT00002579	Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer
NCT00002580	Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer
NCT00002581	Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer
NCT00002582	Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
NCT00002583	Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed
NCT00002585	Pyrazoloacridine in Treating Women With Metastatic Breast Cancer
NCT00002586	13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer
NCT00002587	Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors
NCT00002588	Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia
NCT00002589	Lymphocyte Therapy in Treating Patients With Kidney Cancer
NCT00002590	Combination Chemotherapy in Treating Children With Lymphoma
NCT00002592	Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
NCT00002593	S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed
NCT00002594	Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors
NCT00002595	Toremifene in Treating Patients With Desmoid Tumors
NCT00002596	Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
NCT00002597	Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
NCT00002598	Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia
NCT00002599	Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma
NCT00002600	Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer
NCT00002601	Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma
NCT00002602	Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
NCT00002604	O(6)-Benzylguanine and Carmustine in Treating Patients With Solid Tumors
NCT00002608	Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
NCT00002609	Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission
NCT00002610	Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors
NCT00002611	Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer
NCT00002615	Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
NCT00002616	Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
NCT00002618	Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma
NCT00002619	Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors
NCT00002620	Radiation Therapy in Treating Patients With Brain Cancer
NCT00002621	Interferon Alfa in Treating Children With HIV-Related Cancer
NCT00002622	Talc in Treating Patients With Malignant Pleural Effusion
NCT00002623	Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
NCT00002624	Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
NCT00002625	Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma
NCT00002627	Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
NCT00002628	Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer
NCT00002630	High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse
NCT00002631	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus
NCT00002632	Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer
NCT00002633	Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
NCT00002634	Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma
NCT00002635	Aminocamptothecin in Treating Patients With T-cell Lymphoma
NCT00002637	Biological Therapy in Treating Patients With Prostate Cancer
NCT00002638	Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia
NCT00002639	Suramin in Treating Patients With Recurrent Primary Brain Tumors
NCT00002641	Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
NCT00002642	SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer
NCT00002643	Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
NCT00002644	Tamoxifen for the Prevention of Breast Cancer in High-Risk Women
NCT00002646	Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer
NCT00002647	Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors
NCT00002649	Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
NCT00002650	High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed
NCT00002651	SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer
NCT00002652	Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease
NCT00002653	Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma
NCT00002654	Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer
NCT00002655	Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases
NCT00002656	Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT00002657	SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
NCT00002658	Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
NCT00002659	Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer
NCT00002662	Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer
NCT00002663	Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies
NCT00002664	Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal Cancer
NCT00002665	SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
NCT00002667	Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer
NCT00002668	Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer
NCT00002669	Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
NCT00002670	Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery
NCT00002671	Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer
NCT00002673	Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
NCT00002674	Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
NCT00002675	Chemotherapy in Treating Patients With Retinoblastoma
NCT00002676	Chemotherapy and Whole-Brain Radiation Therapy in Treating Patients With Primary Central Nervous System Non- Hodgkin's Lymphoma
NCT00002677	Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors
NCT00002678	Combination Chemotherapy in Treating Patients With Multiple Myeloma
NCT00002679	Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer
NCT00002680	Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer
NCT00002681	Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma
NCT00002682	Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
NCT00002684	Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer
NCT00002687	Interleukin-2 in Treating Patients With Mycosis Fungoides
NCT00002688	Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT00002689	Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer
NCT00002691	Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma
NCT00002692	Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
NCT00002693	Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia
NCT00002695	Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck
NCT00002696	Combination Chemotherapy in Treating Women With Stage III Breast Cancer
NCT00002697	Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
NCT00002700	Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
NCT00002701	Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia
NCT00002702	Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx
NCT00002703	Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
NCT00002704	Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
NCT00002705	Topotecan in Treating Children With Refractory Leukemia
NCT00002706	Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus
NCT00002707	Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
NCT00002708	Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
NCT00002711	Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
NCT00002714	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease
NCT00002715	Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma
NCT00002716	Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
NCT00002717	Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer
NCT00002718	T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia
NCT00002719	Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia
NCT00002720	Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer
NCT00002721	Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
NCT00002722	High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer
NCT00002723	Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer
NCT00002725	Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
NCT00002727	Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
NCT00002730	Chemotherapy in Treating Children With Neuroblastoma
NCT00002733	Biological Therapy in Treating Patients With Metastatic Cancer
NCT00002734	Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer
NCT00002735	SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue
NCT00002737	Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer
NCT00002738	Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma
NCT00002740	Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma
NCT00002742	Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer
NCT00002744	Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00002745	Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's Lymphoma
NCT00002746	Interleukin-2 in Treating Patients With Myelodysplastic Syndrome
NCT00002747	Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer
NCT00002748	Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma
NCT00002749	Carboplatin in Patients With Progressive Gliomas
NCT00002750	Melphalan in Patients With Neoplastic Meningitis
NCT00002751	Monoclonal Antibody Therapy in Treating Patients With Brain Metastases
NCT00002752	Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers
NCT00002753	Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas
NCT00002754	Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors
NCT00002755	Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
NCT00002756	Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00002757	TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma
NCT00002759	Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma
NCT00002760	Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer
NCT00002761	Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
NCT00002762	Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
NCT00002763	High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
NCT00002764	Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma
NCT00002765	Immunotoxin in Treating Patients With Leukemia or Lymphoma
NCT00002766	Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma
NCT00002767	Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
NCT00002768	Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission
NCT00002771	Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
NCT00002772	S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
NCT00002773	Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer
NCT00002774	Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
NCT00002775	Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
NCT00002777	Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer
NCT00002778	Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
NCT00002779	Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
NCT00002780	Biological Therapy in Treating Women With Metastatic Breast Cancer
NCT00002781	Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma
NCT00002783	Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer
NCT00002784	High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer
NCT00002785	Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia
NCT00002786	Biological Therapy in Treating Patients With Metastatic Melanoma
NCT00002787	Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation
NCT00002788	High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
NCT00002789	Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia
NCT00002790	Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant
NCT00002791	Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma
NCT00002792	Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders
NCT00002793	Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer
NCT00002794	Carboplatin Plus Vincristine in Treating Children With Retinoblastoma
NCT00002796	Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer
NCT00002798	Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
NCT00002800	Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
NCT00002801	Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal Cancer
NCT00002802	Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma
NCT00002803	Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma
NCT00002804	Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma
NCT00002805	Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
NCT00002806	Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
NCT00002807	Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery
NCT00002809	Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer
NCT00002810	High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis
NCT00002811	T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum
NCT00002812	Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
NCT00002813	Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer
NCT00002814	Combination Chemotherapy for Patients With Brain Cancer
NCT00002816	Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia
NCT00002817	Vaccine Therapy in Treating Patients With Metastatic Melanoma
NCT00002818	High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies
NCT00002819	Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer
NCT00002822	Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer
NCT00002823	Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer
NCT00002824	Gene Therapy in Treating Patients With Primary Brain Tumors
NCT00002825	Docetaxel in Treating Children With Recurrent Solid Tumors
NCT00002826	Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer
NCT00002827	Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease
NCT00002828	Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer
NCT00002829	Bone Marrow Transplantation in Treating Patients With Lymphoma
NCT00002831	Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia
NCT00002832	Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
NCT00002833	Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia
NCT00002835	Combination Chemotherapy in Treating Patients With Lymphoma
NCT00002836	Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer
NCT00002837	High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer
NCT00002838	Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia
NCT00002839	Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx
NCT00002840	Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma
NCT00002842	Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer
NCT00002844	Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
NCT00002845	Interleukin-2 in Treating Patients With Metastatic Melanoma
NCT00002846	Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer
NCT00002847	Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
NCT00002848	Group Therapy Compared With Educational Materials in Patients With Prostate Cancer
NCT00002849	S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis
NCT00002850	Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
NCT00002851	Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically Removed
NCT00002852	Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer
NCT00002854	High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
NCT00002855	Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
NCT00002858	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer
NCT00002860	SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
NCT00002862	Perillyl Alcohol in Treating Patients With Refractory Cancer
NCT00002863	Cryosurgery in Treating Patients With Soft Tissue Sarcoma
NCT00002864	Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer
NCT00002865	High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia
NCT00002866	Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer
NCT00002868	Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
NCT00002869	Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
NCT00002870	High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer
NCT00002872	Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions
NCT00002873	Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer
NCT00002874	Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy
NCT00002875	Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
NCT00002876	Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas
NCT00002878	Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT00002879	Cladribine in Patients With Mantle Cell Lymphoma
NCT00002880	Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
NCT00002881	Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer
NCT00002882	Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma
NCT00002883	Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus
NCT00002884	Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
NCT00002887	Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer
NCT00002888	Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
NCT00002889	Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
NCT00002890	Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
NCT00002892	Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma
NCT00002893	Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer
NCT00002894	Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer
NCT00002895	Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer
NCT00002896	Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal Cancer
NCT00002897	Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus
NCT00002898	Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma
NCT00002899	Adjuvant Radiation Therapy in Treating Patients With Brain Metastases
NCT00002900	SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial
NCT00002901	Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function
NCT00002902	Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors
NCT00002903	Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer
NCT00002904	Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors
NCT00002905	Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
NCT00002907	Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma
NCT00002908	Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
NCT00002909	Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma
NCT00002911	Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer
NCT00002912	Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia
NCT00002913	Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer
NCT00002914	Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract
NCT00002915	Penclomedine in Treating Patients With Advanced Solid Tumors
NCT00002916	Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer
NCT00002917	Paclitaxel in Treating Patients With Early-Stage Bladder Cancer
NCT00002919	Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer
NCT00002920	S9630, Medroxyprogesterone in Treating Women With Breast Cancer
NCT00002921	S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery
NCT00002922	Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
NCT00002923	KRN5500 in Treating Patients With Metastatic Solid Tumors
NCT00002924	Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
NCT00002925	Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia
NCT00002926	Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
NCT00002928	Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer
NCT00002930	PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery
NCT00002931	Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer
NCT00002932	Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck
NCT00002933	Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
NCT00002934	Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ
NCT00002935	Photodynamic Therapy in Treating Patients With Early Esophageal Cancer
NCT00002936	Altretamine and Etoposide in Treating Patients With HIV-Related Cancer
NCT00002937	Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer
NCT00002938	Surgery in Treating Patients With Prostate Cancer
NCT00002939	Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer
NCT00002940	Hydroxyurea in Treating Patients With Epstein-Barr Virus-Associated Primary CNS Lymphoma and AIDS
NCT00002941	Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma
NCT00002942	Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer
NCT00002943	Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer
NCT00002944	Combination Chemotherapy in Treating Children With Progressive Brain Tumors
NCT00002945	High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
NCT00002946	Penclomedine in Treating Patients With Solid Tumors or Lymphoma
NCT00002947	Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer
NCT00002948	High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
NCT00002949	Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis
NCT00002950	Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer
NCT00002951	Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
NCT00002952	Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma
NCT00002953	Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer
NCT00002955	Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas
NCT00002956	Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants
NCT00002960	SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084)
NCT00002961	Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia
NCT00002963	Photodynamic Therapy in Treating Patients With Skin Cancer
NCT00002964	Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer
NCT00002965	Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas
NCT00002967	Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
NCT00002968	Edrecolomab in Treating Patients With Stage II Colon Cancer
NCT00002969	S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
NCT00002970	506U78 in Treating Patients With Refractory Hematologic Cancer
NCT00002971	O(6)-Benzylguanine in Treating Patients With Malignant Glioma
NCT00002972	Paclitaxel in Treating Patients With Lung Cancer
NCT00002973	Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma
NCT00002974	Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma
NCT00002975	Photodynamic Therapy in Treating Patients With Skin Cancer
NCT00002976	Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
NCT00002977	Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission
NCT00002980	Decitabine in Treating Patients With Melanoma or Other Advanced Cancer
NCT00002981	PET Scan in Treating Patients With Metastatic Prostate Cancer
NCT00002982	Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma
NCT00002984	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus
NCT00002985	Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma
NCT00002986	Chemotherapy in Treating Patients With Recurrent Malignant Glioma
NCT00002987	Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease
NCT00002988	Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma
NCT00002989	Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome
NCT00002990	Surgery and BCG in Treating Patients With Bladder Cancer
NCT00002993	Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
NCT00002994	Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
NCT00002995	Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
NCT00002996	Flecainide in Treating Patients With Chronic Neuropathic Pain
NCT00002997	Cryosurgery in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer
NCT00002998	Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
NCT00002999	S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx
NCT00003000	Morphine for the Treatment of Pain in Patients With Breast Cancer
NCT00003001	Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
NCT00003002	HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer
NCT00003003	Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia
NCT00003004	Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors
NCT00003005	Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia
NCT00003006	Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
NCT00003007	Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma
NCT00003008	Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma
NCT00003009	Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer
NCT00003010	Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy
NCT00003011	Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer
NCT00003012	Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer
NCT00003013	Chemotherapy Plus Surgery in Treating Women With Breast Cancer
NCT00003014	Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer
NCT00003015	Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma
NCT00003016	Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer
NCT00003017	Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix
NCT00003018	S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer
NCT00003019	Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
NCT00003020	LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases
NCT00003021	Bizelesin in Treating Patients With Advanced Cancer
NCT00003022	Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer
NCT00003023	Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer
NCT00003025	Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer
NCT00003026	Hormone Therapy in Treating Patients With Advanced Prostate Cancer
NCT00003027	Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma
NCT00003028	MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors
NCT00003029	Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
NCT00003031	Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
NCT00003032	High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer
NCT00003034	ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
NCT00003035	Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer
NCT00003037	Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
NCT00003038	Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors
NCT00003039	Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma
NCT00003040	S9709, Laser Surgery Plus Radiation Therapy in Treating Patients With Early Stage Cancer of the Larynx
NCT00003041	Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer
NCT00003042	Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer
NCT00003044	Chemotherapy in Treating Patients With Liver Cancer
NCT00003045	Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer
NCT00003046	Interleukin-12 in Treating Patients With Cancer in the Abdomen
NCT00003048	Amifostine in Treating Patients With Myelodysplastic Syndrome
NCT00003049	Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas
NCT00003050	Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer
NCT00003052	Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma
NCT00003053	Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed
NCT00003054	Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus
NCT00003055	Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer
NCT00003056	Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
NCT00003057	Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer
NCT00003058	Troglitazone in Treating Patients With Liposarcoma
NCT00003060	Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma
NCT00003061	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma
NCT00003062	Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer
NCT00003063	Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer
NCT00003064	Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer
NCT00003065	Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix
NCT00003066	Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer
NCT00003067	Biological Therapy in Treating Patients With Primary or Advanced Glioma
NCT00003068	High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer
NCT00003070	Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer
NCT00003072	Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer
NCT00003073	Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors
NCT00003075	Fenretinide in Treating Patients With Cervical Neoplasia
NCT00003076	Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus
NCT00003077	Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss
NCT00003078	Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix
NCT00003079	Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma
NCT00003080	Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer
NCT00003081	Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma
NCT00003082	Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer
NCT00003084	Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer
NCT00003085	Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer
NCT00003086	Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer
NCT00003087	Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus
NCT00003088	Combination Chemotherapy in Treating Patients With Breast Cancer
NCT00003089	Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
NCT00003090	Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer
NCT00003091	High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma
NCT00003092	Paclitaxel in Treating Older Patients With Solid Tumors
NCT00003093	Combination Chemotherapy in Treating Children With Neuroblastoma
NCT00003094	Carotenoid Rich Diet in Treating Cervical Dysplasia
NCT00003095	S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
NCT00003096	Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors
NCT00003097	Low Fat Diet to Prevent Disease Progression in Patients With Skin Cancer
NCT00003098	Diet and Estrogen Metabolism in Postmenopausal Women
NCT00003099	Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer
NCT00003100	Dietary Soy Isoflavones for the Prevention of Cancer
NCT00003101	Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma
NCT00003102	Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer
NCT00003103	Chemotherapy in Treating Patients With Solid Tumors
NCT00003104	Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer
NCT00003105	Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer
NCT00003107	Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
NCT00003108	Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer
NCT00003109	Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors
NCT00003110	Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma
NCT00003111	Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
NCT00003113	Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas
NCT00003114	Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease
NCT00003115	Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy
NCT00003116	High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
NCT00003117	Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT00003118	Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
NCT00003119	Surgery in Treating Children With Neuroblastoma
NCT00003120	S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
NCT00003122	Surgery in Treating Patients With Neuroblastoma
NCT00003123	Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome
NCT00003124	Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
NCT00003125	Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors
NCT00003126	Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer
NCT00003127	S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer
NCT00003128	Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus
NCT00003129	Chemotherapy in Treating Patients With Early-Stage Bladder Cancer
NCT00003130	Paclitaxel in Treating Women With Recurrent Solid Tumors
NCT00003131	CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse
NCT00003132	Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer
NCT00003133	Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer
NCT00003134	Irinotecan in Treating Patients With Recurrent Glioma
NCT00003135	Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer
NCT00003136	Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer
NCT00003137	Irinotecan in Treating Patients With Advanced Cancer of the Stomach
NCT00003138	Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
NCT00003139	Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
NCT00003140	Letrozole After Tamoxifen in Treating Women With Breast Cancer
NCT00003141	Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors
NCT00003143	Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation
NCT00003144	Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors
NCT00003145	Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia
NCT00003146	Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
NCT00003147	Gene Therapy in Treating Patients With Cancer of The Liver
NCT00003148	Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia
NCT00003149	Interleukin-12 in Treating Patients With Multiple Myeloma
NCT00003150	Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma
NCT00003151	Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
NCT00003152	Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma
NCT00003153	Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation
NCT00003154	Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT00003156	Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus
NCT00003157	Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
NCT00003158	S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer
NCT00003159	Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer
NCT00003160	Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum
NCT00003162	Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
NCT00003163	Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers
NCT00003165	Doxorubicin in Treating Women With Advanced Breast Cancer
NCT00003166	Bryostatin and Vincristine in B-Cell Malignancies
NCT00003167	Gene Therapy in Treating Patients With Advanced Bladder Cancer
NCT00003170	Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
NCT00003171	Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome
NCT00003172	Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer
NCT00003173	High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors
NCT00003174	Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
NCT00003175	Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer
NCT00003176	Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma
NCT00003178	Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia
NCT00003179	Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer
NCT00003181	Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer
NCT00003182	Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck
NCT00003183	Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer
NCT00003184	Vaccine Therapy in Treating Women With Metastatic Breast Cancer
NCT00003185	Biological Therapy in Treating Patients With Glioblastoma Multiforme
NCT00003186	Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer
NCT00003187	Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma
NCT00003190	Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia
NCT00003191	Fenretinide in Treating Children With Solid Tumors
NCT00003192	Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus
NCT00003193	Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer
NCT00003194	Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors
NCT00003195	Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma
NCT00003196	Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma
NCT00003197	Green Tea Extract in Treating Patients With Advanced Solid Tumors
NCT00003198	Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors
NCT00003199	Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer
NCT00003200	Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck
NCT00003202	Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
NCT00003203	Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors
NCT00003204	Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's Lymphoma
NCT00003205	Bryostatin 1 in Treating Patients With Stage IV Breast Cancer
NCT00003206	Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer
NCT00003207	Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers
NCT00003209	Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer
NCT00003210	Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease
NCT00003211	Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
NCT00003212	Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
NCT00003213	Drugs to Reduce the Side Effects of Chemotherapy
NCT00003214	Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer
NCT00003215	Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma
NCT00003216	Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas
NCT00003217	Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia
NCT00003219	Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer
NCT00003220	Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer
NCT00003222	Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
NCT00003223	SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth
NCT00003224	Vaccine Therapy in Treating Patients With Metastatic Melanoma
NCT00003225	Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer
NCT00003229	Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal
NCT00003230	Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia
NCT00003231	Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer
NCT00003232	Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer
NCT00003234	Vinorelbine in Treating Children With Recurrent or Refractory Cancers
NCT00003235	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed
NCT00003236	Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer
NCT00003237	Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach
NCT00003238	Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00003239	Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
NCT00003240	Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
NCT00003241	Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors
NCT00003242	Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid Tumors
NCT00003243	Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer
NCT00003245	Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
NCT00003248	Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic Leukemia
NCT00003249	Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers
NCT00003250	Fenretinide in Treating Patients With Solid Tumors
NCT00003251	Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer
NCT00003252	Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy
NCT00003253	Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer
NCT00003254	SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil
NCT00003255	Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia
NCT00003256	Flavopiridol in Treating Patients With Recurrent Prostate Cancer
NCT00003257	Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer
NCT00003259	Vinorelbine in Treating Patients With Metastatic Prostate Cancer
NCT00003260	Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer
NCT00003261	Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma
NCT00003262	Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection
NCT00003263	Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
NCT00003264	Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer
NCT00003266	Methylphenidate in Treating Patients With Melanoma
NCT00003267	Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer
NCT00003268	Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
NCT00003269	Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
NCT00003270	Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
NCT00003273	Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor
NCT00003274	Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery
NCT00003276	Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
NCT00003278	Radiation Therapy and High-Dose Corticosteroids in Treating Older Patients With Primary CNS Non-Hodgkin's Lymphoma
NCT00003279	Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
NCT00003280	Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma
NCT00003281	Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer
NCT00003282	EF5 in Treating Patients With Solid Tumors
NCT00003283	Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
NCT00003284	High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer
NCT00003287	Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
NCT00003288	Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors
NCT00003289	UCN-01 in Treating Patients With Advanced Cancer
NCT00003290	Radiation Therapy in Treating Patients With Prostate Cancer
NCT00003291	Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia
NCT00003292	S9624 Ifosfamide in Treating Patients With Meningeal Tumors
NCT00003293	SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme
NCT00003294	Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer
NCT00003296	Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer
NCT00003297	Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer
NCT00003298	Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer
NCT00003299	Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer
NCT00003301	Irinotecan in Treating Patients With Recurrent Malignant Glioma
NCT00003302	MRI to Detect Breast Tumors in Women
NCT00003304	Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
NCT00003305	Aminopterin in Treating Patients With Refractory Leukemia
NCT00003307	Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer
NCT00003308	Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma
NCT00003309	Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer
NCT00003311	Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
NCT00003312	Brachytherapy in Treating Patients With Prostate Cancer
NCT00003313	Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
NCT00003315	Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With Invasive Fungal Infection
NCT00003316	Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus
NCT00003317	Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
NCT00003320	Radiation Therapy Following Surgery to Remove Brain Metastases
NCT00003321	Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus
NCT00003322	Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer
NCT00003323	Hormone Therapy in Treating Patients With Prostate Cancer
NCT00003324	Radiation Therapy With or Without Surgery in Treating Patients Who Have Brain Metastases
NCT00003325	Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva
NCT00003326	Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus
NCT00003327	Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
NCT00003328	Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
NCT00003329	Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
NCT00003330	Interleukin-12 in Treating Patients With Advanced Cancer
NCT00003331	Combination Chemotherapy in Treating Patients With Advanced Cancer
NCT00003332	Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer
NCT00003334	Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract
NCT00003335	Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer
NCT00003336	Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions
NCT00003337	Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma
NCT00003338	Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma
NCT00003339	Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma
NCT00003340	Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia
NCT00003341	Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy
NCT00003342	Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer
NCT00003343	Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer
NCT00003344	Radiation Therapy Plus Irinotecan in Treating Patients With Colon Cancer
NCT00003345	Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
NCT00003346	Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma
NCT00003348	Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain
NCT00003350	Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma
NCT00003351	Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
NCT00003352	Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer
NCT00003353	High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis
NCT00003354	Conventional Surgery Compared With Laparoscopic-Assisted Surgery in Treating Patients With Colorectal Cancer
NCT00003356	Rituximab Plus Interleukin-2 in Treating Patients With Lymphoma
NCT00003357	Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease
NCT00003358	Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
NCT00003359	T138067 Sodium in Treating Patients With Advanced Refractory Cancer
NCT00003360	Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Colorectal Cancer
NCT00003361	Decitabine in Treating Patients With Myelodysplastic Syndrome
NCT00003362	Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma
NCT00003364	Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer
NCT00003365	Sulindac and Plant Compounds in Preventing Colon Cancer
NCT00003367	Diet and PSA Levels in Patients With Prostate Cancer
NCT00003368	Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis
NCT00003369	S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer
NCT00003370	Irofulven in Treating Children With Recurrent or Refractory Solid Tumors
NCT00003372	Topotecan in Treating Patients With Recurrent Brain Tumors
NCT00003375	Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma
NCT00003376	Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium
NCT00003377	Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix
NCT00003378	Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer
NCT00003379	Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer
NCT00003380	Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer
NCT00003381	Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781]
NCT00003382	Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer
NCT00003384	Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer
NCT00003385	Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer
NCT00003386	Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
NCT00003387	Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery
NCT00003388	Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
NCT00003389	Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
NCT00003390	6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer
NCT00003391	Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00003392	High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
NCT00003394	Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
NCT00003395	Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer
NCT00003396	Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
NCT00003397	Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
NCT00003398	Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
NCT00003399	Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma
NCT00003400	Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer
NCT00003401	Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma
NCT00003402	Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
NCT00003403	GPX-100 in Treating Patients With Solid Tumors
NCT00003404	Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast
NCT00003405	Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
NCT00003406	Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
NCT00003407	Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
NCT00003408	Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
NCT00003409	Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00003410	Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas
NCT00003411	Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer
NCT00003412	Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation
NCT00003413	Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
NCT00003414	Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
NCT00003415	Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome
NCT00003416	S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia
NCT00003417	Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme
NCT00003418	Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer
NCT00003419	Antiviral Therapy in Treating Patients With Slowly Progressing HIV-Related Kaposi's Sarcoma
NCT00003420	CT Scans in Treating Patients With Stage I Testicular Cancer After Undergoing Orchiectomy
NCT00003421	Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease
NCT00003422	Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed
NCT00003423	Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
NCT00003424	Tamoxifen in Treating Patients With Primary Liver Cancer
NCT00003425	Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect
NCT00003426	Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
NCT00003427	Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer
NCT00003428	Hormone Therapy in Treating Women With Breast Cancer
NCT00003429	PET Scans in Diagnosing Primary or Recurrent Cervical Cancer in Patients Who Are Undergoing Surgery
NCT00003430	L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors
NCT00003431	Flt3L in Treating Patients With Metastatic Colorectal Cancer
NCT00003432	Immunotherapy in Treating Patients With Metastatic Breast Cancer
NCT00003433	Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer
NCT00003434	Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer
NCT00003435	Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer
NCT00003436	Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia
NCT00003437	Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
NCT00003439	Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer
NCT00003440	Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic
NCT00003441	Irofulven in Treating Patients With Metastatic Colorectal Cancer
NCT00003443	Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
NCT00003444	Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin
NCT00003445	Docetaxel in Treating Patients With Advanced Cancer of the Cervix
NCT00003446	Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
NCT00003447	Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
NCT00003449	Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer
NCT00003450	Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer
NCT00003451	Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer
NCT00003452	Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder
NCT00003453	Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
NCT00003454	Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer
NCT00003455	Antineoplaston Therapy in Treating Women With Advanced Breast Cancer
NCT00003456	Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme
NCT00003457	Antineoplaston Therapy in Treating Patients With Brain Tumors
NCT00003458	Antineoplaston Therapy in Treating Children With Brain Tumors
NCT00003459	Antineoplaston Therapy in Treating Patients With Brain Stem Glioma
NCT00003460	Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors
NCT00003461	Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors
NCT00003462	Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors
NCT00003463	Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas
NCT00003464	Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme
NCT00003465	Temozolomide in Treating Patients With Anaplastic Oligodendroglioma
NCT00003466	Temozolomide in Treating Patients With Progressive Low-Grade Glioma
NCT00003467	Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma
NCT00003468	Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma
NCT00003469	Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System
NCT00003470	Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma
NCT00003471	Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma
NCT00003472	Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma
NCT00003473	Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas
NCT00003474	Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme
NCT00003475	Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
NCT00003476	Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
NCT00003477	Antineoplaston Therapy in Treating Children With Visual Pathway Glioma
NCT00003478	Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors
NCT00003479	Antineoplaston Therapy in Treating Patients With Ependymoma
NCT00003483	Antineoplaston Therapy in Treating Patients With Meningioma
NCT00003484	Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors
NCT00003485	Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer
NCT00003486	Antineoplaston Therapy in Treating Patients With Colon Cancer
NCT00003487	Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus
NCT00003489	Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer
NCT00003490	Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma
NCT00003491	Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
NCT00003492	Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
NCT00003493	Combination Chemotherapy in Treating Patients With Multiple Myeloma
NCT00003494	Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
NCT00003495	Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
NCT00003496	Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer
NCT00003497	Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
NCT00003498	Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma
NCT00003499	Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma
NCT00003500	Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma
NCT00003501	Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's Lymphoma
NCT00003502	Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma
NCT00003505	Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma
NCT00003508	Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
NCT00003509	Antineoplaston Therapy in Treating Patients With Stage IV Melanoma
NCT00003511	Antineoplaston Therapy in Treating Patients With Multiple Myeloma
NCT00003512	Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia
NCT00003513	Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma
NCT00003514	Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
NCT00003515	Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors
NCT00003516	Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
NCT00003517	Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
NCT00003518	Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors
NCT00003519	Combination Chemotherapy in Treating Women With Breast Cancer
NCT00003520	Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer
NCT00003521	Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma
NCT00003522	Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine
NCT00003523	Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum
NCT00003524	Antineoplaston Therapy in Treating Patients With Stomach Cancer
NCT00003525	Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva
NCT00003526	Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin
NCT00003528	Raltitrexed in Treating Children With Refractory Acute Leukemia
NCT00003530	Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
NCT00003531	Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer
NCT00003532	Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
NCT00003533	Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer
NCT00003534	Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer
NCT00003535	Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma
NCT00003536	Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer
NCT00003537	Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma
NCT00003538	Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
NCT00003539	Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer
NCT00003540	Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and Paclitaxel
NCT00003541	Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
NCT00003542	Interferon Alfa in Treating Patients With Advanced Kidney Cancer
NCT00003543	Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
NCT00003544	Irinotecan in Treating Patients With Metastatic Colorectal Cancer
NCT00003545	506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
NCT00003546	Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
NCT00003548	Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
NCT00003549	S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer
NCT00003551	Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer
NCT00003552	Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma
NCT00003553	Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer
NCT00003554	Rituximab in Treating Patients With Multiple Myeloma
NCT00003555	Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors
NCT00003556	Vaccine Therapy in Treating Patients With Melanoma
NCT00003557	Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer
NCT00003558	Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin
NCT00003560	Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00003561	Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
NCT00003562	Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
NCT00003563	Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases
NCT00003564	Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas
NCT00003565	Docetaxel in Treating Patients With Solid Tumors
NCT00003566	Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung Cancer
NCT00003567	Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
NCT00003568	Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma
NCT00003569	Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel
NCT00003571	Gene Testing in Patients With Colon Cancer
NCT00003572	Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers
NCT00003573	Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
NCT00003574	Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors
NCT00003575	Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma
NCT00003576	Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery
NCT00003577	Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer
NCT00003578	High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma
NCT00003580	Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer
NCT00003582	Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer
NCT00003583	Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer
NCT00003584	Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer
NCT00003585	Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer
NCT00003587	S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
NCT00003588	Gene Therapy in Treating Patients With Ovarian Cancer
NCT00003589	Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT00003590	S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma
NCT00003591	Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer
NCT00003592	Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
NCT00003593	Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
NCT00003594	Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
NCT00003595	Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma
NCT00003596	Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
NCT00003597	Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
NCT00003598	UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia
NCT00003599	Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung Cancer
NCT00003600	Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
NCT00003601	Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome
NCT00003602	Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
NCT00003603	Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma
NCT00003604	Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery
NCT00003605	Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma
NCT00003606	Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
NCT00003607	Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
NCT00003610	Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
NCT00003611	Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation
NCT00003612	Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer
NCT00003613	O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell Lymphoma
NCT00003614	Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
NCT00003615	Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma
NCT00003616	Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma
NCT00003617	Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach
NCT00003619	Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia
NCT00003620	Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia
NCT00003621	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma
NCT00003622	Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
NCT00003623	High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer
NCT00003624	Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer
NCT00003625	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma
NCT00003626	Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy
NCT00003627	Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx
NCT00003630	Arsenic Trioxide in Treating Patients With Advanced Solid Tumors
NCT00003631	Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
NCT00003632	Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma
NCT00003633	Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
NCT00003634	Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy
NCT00003635	506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents
NCT00003636	Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer
NCT00003637	Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx
NCT00003638	Vaccine Therapy in Treating Women With Metastatic Breast Cancer
NCT00003639	Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma
NCT00003640	Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
NCT00003641	High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
NCT00003642	Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer
NCT00003643	Combination Chemotherapy in Treating Men With Germ Cell Cancer
NCT00003644	Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
NCT00003645	Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
NCT00003646	Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma
NCT00003647	Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma
NCT00003648	Genetic Study of Patients and Families With a History of Colorectal Cancer
NCT00003649	Gene Therapy in Treating Patients With Non-Small Cell Lung Cancer That Cannot Be Surgically Removed
NCT00003650	Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
NCT00003652	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
NCT00003653	Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
NCT00003654	Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer
NCT00003656	Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer
NCT00003657	High-dose ICE With Amifostine
NCT00003658	Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers
NCT00003659	Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia
NCT00003661	Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
NCT00003662	Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases
NCT00003663	Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's Lymphoma
NCT00003664	Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically
NCT00003665	Vaccine Therapy in Treating Patients With Stage IV Melanoma
NCT00003666	Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer
NCT00003667	Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma
NCT00003669	Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer
NCT00003670	Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer
NCT00003671	Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia
NCT00003673	CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse
NCT00003674	Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer
NCT00003675	Topotecan in Treating Patients With Myelodysplastic Syndrome
NCT00003677	Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer
NCT00003678	Tamoxifen in Treating Women With Breast Cancer
NCT00003679	Combination Chemotherapy in Treating Women With Breast Cancer
NCT00003680	Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer
NCT00003681	Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome
NCT00003682	Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer
NCT00003683	Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer
NCT00003684	Theophylline in Treating Cancer Patients With Shortness of Breath
NCT00003685	Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer
NCT00003686	Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids
NCT00003687	Treatment for Chronic Pain in Patients With Advanced Cancer
NCT00003688	Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia
NCT00003690	Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors
NCT00003691	Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
NCT00003692	Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer
NCT00003693	Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
NCT00003694	Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase
NCT00003695	Chemotherapy With or Without Surgery in Treating Patients With Stage II or Stage III Ovarian Cancer
NCT00003696	Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer
NCT00003697	Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors
NCT00003698	Chemotherapy in Treating Patients With Solid Tumors
NCT00003700	Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
NCT00003701	Combination Chemotherapy in Treating Patients With Bladder Cancer
NCT00003702	Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
NCT00003703	Chemotherapy in Treating Patients With Advanced Solid Tumors
NCT00003704	Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
NCT00003705	BMS-184476 in Treating Patients With Advanced Solid Tumors
NCT00003706	LY231514 in Treating Patients With Locally Advanced or Metastatic Solid Tumors and Varying Degrees of Kidney Function
NCT00003707	Combination Chemotherapy in Treating Patients With Advanced Cancer
NCT00003708	Chemotherapy in Treating Patients With Advanced Solid Tumors
NCT00003709	Chemotherapy in Treating Patients With Advanced Solid Tumors
NCT00003710	Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors
NCT00003711	Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors
NCT00003712	CCI-779 in Treating Patients With Advanced Solid Tumors
NCT00003713	Chemotherapy in Treating Patients With Advanced or Metastatic Solid Tumors
NCT00003714	Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer
NCT00003715	Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma
NCT00003716	Monoclonal Antibody Therapy in Treating Patients With Lymphoproliferative Disorder Associated With Immunosuppression Therapy
NCT00003717	Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
NCT00003718	Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
NCT00003719	Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma
NCT00003720	SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
NCT00003721	Chemotherapy in Treating Patients With Advanced Solid Tumors
NCT00003723	S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
NCT00003724	Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
NCT00003725	Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
NCT00003726	Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer
NCT00003727	Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia
NCT00003728	Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma
NCT00003729	Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia
NCT00003730	Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer
NCT00003731	Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
NCT00003732	Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer
NCT00003733	Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer
NCT00003734	Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
NCT00003735	Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
NCT00003736	MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer
NCT00003737	Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma
NCT00003739	Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy
NCT00003740	Trastuzumab in Treating Patients With Prostate Cancer
NCT00003741	Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma
NCT00003742	Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors
NCT00003743	Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation
NCT00003744	Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery
NCT00003745	Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas
NCT00003746	Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia
NCT00003747	Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma
NCT00003748	Irinotecan in Treating Patients With Esophageal or Stomach Cancer
NCT00003749	Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer
NCT00003750	Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors
NCT00003751	Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma
NCT00003752	Bexarotene in Treating Patients With Metastatic Breast Cancer
NCT00003753	Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer
NCT00003754	Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers
NCT00003755	Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid Tumor
NCT00003757	Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy
NCT00003758	Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia
NCT00003759	AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer
NCT00003760	Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer
NCT00003761	Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
NCT00003762	Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
NCT00003763	Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer
NCT00003764	Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
NCT00003765	O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors
NCT00003766	O6-benzylguanine Followed by Surgery in Treating Patients With Solid Tumors That Can Be Removed During Surgery
NCT00003768	Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors
NCT00003769	Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer
NCT00003771	Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer
NCT00003772	Quality-of-Life Assessment in Patients With Ovarian Cancer
NCT00003773	IM-862 in Treating Patients With Recurrent Ovarian Cancer
NCT00003775	Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse
NCT00003776	Combination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
NCT00003777	Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer
NCT00003778	Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma
NCT00003779	Biological Therapy in Treating Patients With Bladder Cancer
NCT00003780	Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas
NCT00003781	Docetaxel in Treating Patients With Stage IV Prostate Cancer
NCT00003782	Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
NCT00003783	Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
NCT00003784	S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
NCT00003786	Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer
NCT00003787	Women's Healthy Eating and Living Study
NCT00003788	Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas
NCT00003789	Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg
NCT00003790	Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome
NCT00003792	Vaccine Therapy in Treating Patients With Metastatic Melanoma
NCT00003793	Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma
NCT00003794	Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
NCT00003795	Quality of Life in Survivors of Gynecologic Cancer
NCT00003796	Irofulven in Treating Patients With Metastatic Breast Cancer
NCT00003797	Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas
NCT00003798	Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery
NCT00003799	Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer
NCT00003800	Diagnostic Study of Patients With Stage I Testicular Cancer
NCT00003801	Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma
NCT00003802	Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma
NCT00003803	Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed
NCT00003804	Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor
NCT00003805	Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
NCT00003808	Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia
NCT00003809	Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
NCT00003810	Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas
NCT00003811	Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
NCT00003812	Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
NCT00003814	Eflornithine in Treating Patients With Bladder Cancer
NCT00003815	Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
NCT00003816	Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
NCT00003817	Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy
NCT00003819	Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
NCT00003820	Rituximab in Treating Patients With Hodgkin's Lymphoma
NCT00003821	Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
NCT00003822	SR-45023A in Treating Patients With Advanced Solid Tumors
NCT00003824	S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer
NCT00003825	Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
NCT00003827	Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome
NCT00003828	S9804: Vinorelbine in Treating Patients With Stage IV Melanoma
NCT00003829	Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
NCT00003830	Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer
NCT00003831	Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
NCT00003832	Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer
NCT00003833	Genetic Study in Patients With Stage II or Stage III Colon Cancer
NCT00003834	Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
NCT00003835	Combination Chemotherapy in Treating Patients With Stage III Colon Cancer
NCT00003837	506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
NCT00003838	Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow
NCT00003840	DTGM Fusion Protein in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia
NCT00003842	IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma
NCT00003843	Irinotecan in Treating Patients With Colorectal Cancer
NCT00003846	Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors
NCT00003847	VX-710, Doxorubicin, and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung Cancer
NCT00003849	Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
NCT00003850	Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT00003851	Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer
NCT00003852	Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
NCT00003853	4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis
NCT00003854	Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
NCT00003855	Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
NCT00003856	Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy
NCT00003857	Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
NCT00003858	Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence
NCT00003859	Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS
NCT00003860	Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer
NCT00003861	Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
NCT00003862	Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer
NCT00003863	Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
NCT00003864	Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus
NCT00003865	Toremifene in Treating Patients With Ovarian Cancer
NCT00003867	Irinotecan and Capecitabine in Treating Patients With Solid Tumors
NCT00003868	Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia
NCT00003869	Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer
NCT00003870	Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia
NCT00003871	PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer
NCT00003873	Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer
NCT00003874	Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia
NCT00003875	Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia
NCT00003876	Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma
NCT00003877	Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer
NCT00003878	Carmustine Implants in Treating Patients With Brain Metastases
NCT00003880	Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer
NCT00003881	Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT00003882	Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors
NCT00003883	Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation
NCT00003884	Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
NCT00003885	Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma
NCT00003887	Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation
NCT00003888	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
NCT00003890	MG98 in Treating Patients With Advanced Solid Tumors
NCT00003891	Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors
NCT00003892	ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer
NCT00003893	Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer
NCT00003894	Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant
NCT00003895	Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma
NCT00003896	S9912 Combination Chemo in Stage III Ovarian Cancer,
NCT00003897	Vaccine Therapy With gp100 and/or Sargramostim in Treating Patients With Malignant Melanoma
NCT00003898	Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation
NCT00003899	Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors
NCT00003900	Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer
NCT00003901	Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery
NCT00003902	Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement
NCT00003903	Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer
NCT00003906	Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
NCT00003907	Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
NCT00003908	S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
NCT00003909	Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
NCT00003910	Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia
NCT00003911	S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases
NCT00003912	Chemotherapy in Treating Children With Liver Cancer
NCT00003913	Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease
NCT00003914	Dolastatin 10 in Treating Patients With Advanced Kidney Cancer
NCT00003916	Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma
NCT00003917	Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer
NCT00003920	Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer
NCT00003923	Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas
NCT00003924	Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
NCT00003925	Combination Chemotherapy In Treating Patients With Advanced Cancer
NCT00003926	Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
NCT00003927	Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
NCT00003928	Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer
NCT00003929	Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
NCT00003930	Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
NCT00003931	Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia
NCT00003933	Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia
NCT00003934	Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia
NCT00003935	Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
NCT00003936	Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease
NCT00003937	Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma
NCT00003938	Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients
NCT00003939	Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
NCT00003941	Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer
NCT00003942	Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
NCT00003943	Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.
NCT00003944	Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00003945	Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
NCT00003946	Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer
NCT00003950	Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer
NCT00003951	DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas
NCT00003953	Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
NCT00003954	Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
NCT00003955	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
NCT00003956	Combination Chemotherapy in Treating Patients With Advanced Cancer
NCT00003957	Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
NCT00003958	Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma
NCT00003959	Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome
NCT00003960	Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
NCT00003961	Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome
NCT00003962	Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
NCT00003963	Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation
NCT00003966	Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation
NCT00003967	Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer
NCT00003968	Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer
NCT00003969	Geldanamycin Analogue in Treating Patients With Advanced Cancer
NCT00003970	Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma
NCT00003972	Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer
NCT00003974	Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma
NCT00003976	E7070 in Treating Patients With Solid Tumors
NCT00003977	Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer
NCT00003979	CHS 828 in Treating Patients With Solid Tumors
NCT00003980	BIBX 1382 in Treating Patients With Solid Tumors
NCT00003981	E7070 in Treating Patients With Solid Tumors
NCT00003982	MEN-10755 in Treating Patients With Solid Tumors
NCT00003984	Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome
NCT00003985	KRN7000 in Treating Patients With Solid Tumors
NCT00003989	ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma
NCT00003991	Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
NCT00003992	Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2
NCT00003993	Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma
NCT00003994	Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer
NCT00003995	Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2
NCT00003996	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00003997	6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
NCT00003998	Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer
NCT00004001	S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00004002	PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma
NCT00004003	Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery
NCT00004004	Procarbazine in Treating Patients With Recurrent Brain Tumor
NCT00004005	Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin
NCT00004006	Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma
NCT00004008	Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer
NCT00004009	R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia
NCT00004010	Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease
NCT00004011	S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
NCT00004012	Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00004013	Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer
NCT00004014	Liposomal Doxorubicin in Treating Patients With Prostate Cancer
NCT00004015	Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery
NCT00004016	Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors
NCT00004017	Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma
NCT00004022	Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma
NCT00004024	Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
NCT00004025	Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
NCT00004026	CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy
NCT00004028	Carmustine in Treating Patients With Recurrent Malignant Glioma
NCT00004029	Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
NCT00004030	VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin
NCT00004031	SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
NCT00004032	Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer
NCT00004033	Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma
NCT00004036	Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer
NCT00004037	Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer
NCT00004038	Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer
NCT00004039	Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma
NCT00004040	Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy
NCT00004041	Gene Therapy in Treating Patients With Recurrent Malignant Gliomas
NCT00004042	Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer
NCT00004043	Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer
NCT00004045	Chemotherapy in Treating Patients With Prostate Cancer
NCT00004046	Chemotherapy in Treating Women With Metastatic Breast Cancer
NCT00004047	Chemotherapy in Treating Patients Who Have Hematologic Cancer
NCT00004048	Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer
NCT00004049	SR-45023A in Treating Patients With Locally Advanced or Metastatic Solid Tumors
NCT00004050	Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer
NCT00004051	Irinotecan in Treating Patients With Advanced Solid Tumors
NCT00004052	Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia
NCT00004054	Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
NCT00004055	Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
NCT00004056	Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia
NCT00004057	Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas
NCT00004058	12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
NCT00004059	Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors
NCT00004060	Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer
NCT00004061	Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer
NCT00004062	Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer
NCT00004063	Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer
NCT00004064	Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
NCT00004065	Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
NCT00004066	Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma
NCT00004067	Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
NCT00004068	Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor
NCT00004070	Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer
NCT00004071	Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer
NCT00004072	O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma
NCT00004073	Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00004074	Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004075	17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
NCT00004076	PNU 166148 in Treating Patients With Metastatic Solid Tumors
NCT00004077	Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer
NCT00004078	Irinotecan in Treating Children With Refractory Solid Tumors
NCT00004079	Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00004080	Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors
NCT00004081	Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer
NCT00004082	Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors
NCT00004083	Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer
NCT00004084	Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia
NCT00004085	Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer
NCT00004086	Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer
NCT00004087	Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer
NCT00004088	Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma
NCT00004089	Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer
NCT00004090	Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors
NCT00004091	Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results
NCT00004092	Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
NCT00004093	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
NCT00004094	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx
NCT00004095	Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
NCT00004096	Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
NCT00004097	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer
NCT00004099	Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
NCT00004100	Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
NCT00004101	Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
NCT00004102	Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
NCT00004103	Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer
NCT00004104	Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma
NCT00004105	Combination Chemotherapy in Treating Patients With Advanced Cancer
NCT00004106	Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome
NCT00004107	Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia
NCT00004108	DX-8951f in Treating Patients With Liver Cancer
NCT00004109	Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma
NCT00004110	Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma
NCT00004112	Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
NCT00004113	Temozolomide in Treating Patients With Recurrent Malignant Glioma
NCT00004114	Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer
NCT00004115	Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy
NCT00004122	BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer
NCT00004123	Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma
NCT00004124	S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
NCT00004125	Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
NCT00004126	Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer
NCT00004127	Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach
NCT00004128	Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
NCT00004129	Phosphorus 32 in Treating Patients With Glioblastoma Multiforme
NCT00004132	Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer
NCT00004135	Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer
NCT00004136	Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
NCT00004137	S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer
NCT00004138	Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
NCT00004139	Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
NCT00004141	Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma
NCT00004142	Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
NCT00004143	Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure Syndromes
NCT00004144	Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer
NCT00004145	Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
NCT00004146	Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM
NCT00004147	COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors
NCT00004148	Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma
NCT00004149	Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy
NCT00004150	High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
NCT00004151	Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT00004152	PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma
NCT00004153	Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma
NCT00004154	Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer
NCT00004156	Vaccine Therapy in Treating Patients With Breast Cancer
NCT00004157	Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors
NCT00004158	Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
NCT00004159	Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor
NCT00004160	Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed
NCT00004161	Fenretinide in Treating Patients With Leukoplakia of the Mouth
NCT00004162	Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma
NCT00004163	Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer
NCT00004164	Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx
NCT00004165	Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
NCT00004166	Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy
NCT00004169	Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease
NCT00004171	Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma
NCT00004172	Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
NCT00004173	Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer
NCT00004174	Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
NCT00004175	Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer
NCT00004176	Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
NCT00004177	Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer
NCT00004178	Gene Therapy in Treating Patients With Cancer
NCT00004179	Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
NCT00004180	Rosiglitazone in Treating Patients With Liposarcoma
NCT00004181	Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia
NCT00004182	Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer
NCT00004183	Capecitabine in Treating Patients With Malignant Mesothelioma
NCT00004184	Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma
NCT00004186	Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
NCT00004187	Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
NCT00004188	Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
NCT00004189	Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer
NCT00004190	Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer
NCT00004192	Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma
NCT00004193	ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal Cancer
NCT00004194	Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease
NCT00004195	Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer
NCT00004196	Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
NCT00004197	Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
NCT00004198	Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma
NCT00004199	Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung Cancer
NCT00004200	Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00004201	Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer
NCT00004202	Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer
NCT00004203	Oxaliplatin in Treating Patients With Metastatic Bladder Cancer
NCT00004204	Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma
NCT00004205	Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer
NCT00004206	Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer
NCT00004207	Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer
NCT00004208	Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome
NCT00004209	Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
NCT00004210	Study of the Results of Education and Counseling for Persons Undergoing Genetic Testing for Hereditary Nonpolyposis Colon Cancer
NCT00004211	Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
NCT00004212	DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas
NCT00004213	3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors
NCT00004215	Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia
NCT00004216	VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy
NCT00004217	S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
NCT00004218	Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
NCT00004219	Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma
NCT00004220	Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer
NCT00004221	Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer
NCT00004223	Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer
NCT00004224	Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma
NCT00004225	Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
NCT00004226	Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy
NCT00004227	Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
NCT00004228	Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma
NCT00004229	Endostatin in Treating Patients With Advanced Solid Tumors
NCT00004230	Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation
NCT00004231	Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
NCT00004232	Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
NCT00004233	S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach
NCT00004234	Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
NCT00004235	Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach
NCT00004236	Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer
NCT00004237	Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer
NCT00004238	10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
NCT00004239	506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
NCT00004241	17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma
NCT00004242	Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00004243	Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor
NCT00004244	Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma
NCT00004245	Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia
NCT00004246	Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx
NCT00004248	Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
NCT00004249	Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy
NCT00004250	Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery
NCT00004251	Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer
NCT00004252	Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer
NCT00004253	Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery
NCT00004254	Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed
NCT00004255	Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation
NCT00004256	Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer
NCT00004257	Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer
NCT00004258	EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer
NCT00004259	Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas
NCT00004260	Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
NCT00004261	EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
NCT00004262	Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme
NCT00004263	Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
NCT00004264	Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT00004265	Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung Cancer
NCT00004266	Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes
NCT00004268	Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension
NCT00004274	Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome
NCT00004275	Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome
NCT00004276	Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections
NCT00004278	Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus Infection
NCT00004284	Phase III Randomized, Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for Absorptive Hypercalciuria
NCT00004285	Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
NCT00004286	Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy
NCT00004287	Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic Fibrosis
NCT00004288	Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis
NCT00004293	Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease
NCT00004294	Phase I Study of Retrovirally Mediated Transfer of the Human Glucocerebrosidase Gene Into Peripheral Blood Stem Cells for Autologous Transplantation in Patients With Type I Gaucher Disease
NCT00004296	Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients
NCT00004297	Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus
NCT00004300	Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis
NCT00004305	Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis
NCT00004306	Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)
NCT00004307	Study of Treatment and Metabolism in Patients With Urea Cycle Disorders
NCT00004310	Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive Disorder
NCT00004311	Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome
NCT00004312	Establishment of a Database for Long-Term Monitoring of Patients With Nephropathic Cystinosis
NCT00004313	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal Insufficiency
NCT00004314	Phase II Pilot Study of Aminoimidazole Carboxamide Riboside (AICAR), a Precursor of Purine Synthesis, for Lesch-Nyhan Disease
NCT00004315	Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease
NCT00004316	Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis
NCT00004317	Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
NCT00004323	Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia
NCT00004324	Developmental Phenomenology of Obsessive Compulsive Disorder and Tourette Syndrome in Children and Adolescents
NCT00004325	Study of the Neurobiology of Tourette Syndrome and Related Disorders
NCT00004326	Hippocampal Complex Volume and Memory Dysfunction in Cushing's Syndrome
NCT00004327	Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia
NCT00004328	Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type I
NCT00004329	Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy
NCT00004330	Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks
NCT00004331	Studies in Porphyria I: Characterization of Enzyme Defects
NCT00004332	Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
NCT00004333	Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type I
NCT00004334	Study of Depression, Peptides, and Steroids in Cushing's Syndrome
NCT00004335	Study of Gonadotropin-Releasing Hormone Pulse Frequency in Sexual Maturation and in the Menstrual Cycle
NCT00004336	Pilot Study of Familial Nonsyndromal Mondini Dysplasia
NCT00004338	Study of Zinc for Wilson Disease
NCT00004339	Study of Tetrathiomolybdate in Patients With Wilson Disease
NCT00004340	Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis
NCT00004341	Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders
NCT00004342	International Registry for Severe Chronic Neutropenia
NCT00004343	Study of Hypercortisolism in Cushing's Syndrome and Stress-Induced Pseudo-Cushing's Syndrome
NCT00004344	Purification of Testis-Stimulating Factor in Precocious Puberty
NCT00004345	Study of Dietary N-3 Fatty Acids in Patients With Retinitis Pigmentosa and Usher Syndrome
NCT00004346	Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis
NCT00004347	Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome
NCT00004348	Study of Protein Translocation in Patients With Beta-Oxidation Disorders
NCT00004350	Evaluation of Fanconi Syndrome and Cystinosis
NCT00004351	Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes
NCT00004353	Study of the Metabolism of Pyruvate and Related Problems in Patients With Lactic Acidemia
NCT00004354	Study of Prevalence and Clinical Phenotype in Patients With Glucocorticoid-Remediable Aldosteronism
NCT00004356	Study of Homocysteine Metabolism in Homocystinuria
NCT00004357	Absorption of Corticosteroids in Children With Juvenile Dermatomyositis
NCT00004358	Phase II Study of Calcitonin for Tumoral Calcinosis
NCT00004359	Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita
NCT00004360	Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus
NCT00004361	Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects
NCT00004363	Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus
NCT00004364	Study of Novel Types of Familial Diabetes Insipidus
NCT00004365	Study of Pituitary Size and Function in Familial Dwarfism of Sindh
NCT00004366	Pilot Study of Vestibular Rehabilitation Training for Panic Disorder With Vestibular Dysfunction
NCT00004367	Vestibular Dysfunction In Adult Patients With Panic Disorder With or Without Agoraphobia
NCT00004368	Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis
NCT00004373	Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety
NCT00004374	Study of Systemic Amyloidosis Presentation and Prognosis
NCT00004375	Ultraviolet Light Therapy for Systemic Lupus Erythematosus
NCT00004376	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder
NCT00004378	Stem Cell Transplantation (SCT) for Genetic Diseases
NCT00004380	Phase II Study of Recombinant Relaxin for Progressive Systemic Sclerosis
NCT00004381	Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
NCT00004382	Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature Newborns
NCT00004386	Phase I Pilot Study of Liver-Directed Gene Therapy for Partial Ornithine Transcarbamylase Deficiency
NCT00004387	Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's Disease
NCT00004390	Phase III Randomized Controlled Study of Morphine and Nortriptyline in the Management of Postherpetic Neuralgia
NCT00004392	Incidence and Severity of Cardiorespiratory Events in Infants at Increased Epidemiological Risk for Sudden Infant Death Syndrome (SIDS)
NCT00004393	Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome
NCT00004396	Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias
NCT00004397	Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria
NCT00004398	Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria
NCT00004399	Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia
NCT00004400	Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women
NCT00004401	Study of Human Botulism Immunoglobulin in Infants With Botulism
NCT00004402	Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital Osteopetrosis
NCT00004403	Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis
NCT00004404	Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes
NCT00004406	Randomized Study of Human Parathyroid Hormone in Middle-Aged Men With Idiopathic Osteoporosis
NCT00004407	Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic Neuropathy
NCT00004408	Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease
NCT00004409	Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease
NCT00004410	Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants
NCT00004412	Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers
NCT00004414	Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis
NCT00004415	Study of Combined Intercostal and Diaphragm Pacing for Artificial Respiration in Quadriplegic Patients
NCT00004416	Randomized Study of Botulinum Toxin Type A for Achalasia
NCT00004418	Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy
NCT00004419	Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance
NCT00004420	Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis
NCT00004421	Deep Brain Stimulation in Treating Patients With Dystonia
NCT00004422	Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection
NCT00004423	Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's Disease
NCT00004424	Randomized Study of Propofol Versus Fentanyl and Midazolam in Pediatric Patients Requiring Mechanical Ventilation and Sedation Therapy
NCT00004426	Leuprolide in Determining the Cause of Gonadotropin Deficiency
NCT00004428	Phase I Randomized Study of CPX for the Treatment of Adult Patients With Mild Cystic Fibrosis
NCT00004429	Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis or Peritoneal Dialysis
NCT00004430	Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal Neovascularization
NCT00004431	Randomized Study of L-Baclofen in Patients With Refractory Trigeminal Neuralgia
NCT00004433	Randomized Study of Pergolide in Children With Tourette Syndrome
NCT00004436	Randomized Study of Hormonal Regulation of Infantile Hemangioma
NCT00004437	Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2
NCT00004438	Leuprolide in Treating Adults With Hypogonadotropism
NCT00004440	Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis
NCT00004441	Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis
NCT00004442	Study of Bile Acids in Patients With Peroxisomal Disorders
NCT00004443	Study of NTBC for Tyrosinemia I
NCT00004444	Pilot Randomized Study of Paromomycin (Aminosidine) vs Streptomycin for Uncomplicated Pulmonary Tuberculosis
NCT00004445	Study of an Implantable Functional Neuromuscular Stimulation System for Patients With Spinal Cord Injuries
NCT00004446	Study of Fluoxetine in Patients With Depersonalization Disorder
NCT00004448	Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy
NCT00004449	Randomized Study of Intensive One-on-one Behavioral Treatment for Preschool Aged Children With Autism
NCT00004450	Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy
NCT00004451	Randomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly People and Parkinson's Disease Patients
NCT00004454	Phase I/II Study of Retroviral-Mediated Transfer of Iduronate-2-Sulfatase Gene Into Lymphocytes of Patients With Mucopolysaccharidosis II (Mild Hunter Syndrome)
NCT00004457	Determinants of Disease Severity in Amyotrophic Lateral Sclerosis
NCT00004458	Longitudinal and Biological Study of Childhood Disintegrative Disorder
NCT00004464	Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
NCT00004465	Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome
NCT00004466	Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome
NCT00004467	Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen
NCT00004468	Study of Topical Calcitriol or Oral Calcitriol in Patients With Psoriasis
NCT00004471	Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer
NCT00004474	Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia
NCT00004475	Genetic Linkage Study for Hereditary Pancreatitis
NCT00004478	Droxidopa in Treating Patients With Neurogenic Hypotension
NCT00004479	Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope
NCT00004480	Study of Botulinum Toxin in Patients With Primary Hyperhidrosis
NCT00004481	Genetic Study of Sitosterolemia
NCT00004482	Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis
NCT00004483	NF2 Natural History Consortium
NCT00004485	Bone Marrow Transplantation in Treating Children With Sickle Cell Disease
NCT00004486	Randomized Study of Fluoxetine in Children and Adolescents With Autism
NCT00004487	Phase III Study of Chondrocyte Alginate Gel Suspension in Pediatric Patients With Vesicoureteral Reflux
NCT00004488	Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease
NCT00004489	Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis
NCT00004490	Phase III Randomized Study of Sodium Dichloroacetate in Children With Congenital Lactic Acidosis
NCT00004492	Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia
NCT00004493	Phase II Pilot Randomized Study of Sodium Dichloroacetate in Patients With Congenital Lactic Acidemia
NCT00004494	Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis
NCT00004495	Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis
NCT00004496	Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure
NCT00004497	Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension
NCT00004498	Phase I Study of Adenoviral Vector Mediated Gene Transfer for Ornithine Transcarbamylase in Adults With Partial Ornithine Transcarbamylase Deficiency
NCT00004500	Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome
NCT00004533	Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic Fibrosis
NCT00004547	Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy
NCT00004549	Magnetic Resonance Imaging to Detect Blood Vessel Inflammation in Patients Undergoing Peripheral Balloon Angioplasty
NCT00004550	Evaluation and Follow-up of Individuals With Obsessive-Compulsive Disorder and Related Conditions
NCT00004551	Behavioral Counseling for Alcohol Dependent Smokers (Nicotine Patch)
NCT00004552	Acamprosate Treatment: Mechanisms of Action
NCT00004553	Electromyography to Diagnose Neuromuscular Disorders
NCT00004554	Sertraline for Alcohol Dependence and Depression
NCT00004556	The Effects of Dextroamphetamine on Brain Function
NCT00004557	Models of Disordered Knowledge and Memory Systems in Dementia and Related Disorders
NCT00004558	Antiarrhythmic Effects of N-3 Fatty Acids
NCT00004559	Fatty Acid Antiarrhythmia Trial (FAAT)
NCT00004560	Public Access Defibrillation (PAD) Community Trial
NCT00004561	Treatment of Hypertension With Two Exercise Intensities
NCT00004562	Occluded Artery Trial (OAT)
NCT00004563	Scleroderma Lung Disease
NCT00004564	The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A
NCT00004565	Susceptibility to Breast Cancer
NCT00004566	Study of Fetal Swallowing
NCT00004567	Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes
NCT00004568	Study of Inherited Neurological Disorders
NCT00004569	Incorporating Flow Limitation Into the Diagnosis and Quantification of Sleep Disordered Breathing
NCT00004570	Hereditary Deficits in Auditory Processing Leading to Language Impairment
NCT00004571	Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers
NCT00004572	Identification and Therapy Efficacy of Type 2 Diabetes in Hispanic Patients
NCT00004573	Kinetics of Response of Cytomegalovirus With Ganciclovir Treatment Using Quantitative Real-Time PCR
NCT00004574	Vitamin Replacement in Abetalipoproteinemia
NCT00004575	Effects of Miconazole on Blood Flow
NCT00004576	Study of LY300164 for the Treatment of Parkinson's Disease
NCT00004577	Study of New Magnetic Resonance Imaging Methods of the Brain
NCT00004578	ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects
NCT00004579	A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection
NCT00004580	A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors
NCT00004581	A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment
NCT00004582	ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past
NCT00004583	A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy
NCT00004584	Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment
NCT00004585	A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults
NCT00004604	Biological Therapy in Treating Patients With Metastatic Cancer
NCT00004635	Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer
NCT00004637	Double-Blind, Placebo-Controlled Trial of Vitamin E as Add-on Therapy for Children With Epilepsy
NCT00004638	Immunologic Aspects of the Pathogenesis of Chronic Sinusitis in Children
NCT00004639	Cleft Palate Surgery and Speech Development
NCT00004640	"""Clinical Trials to Enhance Elders' Oral Health (TEETH)"""
NCT00004642	Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System Disease
NCT00004643	Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus
NCT00004644	Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated Neonatal Herpes Simplex Virus Infection
NCT00004645	Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
NCT00004646	Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy
NCT00004647	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Mexiletine for Painful Diabetic Neuropathy
NCT00004648	Studies of Hereditary Hemorrhagic Telangiectasia
NCT00004649	Study of the Natural History and Genotype-Phenotype Correlations of Hereditary Hemorrhagic Telangiectasia Patients
NCT00004650	Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss
NCT00004652	Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome
NCT00004654	Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia
NCT00004656	Nutritional Aspects of Rett Syndrome
NCT00004658	Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucleotidase Activity
NCT00004659	Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors
NCT00004660	Randomized Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy
NCT00004661	Study of the Regulation of Parathyroid Hormone Secretion in Pseudohypoparathyroidism
NCT00004662	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus
NCT00004663	Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus
NCT00004664	Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-Wasting
NCT00004665	Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus
NCT00004667	Phase I Study of Human Von Willebrand Factor for Von Willebrand's Disease
NCT00004669	Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia
NCT00004670	Phase II Study of Pallidotomy for Parkinson Disease
NCT00004682	Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
NCT00004685	Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy
NCT00004686	Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis
NCT00004688	Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms
NCT00004689	Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease
NCT00004690	Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis
NCT00004694	Study of Heparin Prophylaxis of Hereditary Angioedema Exacerbations
NCT00004695	Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency
NCT00004696	Study of Morphine in Postoperative Infants to Allow Normal Ventilation
NCT00004697	Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition
NCT00004699	Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism
NCT00004700	Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism
NCT00004705	Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis
NCT00004727	Antiplatelet Therapy to Prevent Stroke in African Americans
NCT00004728	Aspirin Or Warfarin To Prevent Stroke
NCT00004729	Ketogenic Diet for Child Epilepsy and Seizure Control
NCT00004730	Magnesium Sulfate For Brain Injury
NCT00004731	Parkinson's Disease Treatment With Coenzyme Q10
NCT00004732	Carotid Revascularization Endarterectomy Versus Stenting Trial
NCT00004733	Timing of Levodopa Treatment in Parkinson's Disease
NCT00004734	Vitamin Therapy for Prevention of Stroke
NCT00004735	The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV
NCT00004736	Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis
NCT00004738	Genetic Analysis of the Chiari I Malformation
NCT00004739	The Metabolic Effects of Protease Inhibitors in HIV Infected Children
NCT00004740	Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users
NCT00004744	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis
NCT00004747	Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis
NCT00004748	Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis
NCT00004751	Phase II Randomized Study of Selective Dorsal Rhizotomy and Physiotherapy Vs Physiotherapy Alone for Spastic Diplegia
NCT00004753	Long-Term Study of Cerebral Glucose Metabolism in Huntington's Disease
NCT00004754	Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension
NCT00004755	Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil
NCT00004756	Study of Individualized Instruction Versus Pamphlet in Systemic Lupus Erythematosus
NCT00004757	Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and Mouth
NCT00004758	Phase II Randomized Study of Early Surgery Vs Multiple Sequential Antiepileptic Drug Therapy for Infantile Spasms Refractory to Standard Treatment
NCT00004759	Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury
NCT00004760	Study of Axial Mobility Exercises in Parkinson Disease
NCT00004761	Establishment of the National Epidermolysis Bullosa Registry
NCT00004762	Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis
NCT00004763	Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism
NCT00004767	Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders
NCT00004769	Study of Muscle Wasting and Altered Metabolism in Patients With Myotonic Dystrophy
NCT00004770	Pilot Compassionate Use Study of Thioctic Acid Treatment in Mitochondrial Myopathy
NCT00004771	Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease
NCT00004772	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy
NCT00004773	Study of Cardiac and Paroxysmal Abnormalities in Rett Syndrome
NCT00004776	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Topiramate for Lennox-Gastaut Syndrome
NCT00004778	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Antenatal Thyrotropin-Releasing Hormone in Pregnant Women With Threatened Premature Delivery
NCT00004779	Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic Fibrosis
NCT00004781	Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups
NCT00004784	Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis
NCT00004785	Phase III Randomized, Double-Blind Study of Dexamethasone Vs Dexamethasone/Methylprednisolone Vs Placebo for Bronchopulmonary Dysplasia
NCT00004786	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis
NCT00004787	Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes
NCT00004788	Study of Nutritional Factors in Porphyria
NCT00004789	Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria
NCT00004791	Study of the Nutritional, Metabolic, and Body Composition Profile in Children and Adolescents With Epidermolysis Bullosa
NCT00004793	Pilot Study of the Effect of Baclofen and Bromocriptine on Luteinizing Hormone Secretion in Pubertal Children
NCT00004794	Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis
NCT00004795	Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus
NCT00004796	Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis
NCT00004797	Pilot Study of Fructose for Sickle Cell Crisis
NCT00004799	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines
NCT00004800	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines
NCT00004801	Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency
NCT00004802	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders
NCT00004804	Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis C
NCT00004805	Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden Death
NCT00004806	Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis
NCT00004807	Study of the Pathogenesis of Rett Syndrome
NCT00004808	Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis
NCT00004809	Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia
NCT00004810	Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis
NCT00004811	Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis
NCT00004812	Phase II Randomized Pilot Study of Body Weight Support and Treadmill Training for Chronic Thoracic Spinal Cord Injury
NCT00004814	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis
NCT00004815	Descriptive Study of Recombinant Human Insulin-Like Growth Factor for Osteoporosis in Werner's Syndrome
NCT00004816	A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple Sclerosis
NCT00004817	Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures
NCT00004825	Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism
NCT00004826	Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease
NCT00004827	Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa
NCT00004828	Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan Procedure
NCT00004829	Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis
NCT00004831	Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria
NCT00004832	Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome
NCT00004833	Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome
NCT00004834	Randomized Study of Cognitive-Behavioral Therapy vs Imipramine and Their Combination for Panic Disorder
NCT00004838	Randomized Study of Succimer (Dimercaptosuccinic Acid) on Growth of Lead-Poisoned Children
NCT00004840	Study of Antenatal Thyrotropin-Releasing Hormone in Women in Premature Labor to Prevent Lung Disease in Preterm Infants
NCT00004842	Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
NCT00004843	A Randomized Study of Surgery vs No Surgery in Patients With Mild Asymptomatic Primary Hyperparathyroidism
NCT00004844	Randomized Study of Fetal Neurotransplantation for the Treatment of Parkinson's Disease
NCT00004845	A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)
NCT00004846	Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV
NCT00004847	Diagnosis of Pheochromocytoma
NCT00004848	A Controlled Prospective Study of Transfusion-Associated Hepatitis
NCT00004850	Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection
NCT00004851	Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies
NCT00004852	Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs
NCT00004853	Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy
NCT00004854	The Safety and Efficacy of Adjunct Carvedilol in Children With Moderate Heart Failure
NCT00004855	Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
NCT00004856	Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium
NCT00004857	Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
NCT00004858	Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
NCT00004859	Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer
NCT00004860	Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer
NCT00004861	Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer
NCT00004862	Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
NCT00004863	Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors
NCT00004864	Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors
NCT00004865	Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy
NCT00004866	DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix
NCT00004867	Positron Emission Tomography in Determining Stage of Esophageal Cancer
NCT00004868	SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy
NCT00004870	Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
NCT00004871	Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
NCT00004872	Endostatin in Treating Patients With Advanced Refractory Solid Tumors
NCT00004873	Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer
NCT00004874	Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
NCT00004875	Heparin or Enoxaparin in Patients With Cancer
NCT00004876	Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer
NCT00004877	BMS-214662 in Treating Patients With Advanced Solid Tumors
NCT00004878	Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia
NCT00004879	Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer
NCT00004880	Vaccine Therapy in Treating Patients With Advanced Kidney Cancer
NCT00004881	Vaccine Therapy in Treating Patients With Advanced Cancer
NCT00004883	Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2
NCT00004884	Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
NCT00004885	Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer
NCT00004886	MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors
NCT00004887	Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery
NCT00004888	Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer
NCT00004889	Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
NCT00004890	Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer
NCT00004891	PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery
NCT00004892	O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma
NCT00004893	Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer
NCT00004895	Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery
NCT00004896	Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
NCT00004897	Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer
NCT00004898	Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia
NCT00004899	Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
NCT00004900	Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer
NCT00004901	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer
NCT00004902	Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma
NCT00004903	Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
NCT00004904	Stem Cell Transplantation in Treating Patients With Hematologic Cancer
NCT00004905	Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia
NCT00004906	Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer
NCT00004907	Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma
NCT00004908	Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
NCT00004909	Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial Cancer
NCT00004910	Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction
NCT00004911	Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction
NCT00004912	Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss
NCT00004913	Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
NCT00004914	Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue
NCT00004915	Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer
NCT00004916	Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
NCT00004917	Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
NCT00004918	Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
NCT00004919	Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
NCT00004920	Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura
NCT00004921	High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery
NCT00004922	Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors
NCT00004923	Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors
NCT00004924	Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT00004925	Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer
NCT00004926	ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy
NCT00004927	BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
NCT00004928	Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer
NCT00004929	Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
NCT00004930	Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases
NCT00004931	Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer
NCT00004932	STI571 in Treating Patients With Recurrent Leukemia
NCT00004933	Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa
NCT00004934	Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
NCT00004935	Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2
NCT00004936	MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients
NCT00004937	Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme
NCT00004938	Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis
NCT00004939	Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy
NCT00004940	Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria
NCT00004941	Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease
NCT00004978	An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy
NCT00004979	Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors
NCT00004980	"""Repetitive Transcranial Magnetic Stimulation for Voices"""
NCT00004981	Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)
NCT00004982	Combination Iron Chelation Therapy
NCT00004983	Education and Group Support for Diabetic Hispanics
NCT00004984	The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)
NCT00004985	Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy
NCT00004986	Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients
NCT00004987	Treatment of Advanced AIDS Patients With Dextrin Sulfate
NCT00004988	Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria
NCT00004990	Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis
NCT00004991	Study of Brain Activity During Speech Production and Speech Perception
NCT00004992	Diabetes Prevention Program
NCT00004993	Can Parathyroid Hormone Injections Reverse Glucocorticoid-induced Osteoporosis
NCT00004994	Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant
NCT00004996	Comparison of Immune Response in Normal Volunteers and Patients With Helminth Infections
NCT00004997	Leucovorin for the Treatment of 5 q Minus Syndrome
NCT00004998	Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients
NCT00004999	Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients
NCT00005000	Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
NCT00005001	Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)
NCT00005002	Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)
NCT00005003	Genetic Component of Handedness
NCT00005004	Brain Processing of Language Meanings
NCT00005005	PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis
NCT00005006	Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
NCT00005007	Etanercept for Wegener's Granulomatosis
NCT00005009	Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients
NCT00005010	Prevention of Kidney Transplant Rejection
NCT00005011	Combined Hormone Replacement in Menstrually-Related Mood Disorders
NCT00005012	Safety and Effectiveness of PEG-Intron in HIV-Infected Patients
NCT00005013	Treatment of Major Depression With St. John's Wort (Hypericum)
NCT00005014	Treatment of Autism in Children and Adolescents
NCT00005015	Treatment of Depression in Youth With Bipolar Disorders
NCT00005016	Study of the Experiences and Needs of Parents Continuing a Pregnancy Following a Prenatal Diagnosis of Holopresencephaly
NCT00005017	Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
NCT00005018	Safety and Effectiveness of a Combination Anti-HIV Drug Treatment
NCT00005020	Observing Patients With Early HIV Infection
NCT00005021	Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma
NCT00005022	Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
NCT00005023	Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer
NCT00005024	Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease
NCT00005025	Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
NCT00005026	Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
NCT00005027	Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer
NCT00005028	Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer
NCT00005029	Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
NCT00005030	SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver
NCT00005031	Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
NCT00005032	Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
NCT00005033	Trastuzumab in Treating Patients With Recurrent Osteosarcoma
NCT00005035	Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer
NCT00005036	Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
NCT00005037	Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer
NCT00005038	Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer
NCT00005039	Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer)
NCT00005040	Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma
NCT00005041	R115777 in Treating Patients With Relapsed Small Cell Lung Cancer
NCT00005042	SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
NCT00005044	Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
NCT00005045	Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer
NCT00005046	Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer
NCT00005047	4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer
NCT00005048	Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00005049	Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer
NCT00005050	Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer
NCT00005051	Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer
NCT00005052	Vaccine Therapy in Treating Patients With Primary Stage II Melanoma
NCT00005053	Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer
NCT00005054	Temozolomide in Treating Women With Advanced Breast Cancer
NCT00005055	Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT00005056	Bryostatin 1 In Treating Patients With Progressive Kidney Cancer
NCT00005057	Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma
NCT00005058	Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast Cancer
NCT00005059	Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer
NCT00005060	Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer
NCT00005061	Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors
NCT00005062	Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission
NCT00005064	PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome
NCT00005065	Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
NCT00005066	O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma
NCT00005067	Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer
NCT00005068	Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00005069	Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer
NCT00005070	Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer
NCT00005071	Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer
NCT00005072	Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer
NCT00005073	Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms
NCT00005074	Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma
NCT00005075	Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer
NCT00005076	Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer
NCT00005077	Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction
NCT00005078	Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors
NCT00005079	Timing of Menstrual Cycle and Surgery in Treating Premenopausal Women With Stage I, Stage II, or Stage III Breast Cancer
NCT00005080	506U78 in Treating Patients With Lymphoma
NCT00005081	Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma
NCT00005082	Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma
NCT00005083	Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
NCT00005084	Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma
NCT00005085	Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
NCT00005086	Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer
NCT00005087	Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer
NCT00005088	Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
NCT00005089	S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma
NCT00005090	S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease
NCT00005091	DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
NCT00005092	Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
NCT00005093	Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT00005094	Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps
NCT00005095	Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
NCT00005096	Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer
NCT00005097	Green Tea Extract in Treating Patients With Actinic Keratosis
NCT00005098	Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency
NCT00005100	Measurement of Outcome of Surgical Treatment in Patients With Acromegaly
NCT00005101	Study of Low Bone Mass in Premenopausal or Perimenopausal Women
NCT00005102	Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome
NCT00005103	Study of the Pathogenesis of Porphyria Cutanea Tarda
NCT00005104	Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome
NCT00005105	Genetic Study of Insulin-Like Growth Factor-I Receptor Mutations in Patients With Intrauterine Growth Retardation
NCT00005106	A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients
NCT00005107	Role of Nitric Oxide in Cirrhosis: Relationship With Systemic Hemodynamics, Renal Function, Vasoactive Systems and Endotoxemia
NCT00005108	Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls
NCT00005110	A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic Fibrosis
NCT00005111	PET Scans in Normal Volunteers and Patients With Fabry Disease
NCT00005112	Growth Hormone Use in Cystic Fibrosis - a Multicenter Study
NCT00005113	A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant
NCT00005116	Depression In Juvenile Diabetics
NCT00005117	Effect of Pravastatin on Endothelial Dysfunction Following a Single High Fat Meal
NCT00005118	The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention Treatment
NCT00005119	Altered Calcium and Vitamin D in PMDD or Severe PMS
NCT00005120	The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00005121	Framingham Heart Study
NCT00005122	Evans County Studies
NCT00005123	Honolulu Heart Program
NCT00005124	National Heart, Lung, and Blood Institute Twin Study
NCT00005125	NAS-NRC Twin Registry
NCT00005126	Vietnam Era Twin (VET) Registry
NCT00005127	Muscatine Heart Study
NCT00005128	Lipid Research Clinics Population Studies
NCT00005129	Bogalusa Heart Study
NCT00005130	Coronary Artery Risk Development in Young Adults (CARDIA)
NCT00005131	Atherosclerosis Risk in Communities (ARIC)
NCT00005132	National Growth and Health Study (NGHS)
NCT00005133	Cardiovascular Health Study (CHS)
NCT00005134	Strong Heart Study
NCT00005135	Insulin Resistance Atherosclerosis Study (IRAS)
NCT00005136	Family Heart Study (FHS)
NCT00005137	Heritage Study--Genetics, Exercise and Risk Factors
NCT00005138	High Blood Pressure in the Young
NCT00005139	Characterization Of Coronary Prone Pedigrees
NCT00005140	Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago
NCT00005141	Minneapolis Children's Blood Pressure Study
NCT00005142	Etiology and Prevalence of Peripheral Arterial Disease
NCT00005143	Stanford Five-City Multifactor Risk Reduction Study
NCT00005144	Coronary-Prone Behavior and Cardiovascular Reactivity
NCT00005145	Minnesota Heart Survey - Risk Factor Survey
NCT00005146	Diabetes and Cardiovascular Risk In Mexico City (San Antonio Heart Study)
NCT00005147	Epidemiology of Atherosclerosis
NCT00005148	Coronary Heart Disease Incidence, Mortality, and Risk Factor Relationships
NCT00005149	Genetic and Environmental Determinants of Hypertension
NCT00005150	Minnesota Heart Health Program
NCT00005151	Pawtucket Heart Health Program
NCT00005152	Nurses' Health Study (Cardiovascular Component)
NCT00005153	Etiologic Risk Factors of Cardiovascular Malformations
NCT00005154	National Health and Nutrition Examination Survey IV (NHANES (IV)
NCT00005155	Physiological and Psychosocial Correlates of Type A Behavior
NCT00005156	Mortality Surveillance of MRFIT Screenees
NCT00005157	Speech Characteristics in Coronary Heart Disease
NCT00005158	Segregation/Linkage Analysis for Hypertension
NCT00005159	National Longitudinal Mortality Study (NLMS)
NCT00005160	Epidemiology of Cardiovascular Risk Factors in Women (Healthy Women Study)
NCT00005161	Longitudinal Twin Study - Cohort Study of Blood Pressure
NCT00005162	Epidemiology of Decline in Heart Disease Mortality
NCT00005163	Validation and Field Test for Risk Appraisal Instruments
NCT00005164	Insulin Resistance and Blood Pressure Regulation in Blacks
NCT00005165	Charleston Heart Study - Predictors of Coronary Disease in Blacks
NCT00005166	Sodium Transport: Genetics and Hypertension
NCT00005167	Diet Modification and Blood Pressure in Young People
NCT00005168	Hyperapo B and Coronary Heart Disease
NCT00005169	Lifestyle and Chronic Disease in College Alumni (Harvard Alumni Health Study)
NCT00005170	Ambulatory Blood Pressure and Behavior
NCT00005171	Cardiovascular Risk Factors in United States Adolescents and Adults
NCT00005172	Socioeconomic Status, John Henryism and Hypertension Risk in Blacks
NCT00005173	Myocardial Infarction and Past Oral Contraceptive Use
NCT00005174	Western Collaborative Group Study (WCGS): 25-Year Follow-up of Cardiovascular Disease Morbidity and Mortality
NCT00005175	Coronary Heart Disease Risk Factors in Upwardly Mobile Blacks and Whites
NCT00005176	Long QT Syndrome-Population Genetics and Cardiac Studies
NCT00005177	Reno Diet Heart Study
NCT00005178	Study of Children's Activity and Nutrition (SCAN)
NCT00005179	Diet, Exercise and Cardiovascular Health Among Ethnic Children
NCT00005180	End-organ Pathology in Childhood Essential Hypertension
NCT00005181	Blood Pressure Control in Juveniles - Longitudinal Study
NCT00005182	Health Professionals Follow-up Study
NCT00005183	Apolipoprotein A-I Gene Polymorphism and Atherosclerosis
NCT00005184	Immunogenetic Factors of Coronary Heart Disease
NCT00005185	Myocardial Infarction and Non-contraceptive Estrogen Use
NCT00005186	Epidemiology of Cardiovascular Diseases in The Elderly
NCT00005187	Cardiovascular Risk Profile Among Mexican-Americans
NCT00005188	Quantitative Genetic Analysis of Lipid Research Clinic Family Data
NCT00005189	Carotid Atherosclerosis Follow-up Study
NCT00005190	Reproduction and Survival After Cardiac Defect Repair
NCT00005191	Clinical Course of Coronary Artery Disease Among Blacks
NCT00005192	Psychophysiology of Cardiovascular Reactivity
NCT00005193	Prospective Study of Diabetes-related Vascular Disease in Oklahoma Indians
NCT00005194	Insulin and Biogenic Amines in Cardiovascular Disease
NCT00005195	Catheter Ablation Registry
NCT00005196	Worcester Heart Attack Community Surveillance Study
NCT00005197	Predictors of Perioperative Cardiac Morbidity
NCT00005198	Survival After Myocardial Infarction in A Biethnic Texas Community (Corpus Christi Heart Project)
NCT00005199	Balloon Valvuloplasty Registry
NCT00005200	Adolescent Blood Pressure Variation and Ventricular Mass
NCT00005201	Idiopathic Dilated Cardiomyopathy
NCT00005202	Identifying High Risk Patients With Syncope
NCT00005203	Genetics of Low Density Lipoprotein Subclasses in Hypercholesterolemia
NCT00005204	Blood Pressure and Diurnal Variation in Sodium, Potassium, and Water Excretion
NCT00005205	Incidence of Diabetes and Cardiovascular Disease in Mexican Americans
NCT00005206	Calcium Intake, Metabolism, and Gestational Blood Pressure
NCT00005207	Renin and Prorenin in Pregnancy
NCT00005208	Regulation of Placental Vascular Reactivity in Pregnancy-induced Hypertension
NCT00005209	Genetic Epidemiology of Coronary Heart Disease
NCT00005210	Sex Steroids, Obesity and Lipids in Adolescent Females
NCT00005211	Cardiovascular Mortality Among Tunnel and Bridge Workers Exposed To Carbon Monoxide
NCT00005212	Work Organization and Cardiovascular Disease
NCT00005213	Lithium Countertransport and Blood Pressure In CARDIA and TOMHS
NCT00005214	Epidemiology of Genetic Factors in Lipid Metabolism
NCT00005215	Lipoprotein Subfractions and Coronary Heart Disease During 25 Year Follow-up
NCT00005216	Multicenter Study of Silent Myocardial Ischemia (MSSMI)
NCT00005217	Intermittent ST Depression and Prognosis After Myocardial Infarction
NCT00005218	Epidemiological Tool To Detect Angina Pectoris in Blacks
NCT00005219	Predicting Physical Activity Change: an Epidemiologic Study
NCT00005220	Postmenopausal Progestins, MI and Stroke
NCT00005221	Analysis of Longitudinal Cardiopulmonary Data
NCT00005222	Decline in Cardiovascular Mortality: Framingham 1950-1984
NCT00005223	Epidemiology of APO- and Lipoproteins in Elderly Women
NCT00005224	Gender Response To Coronary Risk
NCT00005225	Apolipoprotein Polymorphisms and Risk of Coronary Heart Disease
NCT00005226	Epidemiology of Plasma Fatty Acids and Atherosclerosis
NCT00005227	AIDS-Associated Cardiomyopathy
NCT00005228	AIDS-Associated Heart Disease -- Incidence and Etiology
NCT00005229	HIV-Associated Heart Disease
NCT00005230	Epidemiology of Carotid Disease in Elderly Adults
NCT00005231	Development, Testing, and Validation of A Protocol To Assess Cardiovascular Reactivity in Human Populations
NCT00005232	Gubbio Study Five-year Follow-up: Lithium Countertransport, Blood Pressure, and Other Variables
NCT00005233	Patterns of Fatty Acids in Framingham Offspring
NCT00005234	Cardiovascular Disease in Black Versus White Physicians
NCT00005235	Heart Rate Variability and Sudden Cardiac Death
NCT00005236	Atherosclerosis and Omega-3 Fatty Acids in Alaskan Natives
NCT00005237	Epidemiology of Symptomatic Arrhythmias
NCT00005238	Antecedents of Hypertension: Role of Race and Stress
NCT00005239	Genetic Epidemiology of Coronary Heart Disease Risk in Women Twins
NCT00005240	Epidemiology of Hypertensive Emergency
NCT00005241	Myocardial Infarction and Current Oral Contraceptive Use
NCT00005242	Childhood Passive Smoking: Cohort Study of Cardiac Risk
NCT00005243	Triggers of Ventricular Arrhythmias (TOVA) Study
NCT00005244	Anger Expression, Self-focus and Coronary Heart Disease Risk Factors
NCT00005245	Community Structure and Cardiovascular Mortality Trends
NCT00005246	Epidemiology of Insulin and Dehydroepiandrosterone Sulfate and Coronary Heart Disease Mortality
NCT00005247	Nutritional Determinants of Cardiovascular Disease
NCT00005248	Adiposity and Fat Patterning in Black Americans
NCT00005249	Epidemiology of Blood Pressure, Insulin, Salt Transport
NCT00005250	Linkage Study of Long QT Syndrome In An Amish Kindred
NCT00005251	Genetic Analysis of Familial Hypertrophic Cardiomyopathy
NCT00005252	Physicians' Health Study: Study of Low Cardiovascular Disease Mortality
NCT00005253	Proarrhythmic Medicines and Primary Cardiac Arrest
NCT00005254	Natural History of Peripheral Arterial Disease
NCT00005255	Ischemic Heart Disease Incidence and Indices of Body-fat Distribution
NCT00005256	Coronary Screening in a High Risk Subset
NCT00005257	Diet and Plasma Cholesterol - Secular Trend Analysis
NCT00005258	Family Study of Congenital Cardiovascular Malformations
NCT00005259	Polyunsaturated Fats and Risk of Primary Cardiac Arrest
NCT00005260	Mechanisms Underlying Psychosocial Associations With Ischemic Heart Disease (Kuopio)
NCT00005261	Urinary Kallikrein and Hypertension: A Prospective Study
NCT00005262	Epidemiology of Idiopathic Dilated Cardiomyopathy (Washington, DC Dilated Cardiomyopathy Study)
NCT00005263	Postprandial Lipoproteins and Atherosclerosis
NCT00005264	Pediatric Epidemiology of Cardiovascular Disease Risk Factors (Project Heartbeat)
NCT00005265	Natural History of Coronary Heart Disease
NCT00005266	Cardiovascular Disease Mortality in The NAS-NRC Twin Registry
NCT00005267	Family Blood Pressure Program - HyperGEN
NCT00005268	Family Blood Pressure Program - GenNet Network
NCT00005269	Family Blood Pressure Program - GENOA
NCT00005270	Family Blood Pressure Program - SAPPHIRe Network
NCT00005271	INTERMAP: International Population Study on Macronutrients and BP
NCT00005272	Smoking and Body Weight: Analysis of HHANES
NCT00005273	Pulmonary Complications of HIV Infection Study (PACS)
NCT00005274	Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2)
NCT00005275	Sleep Heart Health Study (SHHS) Data Coordinating Center
NCT00005276	A Case Controlled Etiologic Study of Sarcoidosis (ACCESS)
NCT00005277	Cooperative Study of The Clinical Course of Sickle Cell Disease
NCT00005278	Retrovirus Epidemiology Donor Study I (REDS I)
NCT00005279	Tucson Epidemiology Study of Chronic Obstructive Lung Diseases
NCT00005280	Specialized Center of Research in Occupational and Immunologic Lung Disease
NCT00005281	Early Risk Predictors For Chronic Pulmonary Disease
NCT00005282	Prospective Evaluation of Airways Reactivity
NCT00005283	Risk Factors For Asthma in Laboratory Animal Allergy
NCT00005284	Epidemiology of Airway Responsiveness
NCT00005285	Effect of Maternal Smoking On Neonatal Lung Function
NCT00005286	Epidemiology of Sleep Apnea Syndrome
NCT00005287	Late Sequelae of Bronchopulmonary Dysplasia
NCT00005288	Epidemiology and Pulmonary Response To Organic Dust Exposure
NCT00005289	Risk Factors in Bronchopulmonary Dysplasia (Newborn Lung Project)
NCT00005290	Epidemiology of Interstitial Lung Disease
NCT00005291	Clinical Epidemiology of Asthma in An HMO
NCT00005292	Alpha1-antitrypsin Deficiency Registry
NCT00005293	Antecedents of Bronchopulmonary Dysplasia
NCT00005294	Developmental Sequelae of Severe Chronic Lung Disorders
NCT00005295	Idiopathic Pulmonary Fibrosis: a Case-control Study
NCT00005296	Sleep Apnea: Age Effects On Prevalence and Natural History
NCT00005297	Age-related Prevalence of Sleep Respiratory Disturbances
NCT00005298	Inflammation, Autonomic Dysfunction and Airway Disease
NCT00005299	Familial Aggregation and Natural History of Sleep Apnea
NCT00005300	Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease
NCT00005301	Transfusion Safety Study (TSS)
NCT00005302	Drug Etiology of Aplastic Anemia and Related Dyscrasias
NCT00005303	Effectiveness of AIDS Antibody Screening
NCT00005304	Delta Hepatitis and Liver Disease in Hemophiliacs
NCT00005305	Hepatitis Delta Infections in Hemophiliacs
NCT00005306	Natural History of Post-transfusion Non-A, Non-B Hepatitis
NCT00005307	Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study Data
NCT00005308	Anemia and Surgery: Indications For Transfusion
NCT00005309	Prospective Study of HIV Infection in Hemophiliacs
NCT00005311	Hypertension in Minorities Database-Workshop and Publication
NCT00005312	International Programs Collaborative Studies Coordinating Center
NCT00005313	Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia
NCT00005314	Behavioral Factors in Coronary Heart Disease
NCT00005315	Psychosocial Factors and Cardiovascular Disease
NCT00005316	White Coat Hypertension and Antihypertensive Treatment Effect - SCOR in Hypertension
NCT00005317	Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases
NCT00005318	ARDS - Clinical Epidemiology and the Role of the Inflammatory Response - SCOR in Acute Lung Injury
NCT00005319	Epidemiologic Studies of Blood Use in the United States - SCOR in Transfusion Medicine
NCT00005320	Regulation of Pharyngeal Muscle Contraction - SCOR in Cardiopulmonary Disorders of Sleep
NCT00005321	Epidemiology of Sleep Disordered Breathing - SCOR in Cardiopulmonary Disorders of Sleep
NCT00005322	Molecular Genetic Epidemiology of Endocardial Cushion Defects - SCOR in Pediatric Cardiovascular Disease
NCT00005323	Epidemiology of Persistent Pulmonary Hypertension of the Newborn - SCOR in Lung Biology and Diseases in Infants and Children
NCT00005324	Genetic and Epidemiologic Studies of Premature Coronary Artery Disease - SCOR in Arteriosclerosis
NCT00005325	Identifying Genes Involved in Abnormal Blood Pressure - Hypertension SCOR
NCT00005326	Cerebrovascular Involvement in Sickle Cell Disease - Comprehensive Sickle Cell Center
NCT00005327	Prevention of Cerebral Infarction in Sickle Cell Anemia - Comprehensive Sickle Cell Center
NCT00005328	Antecedents of the Type A Behavior Pattern
NCT00005329	Protein S and Myocardial Infarction
NCT00005330	Framingham Children's Study - Food and Exercise Habits in Framingham Study Descendents
NCT00005331	Providers for Smoking Prevention Programs
NCT00005332	Antihypertensive Drug/Gene Interactions and CV Events
NCT00005333	Epidemic Hypertension in Nigerian Workers
NCT00005334	Effects of Personality and Context on Recovery From Coronary Artery Bypass
NCT00005335	Genetic Epidemiology of Lipoprotein-Lipid Levels
NCT00005336	Dietary Treatment of Hyperlipidemia in Women vs. Men
NCT00005337	Hostility and Coronary Risk--Role of Weak Vagal Function
NCT00005338	Homocysteine and Progression of Atherosclerosis
NCT00005339	Risk of Post Transfusion Hepatitis C Virus Infection
NCT00005340	Hypertension in Blacks of West African Origin
NCT00005341	Blood Donation--Immune Sequelae and Recruitment
NCT00005342	Weight Set-Point and HDL Concentration in Runners
NCT00005343	Social Support and CHD Risk Factors--A Community Study
NCT00005344	Mediators of Social Support in Coronary Disease
NCT00005345	Genetic Epidemiology of Blood Lipids and Obesity - Ancillary to NGHS
NCT00005346	Mechanisms Underlying Abnormal Ambulatory BP Patterns
NCT00005347	Framingham Cycle V Offspring-Spouse Nutrition Studies
NCT00005348	Adipose Distribution and Atherosclerosis
NCT00005349	Epidemiology of Coronary Artery Calcification
NCT00005350	Evaluating Strategies to Control Hypercholesterolemia
NCT00005351	Incidence and Outcomes of Venous Thromboembolism
NCT00005352	Chronic Stress as a Risk Factor in the Etiology of Coronary Heart Disease
NCT00005353	Cardiac Autonomic Control in Children of HIV Positive Mothers
NCT00005354	Computed Tomography (CT)--An Epidemiologic Study in the Young
NCT00005355	Gender Differences in Familial Risk
NCT00005356	Novel Hemostatic Cardiac Risk Factors in Framingham
NCT00005357	Pulmonary Hypertension--Mechanisms and Family Registry
NCT00005358	Thrombogenic Factors and Recurrent Coronary Events
NCT00005359	Genetics of Asthma and Bronchial Hyperresponsiveness
NCT00005360	HIV Diversity and Pathogenesis in Donor-Recipient Clusters
NCT00005361	Determinants of Respiratory Health in Young Adults
NCT00005362	Dose Estimation for Studies of Acute Respiratory Effects
NCT00005363	Ambulatory Blood Pressure and Prognosis
NCT00005364	Genetic Epidemiology of CHD Risk Factors in Blacks
NCT00005365	Central Obesity and Disease Risk in Japanese Americans
NCT00005366	Biobehavioral Mechanisms of Blood Pressure Regulation
NCT00005367	Epidemiology of Long QTand Asian Sudden Death in Sleep
NCT00005368	Genetic Epidemiology of Hypertriglyceridemia
NCT00005369	Coronary Artery Disease Mechanisms in High Risk Families--Racial Difference
NCT00005370	Longitudinal Study of Cortisol and Pulmonary Function
NCT00005371	Epidemiology of Acute Phase Protein and CHD
NCT00005372	Intimal Thickening and Antioxidants in Hispanics and Anglos (Los Angeles Atherosclerosis Study)
NCT00005373	Racial Differences in the Coronary Microcirculation
NCT00005374	Genetics of the Metabolic Syndrome in Japanese Americans
NCT00005375	Smoking Onset in a Biethnic Population
NCT00005376	Premature Birth and Its Sequelae in Women
NCT00005377	Molecular Epidemiology of Essential Hypertension
NCT00005378	Impact of Sleep Disordered Breathing in Older Adults
NCT00005379	Tuberculosis in a Multiethnic Inner City Population
NCT00005380	Insulin, Androgen, and Risk in African-American Women
NCT00005381	Prevalence of Sleep Apnea in Women
NCT00005382	Sources of Variability in Peak Expiratory Flow
NCT00005383	Anger and Cardiovascular Risk in Urban Youth
NCT00005384	Diet/Activity of Mexican American and Anglo Children
NCT00005385	Seasonal Variation of Blood Cholesterol Levels
NCT00005386	Biobehavioral Determinants of Obesity in Black Women
NCT00005387	Genetics of Hypertension in Blacks
NCT00005388	Visceral Fat, Metabolic Rate, and CHD Risk in Young Adults
NCT00005389	Effect of Drug Therapy on Reinfarction Risk in Women
NCT00005390	Family Process, Adherence, and Child Asthma Outcome
NCT00005391	Pediatric Cardiomyopathy Registry
NCT00005392	Epidemiology of Venous Disease
NCT00005393	Epidemiology: Oxidative Stress and Early Atherosclerosis
NCT00005394	Diagnosis/Pathophysiology of Glucocorticoid Remediable Aldosteronism Hypertension
NCT00005395	Honolulu Heart Program-Study of Stroke and Dementia
NCT00005396	Motivating Smokers--Reduce Child Environmental Tobacco Smoke Exposure
NCT00005397	Epidemiology of Carotid Artery Atherosclerosis in Youth
NCT00005398	University of North Carolina Alumni Heart Study
NCT00005399	Cohort Study of Heart Rate Variability
NCT00005400	Angiotensinogen Variants and Adverse Pregnancy Outcomes
NCT00005401	Validation and Exploration of Sleep and Mood Predictors
NCT00005402	Transfusion Associated HCV in a Pediatric Population
NCT00005403	Heart Disease and the Black Health Disadvantage
NCT00005404	Compliance in the Physicians' Health Study
NCT00005405	Parity and Serum Lipids in White and Hispanic Women
NCT00005406	Change in Coronary Heart Disease Risk Factors in Young Adults
NCT00005407	Statistical Analysis of Pediatric Task Force Data Base
NCT00005408	Reanalysis of CVD Risk Factors Via Likelihood Methods
NCT00005409	Longitudinal Studies of Blood Pressure in the Elderly
NCT00005410	Epidemiology of Coronary Heart Disease in Blacks
NCT00005411	Study of Children's Activity and Nutrition (SCAN)--Extended Analyses
NCT00005412	Dietary Antioxidants and Atherosclerosis
NCT00005413	Stroke Risk in the NAS-NRC Twin Registry
NCT00005414	Validation of a Historical Physical Activity Survey
NCT00005415	Physical Activity Effects on Health Care Utilization
NCT00005416	Diet, Exercise, and Cardiovascular Health Among Ethnic Children
NCT00005417	Fifteen Year Follow-up of 5,500 Black and 5,500 Other Hypertensives
NCT00005418	Epidemiology of Cardiotoxicity in Children With Cancer
NCT00005419	Physical Activity, Hypertension, Diabetes, and Coronary Heart Disease
NCT00005420	Prediction of Quality of Life in Cardiovascular Disease
NCT00005421	Blood Pressure Tracking--Childhood to Young Adulthood
NCT00005422	Longitudinal Analysis of Spirometry in Black Children
NCT00005423	Dietary Quality and Subsequent Cardiovascular Disease
NCT00005424	Prospective Analysis of the Effect of Widowhood on CVD
NCT00005425	Statistical Analysis of Vlagtwedde-Vlaardingen Data Set
NCT00005426	Effects of CHD Prevention on Lipoprotein Subclasses
NCT00005427	Cohort Study of Respiratory Illness in Early Childhood
NCT00005428	Familial Aggregation of Stress Response
NCT00005429	Clinical Cardiovascular Outcomes of African-Americans
NCT00005430	Low Cholesterol and Mortality in Blacks and Women
NCT00005431	Coronary Heart Disease Risk Factors in Blacks Vs Whites
NCT00005432	Impact of Surfactant's Availability on Newborns
NCT00005433	Correlates of Angiographic Changes and Coronary Events
NCT00005434	Opioid Compromise in Hypertension--Modulating Factors
NCT00005435	Hostility and Pathogenic Mechanisms of Coronary Heart Disease in Women
NCT00005436	Lupus Cohort--Thrombotic Events and Coronary Artery Disease
NCT00005437	Physical Activity and Cardiovascular Risk in Black Girls
NCT00005438	Neuropsychological Studies of Children With Sickle Cell
NCT00005439	Evaluation of Childhood Blood Pressure and Lipid Screening
NCT00005440	Disability Among Adults With Asthma
NCT00005441	Lifestyle Management for Women With CHD and NIDDM
NCT00005442	Re-evaluating Triglycerides in Coronary Heart Disease
NCT00005443	Race, Class, and Gender--Studies of Health Effects
NCT00005444	Hypertension in Families of African Origin
NCT00005445	Epidemiology of Pediatric Asthma Hospitalization
NCT00005446	Endogenous Estrogen and Coronary Heart Disease in Women
NCT00005447	Physical Activity and Cardiovascular Disease Prevention
NCT00005448	Adverse Events With Magnesium Sulfate
NCT00005449	Social Support and Myocardial Ischemia
NCT00005450	Health Promotion in the Elderly--Prevention of Cardiovascular Disorders
NCT00005451	WINCATI Software Tool for Survey Research
NCT00005452	Ti PC Software for Analyzing Longitudinal Data
NCT00005453	Adherence in Clinical Trials-Induction Strategies
NCT00005455	Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States
NCT00005456	Hypertensive and Normal Pregnancy--Calcium Metabolism and Renin-Angiotensin - SCOR in Hypertension
NCT00005457	Model-Free Time Curves for Longitudinal Data Analysis
NCT00005458	Suppressed Anger, Blood Pressure and Mortality Follow-up
NCT00005459	Risk of Coronary Heart Disease in Women With Polycystic Ovary Syndrome
NCT00005460	Predictors of Cardiovascular Disease in the Elderly
NCT00005461	Epidemiology of Symptom Perception in Childhood Asthma
NCT00005462	Genetics of Atherosclerosis in Mexican Americans
NCT00005463	Population-Based Modeling of Cholesterol Lowering in the United States
NCT00005464	DISH Data Analysis Study
NCT00005465	Genetic Mapping of Atherogenic Lipoprotein Phenotypes
NCT00005466	Stroke and MI in Users of Estrogen/Progestogen
NCT00005467	Indices of Severity and Prognosis for Sickle Cell Disease
NCT00005468	Lipid Variability--Influence of Stress
NCT00005469	Maturational Changes in Cardiac Structures -- Blood Pressure Relationship -- SCOR in Hypertension
NCT00005470	Divergence of Blood Pressure By Race in Adolescent Girls
NCT00005471	Anxiety and Cardiovascular Autonomic Control
NCT00005472	Job Strain, Ambulatory Blood Pressure and Hypertension
NCT00005473	Cardiovascular Disease Trends 1980-91--A Gender Specific Perspective
NCT00005474	Markers and Mechanisms of Macrovascular Disease in IDDM
NCT00005475	Longitudinal Study of Asthma From Birth to Adulthood
NCT00005476	Sociodemographic Regulation of Cardiovascular Function and Structure
NCT00005477	Hispanic and White Women's Cardiovascular Health
NCT00005478	Precursors of CVD Risk Factors--Project Heartbeat
NCT00005479	Diabetes, Lipoproteins and Accelerated Vascular Disease
NCT00005480	Cardiovascular Disease Knowledge/Morbidity--Socioeconomic Cohort Outcomes
NCT00005481	Epidemiology of Impaired Coagulant Balance in Diabetes
NCT00005482	Homocyst(e)Ine, Vitamin Status, and CVD Risk
NCT00005483	Plasma Homocysteine Distribution in the United States
NCT00005484	Predictors of Hospital-Based Care in Asthma
NCT00005485	The Jackson Heart Study of Cardiovascular Disease Among African Americans
NCT00005486	Lymphangioleiomyomatosis (LAM) Registry
NCT00005487	Multi-Ethnic Study of Atherosclerosis (MESA)
NCT00005488	Common Variants in Candidate Genes and Premature MI Risk
NCT00005489	Salt Sensitivity, Cardiovascular and Metabolic Disease
NCT00005490	Modeling DNA Diversity in Cardiovascular Health/Disease
NCT00005492	Pooled Analysis of NHANES I/II--Race, Gender, and CHD
NCT00005493	Observational Aspirin Use and CVD in the Physicians' Health Study
NCT00005494	Prospective Study of Health in Runners and Walkers
NCT00005495	Primary Prevention of CHD Risk Factors Occurring in US
NCT00005496	Inflammation, Infection, and Future Cardiovascular Risk
NCT00005497	Risk Factors for Pulmonary Hypertension of the Newborn
NCT00005498	Do Hostility and Stress Predict Cardiovascular Mortality in MRFIT?
NCT00005499	Congestive Heart Failure Trends in the Elderly 1970-94
NCT00005500	Collaborative Studies on the Genetics of Asthma (CSGA)
NCT00005501	Hypertensive Treatment and Epidemiological Analyses
NCT00005502	Coronary Disease Morbidity and Mortality in a Population
NCT00005503	Epidemiology of Cardiac Development in Youth
NCT00005504	Epidemiology of Venous Thrombosis and Pulmonary Embolism
NCT00005505	Neighborhood Environments and Cardiovascular Disease
NCT00005506	Vascular Disease--Structure/Function
NCT00005507	Race and the Use of Cardiovascular Surgical Procedures
NCT00005508	Determinants of Coronary Disease in High Risk Families
NCT00005509	Cardiovascular Risk Factors in a Cohort of Latina Women
NCT00005510	Strong Heart Study Analyses Obesity and Lipoproteins
NCT00005511	SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea
NCT00005512	Genetic Epidemiology--Development of Cardiovascular Risk
NCT00005513	Framingham Nutrition Studies
NCT00005514	Dietary Patterns and Risk of Cardiovascular Disease
NCT00005515	Mutations, Hormone Therapy (HRT) and Venous Thromboembolism
NCT00005516	Epidemiology of Sleep Disordered Breathing in Children
NCT00005517	Community Surveillance of Congestive Heart Failure
NCT00005518	Epidemiology and Immunology of Hemophilia A Inhibitors
NCT00005519	Prospective Study of Diet and Cardiovascular Disease
NCT00005520	Genetic Epidemiology of Responses to Antihypertensives
NCT00005521	Exercise and Blood Pressure in Children: A Meta-Analysis
NCT00005522	Social Dominance, Gender, and Cardiovascular Reactivity
NCT00005523	Home Based Environmental Adherence Trial
NCT00005524	Mental Stress, Autonomic Function, and Heart Disease
NCT00005525	Sleep Apnea in Elderly Male Twins
NCT00005526	Genetic Basis of Abdominal Aortic Aneurysm
NCT00005528	Genetics of CVD Risk Factors in Samoans
NCT00005529	Self-Scored Cardiovascular Disease Risk Appraisal
NCT00005530	Diet, Insulin Resistance, and Cardiovascular Risk
NCT00005531	Genetic Epidemiology of Sarcoidosis
NCT00005532	Dietary Fat, Plasma Lipids, and Other CHD Risk Factors
NCT00005533	Hostility, Depression, Social Environment and CHD Risk
NCT00005534	Prevalence of Asymptomatic Ventricular Dysfunction
NCT00005535	Gene Mapping for Quantitative Traits
NCT00005536	Genetic Analysis of Human Hypertensive End Stage Renal Disease (H-ESRD)
NCT00005537	Genetics of Airway Responsiveness and Lung Function
NCT00005538	CHD Risk, Behavioral Stress and Reproductive Hormones
NCT00005539	Wisconsin Epidemiological Study of Cardiovascular Disease in Type 1 Diabetes
NCT00005540	Physical Fitness and Cardiovascular Mortality in Firefighters
NCT00005541	Hemochromatosis and Iron Overload Screening Study (HEIRS)
NCT00005542	Sarcoid Genetic Analysis (SAGA)
NCT00005543	Genetic Epidemiology of Venous Thromboembolism
NCT00005544	Community Based Study of Adult Onset Asthma
NCT00005545	Arterial Endothelial Function--An Epidemiologic Study
NCT00005546	Molecular Genetic Epidemiology of Three Cardiac Defects -SCOR in Pediatric Cardiovascular Disease
NCT00005547	Infection and Cardiovascular Disease
NCT00005548	Green Tea Consumption and Coronary Heart Disease
NCT00005549	Isocyanate Antigens and T Cells That Cause Asthma
NCT00005550	Endotoxin and Bronchial Inflammation in Asthma
NCT00005551	Sleep Apnea in a Non-Clinical Population
NCT00005552	Isocyanate Dermal Exposures in Autobody Shops
NCT00005553	Prospective Assessment After Pediatric Cardiac Ablation (PAPCA)
NCT00005554	Biobehavioral Predictors of Coronary Angioplasty Outcome
NCT00005555	Dose Response to Exercise and Cardiovascular Health
NCT00005556	Retention of Bone Marrow Donors in a National Registry
NCT00005557	Epidemiology of Sleep-Disordered Breathing in Adults
NCT00005559	Statistical Basis for Hemochromatosis Screening
NCT00005560	Prevalence and Correlates of Childhood Sleep Apnea
NCT00005562	Coronary Artery Calcium, Exercise Tests, and CHD Outcome
NCT00005563	Multicenter Asthma Research Collaboration
NCT00005564	Impact of Adult Asthma
NCT00005565	Mechanisms of Low Levels of Apolipoprotein B
NCT00005566	Cognitive Aspects of Adolescent Suicide
NCT00005567	Parental Knowledge and Beliefs About Infant Sleep Position
NCT00005569	Effects of Topical SLPI on Skin Wounds
NCT00005570	An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
NCT00005571	Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis
NCT00005572	A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) Infection
NCT00005574	Gentamicin Treatment of Muscular Dystrophy
NCT00005575	Treatment of Non-Cardiac Chest Pain With Imipramine or Cognitive-Behavioral Therapy
NCT00005576	Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma
NCT00005577	Gemcitabine in Treating Children With Refractory Solid Tumors
NCT00005578	Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
NCT00005579	Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia
NCT00005580	Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma
NCT00005581	Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer
NCT00005583	Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer
NCT00005584	Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
NCT00005585	Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
NCT00005586	Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
NCT00005587	Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer
NCT00005588	Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer
NCT00005589	Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
NCT00005590	Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma
NCT00005591	Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas
NCT00005592	Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT00005593	Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome
NCT00005594	ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas
NCT00005595	Arsenic Trioxide in Treating Patients With Relapsed or Refractory Hodgkin's Disease
NCT00005596	Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00005597	S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors
NCT00005598	Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome
NCT00005599	Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer
NCT00005600	Axillary Drainage Following Lymph Node Dissection in Women With Stage I or Stage II Breast Cancer
NCT00005601	Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
NCT00005602	Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas
NCT00005603	Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
NCT00005604	Interleukin-12 Plus Interleukin-2 in Treating Patients With Advanced Solid Tumors
NCT00005605	Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer
NCT00005606	Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation
NCT00005607	Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus
NCT00005608	Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer
NCT00005609	Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
NCT00005610	Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
NCT00005611	BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment
NCT00005612	Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer
NCT00005613	Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
NCT00005614	Management of Metastatic Breast Cancer in Frail Patients
NCT00005615	Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa
NCT00005616	Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer
NCT00005617	Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant Melanoma
NCT00005618	Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia
NCT00005619	Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia
NCT00005622	Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
NCT00005623	Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer
NCT00005624	CI-994 in Treating Patients With Advanced Myeloma
NCT00005625	Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma
NCT00005626	Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)
NCT00005627	Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00005628	Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma
NCT00005629	Vaccine Therapy in Treating Patients With Liver Cancer
NCT00005630	Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer
NCT00005631	Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma
NCT00005632	Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer
NCT00005633	Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
NCT00005634	Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
NCT00005635	Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2
NCT00005636	Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery
NCT00005637	Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma
NCT00005638	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
NCT00005639	Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment
NCT00005640	Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer
NCT00005641	Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
NCT00005642	SU5416 in Treating Patients With Advanced Solid Tumors
NCT00005643	Chemotherapy in Treating Patients With Sarcoma of the Uterus
NCT00005644	Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function
NCT00005645	ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment
NCT00005646	Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer
NCT00005647	SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck
NCT00005648	Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer
NCT00005649	Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer
NCT00005650	Genetic Study of Patients With Primary Ciliary Dyskinesia
NCT00005652	Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura
NCT00005654	Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome
NCT00005655	Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer
NCT00005657	Genetics of Hepatitis C Virus Infection
NCT00005658	Glycine to Treat Psychotic Disorders in Children
NCT00005660	The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases
NCT00005663	A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients
NCT00005664	Evaluation of Patients With Endocrine-Related Conditions
NCT00005665	"""Ingested Interferon Alpha: Prolongation or Permanence of the Honeymoon Phase in Newly Diagnosed Type 1 Diabetes Mellitus"""
NCT00005666	Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer
NCT00005667	Vancomycin Resistant Enterococci in Patients Awaiting Liver Transplantation at the University of Michigan: Prevalence, Risk Factors, Natural History and Outcome of Colonization
NCT00005668	A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma
NCT00005669	Metformin to Treat Obesity in Children With Insulin Resistance
NCT00005671	Quality of Life in Patients With Chronic Ischemic Heart Disease
NCT00005673	Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV Drugs
NCT00005674	Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS]
NCT00005675	Oral Type I Collagen for Relieving Scleroderma
NCT00005676	High Density Lipoprotein Subspecies and Coronary Disease
NCT00005677	Percutaneous Transluminal Coronary Angioplasty (PTCA) Registries I, II, and III and the Dynamic Registry
NCT00005678	Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA)
NCT00005679	Pathobiological Determinants of Atherosclerosis in Youth (PDAY)
NCT00005680	Whitehall II - Social and Occupational Influences On Health and Illness
NCT00005681	Vascular Basis for the Treatment of Ischemia
NCT00005682	Aplastic Anemia Epidemiology: Incidence and Case-control
NCT00005683	Clinical Interventions in Respiratory Distress Syndrome and Neonatal Lung Injury - SCOR in Lung Biology and Diseases in Infants and Children
NCT00005684	Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis
NCT00005685	Blood Pressure Control--Racial and Psychosocial Influences
NCT00005686	Dietary Intervention Methods for Clinical Trials
NCT00005687	Recycling Attempters and Relapsers in Smoking Cessation
NCT00005688	Cardiac Arrhythmias and the Perception of Symptoms
NCT00005689	Trial of Smoking Cessation Programs in Black Churches
NCT00005690	Improving Outcomes and Quality of Life After CABG
NCT00005691	Psychosocial Risk Factors for Coronary Heart Disease in Swedish Women
NCT00005692	Inflammation Markers Over Time in Cardiovascular Disease
NCT00005693	Computer Assisted Instruction Weight Management for Low Literacy Populations
NCT00005694	Worksites, Occupational Nurses and Cholesterol Change
NCT00005695	Physical Training and Blood Pressure in High Risk Youths
NCT00005696	Early Atherosclerosis Change in Two Clinical Trials
NCT00005697	Intervention for Resistant Pregnant Smokers
NCT00005698	IN CONTROL--Hypertension Reduction in Inner City Seattle
NCT00005699	Improving Hypertension Control in the Inner City
NCT00005700	Fat Reduction Intervention Trial in African-Americans
NCT00005701	Acute Cardiac Ischemia in Women in the ACI/TIPI Trial
NCT00005702	Promoting Smoking Cessation in Hospital Patients
NCT00005703	Hemostasis in Sickle Cell Disease--Infancy to Adulthood
NCT00005704	Pharmacologic Intervention for Postcessation Weight Gain
NCT00005705	Adherence in the Childhood Asthma Management Program
NCT00005706	Urban African-American Community Hypertension Control
NCT00005707	Improving Hypertension Care for Inner City Minorities
NCT00005708	Improving Adherence to Interventions for Hypertension
NCT00005709	Lipoprotein Metabolism in Hypertensive African-Americans
NCT00005710	Recycling of Chronic Smokers to Sustained Abstinence
NCT00005711	Intervention for Hispanic Children With Asthma
NCT00005712	Self Management Education Asthma
NCT00005713	Childhood Asthma Program in NYC Health Department Clinics
NCT00005714	Development and Evaluation of Community Asthma Program
NCT00005715	Community Intervention for Minority Children With Asthma
NCT00005716	Asthma Partnership for Minority Children
NCT00005717	Medication Adherence in COPD--A Self-Regulation Study
NCT00005718	Evaluation of Cholesterol Education for At-Risk Children
NCT00005719	Sustaining Women's Smoking Cessation Postpartum
NCT00005720	Lay-Led Smoking Cessation Approach for Southeast Asian Men
NCT00005721	Retaining Donors and Increasing Donation Frequency
NCT00005722	Stroke Belt Initiative
NCT00005723	Worksite Issues in Organizational Health Promotion (Take Heart)
NCT00005724	CVD Nutrition Modules Tailored to Low Literacy Skills
NCT00005725	Low Literacy CVD Diet Education for Blacks
NCT00005726	Evaluation of Low Literacy CVD Nutrition Education
NCT00005727	CVD Nutrition Education
NCT00005728	Nutrition Education
NCT00005729	CVD Nutrition Education for Low Literacy ESL Students
NCT00005730	National Marrow Donor Program (NMDP)
NCT00005731	Develop and Implement Asthma Controlling Strategies
NCT00005732	Develop and Implement Asthma Controlling Strategies (1)
NCT00005733	Develop and Implement Asthma Controlling Strategies (2)
NCT00005734	Intervention to Improve Asthma Management/Prevention
NCT00005735	Controlling Asthma at School
NCT00005736	Interventions to Improve Asthma Management/Prevention at School
NCT00005737	Tuberculosis Prophylaxis in the Homeless--A Controlled Trial
NCT00005738	Promoting Adherence to TB Regimens in Latino Adolescents
NCT00005739	Behavioral Interventions for Control of TB
NCT00005740	TB Contact Investigation: Behavioral Intervention
NCT00005741	Indigenous Outreach Among Injection Drug Users to Treat and Control TB
NCT00005742	Behavioral Interventions for Control of Tuberculosis
NCT00005743	Exercise Adherence in a Behavioral Weight Loss Program
NCT00005744	Increased Physical Activity in African-American Women
NCT00005745	Consequences and Correlates of Weight Fluctuations
NCT00005746	Community Site Coronary Risk Control in Black Families
NCT00005748	Stress Reduction and Prevention of Hypertension in Blacks
NCT00005749	Project Andale--Increasing Exercise in Hispanic Women
NCT00005750	School and Family-Based Obesity Prevention for Children
NCT00005751	Endothelial Vasomotor Function in the Framingham Study
NCT00005752	Overweight Adults--Ethnic, SES and Behavioral Influences
NCT00005753	Pharmacological and Behavioral Treatment of Insomnia
NCT00005754	Coronary Artery Calcification in Type 1 Diabetes
NCT00005755	Community Based Study on Occupational Asthma
NCT00005756	Epidemiology of Coronary Calcification in the Elderly
NCT00005757	Racial Variation in ACE--Genetic and Physiologic Bases
NCT00005758	Effectiveness of Giving an HIV Vaccine (Remune) to HIV-Positive Patients Receiving an Anti-HIV Drug Combination
NCT00005760	Health Effects of Liposuction in Overweight Women With Elevated Insulin Levels, Impaired Glucose Tolerance and/or Type 2 Diabetes
NCT00005761	Blood Factors and Diabetic Retinopathy
NCT00005762	Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers
NCT00005763	INTERSALT: International Study of Sodium, Potassium, and Blood Pressure
NCT00005764	A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients
NCT00005765	Behavioral Economics of Human Drug Self-Administration
NCT00005766	Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis
NCT00005767	Dynamic Aspects of Amino Acid Metabolism
NCT00005768	Estrogen Modulation of Mood and Cognition Following Monoaminergic Depletion in Post-Menopausal Women
NCT00005769	Hormone Replacement Therapy and Insulin Action: A Double-Blind, Parallel, Placebo-Controlled Hormone Intervention Study in Postmenopausal Women
NCT00005770	Investigation of the Effect of Acupuncture Needling on Connective Tissue Using Ultrasound Elastography
NCT00005771	The Use of Real Time Ultrasound Feedback in Teaching Abdominal Hollowing Exercises
NCT00005772	Whole-Body Cooling for Birth Asphyxia in Term Infants
NCT00005773	Early Inhaled Nitric Oxide for Respiratory Failure in Newborns
NCT00005774	Early Surfactant to Reduce Use of Mechanical Breathing in Low Birth Weight Infants
NCT00005775	Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants
NCT00005776	Inhaled Nitric Oxide Study for Respiratory Failure in Newborns
NCT00005777	Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE)
NCT00005778	High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide
NCT00005779	Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy
NCT00005780	Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma
NCT00005781	Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles
NCT00005782	Mobilization and Handling of Stem Cells for Transplant From Healthy Volunteers With Sickle Cell Trait
NCT00005783	A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders
NCT00005784	Evaluation and Treatment of Patients With Retinal Disease
NCT00005785	Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer
NCT00005786	Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia
NCT00005787	Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT00005788	Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome
NCT00005790	Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors
NCT00005791	Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors
NCT00005792	Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
NCT00005793	A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide
NCT00005794	Perifosine in Treating Patients With Advanced Solid Tumors
NCT00005795	Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia
NCT00005796	Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors
NCT00005797	Bone Marrow Transplant in Treating Patients With Hematologic Cancers
NCT00005798	Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
NCT00005799	Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
NCT00005800	Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer
NCT00005801	Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia
NCT00005802	Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia
NCT00005803	Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma
NCT00005804	Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
NCT00005805	St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer
NCT00005806	Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
NCT00005807	Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer
NCT00005808	Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia
NCT00005809	Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia
NCT00005810	Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00005811	Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment
NCT00005812	Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma
NCT00005813	Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme
NCT00005814	Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer
NCT00005815	Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma
NCT00005816	Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer
NCT00005817	Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer
NCT00005818	SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer
NCT00005819	Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
NCT00005820	Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00005821	Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer
NCT00005822	SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer
NCT00005823	Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
NCT00005824	Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related Lymphoma
NCT00005825	Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
NCT00005826	Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme
NCT00005827	Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer
NCT00005828	Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00005829	Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia
NCT00005830	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
NCT00005831	Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer
NCT00005832	S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
NCT00005833	S9923 R115777 in Treating Patients With Advanced Colorectal Cancer
NCT00005834	S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma
NCT00005835	N99-02: Melphalan and Buthionine Sulfoximine
NCT00005836	Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy
NCT00005837	Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer
NCT00005838	Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery
NCT00005839	Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor
NCT00005840	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
NCT00005841	Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
NCT00005842	Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
NCT00005843	R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer
NCT00005844	Oxaliplatin in Treating Children With Advanced Solid Tumors
NCT00005845	Tipifarnib in Treating Patients With Myelodysplastic Syndromes
NCT00005847	Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00005848	R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00005849	Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer
NCT00005850	Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
NCT00005851	Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer
NCT00005852	Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant
NCT00005853	Biological Therapy in Treating Patients With Myelodysplastic Syndrome
NCT00005854	Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
NCT00005855	Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma
NCT00005856	Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00005857	Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
NCT00005858	LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer
NCT00005859	Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma
NCT00005860	Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum
NCT00005861	Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer
NCT00005862	SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas
NCT00005863	Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia
NCT00005864	Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer
NCT00005865	Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT00005866	S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia
NCT00005867	Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
NCT00005868	Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer
NCT00005869	Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
NCT00005870	Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas
NCT00005871	Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer
NCT00005872	Nitrocamptothecin in Treating Patients With Recurrent Non-small Cell Lung Cancer
NCT00005873	Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
NCT00005874	Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas
NCT00005875	Nitrocamptothecin in Treating Patients With Metastatic Melanoma
NCT00005876	Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery
NCT00005877	Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer
NCT00005878	Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus
NCT00005879	LY353381 in Preventing Breast Cancer in Women With Hyperplasia
NCT00005880	Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia
NCT00005881	Quality of Life in Children Treated for Cancer
NCT00005883	Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke
NCT00005884	Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer
NCT00005886	Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer
NCT00005887	Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases
NCT00005888	Study of the Relationship Between Feeding and Late Onset Sepsis and/or Necrotizing Enterocolitis in Low Birth Weight Infants
NCT00005889	Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion
NCT00005890	Diagnostic Study of Adrenal Cortical Function in Children With Septic Shock
NCT00005891	Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Fanconi's Anemia
NCT00005892	Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia
NCT00005893	Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders
NCT00005896	Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's Anemia
NCT00005898	Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconi's Anemia
NCT00005900	Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
NCT00005901	Pamidronate to Treat Osteogenesis Imperfecta in Children
NCT00005902	Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease
NCT00005903	Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) to Treat Progressive Supranuclear Palsy
NCT00005905	Leptin to Treat Lipodystrophy
NCT00005906	Treatment With Octreotide in Patients With Lymphangioleiomyomatosis
NCT00005907	Comparison of Immune Response to Booster Vaccines in Blood Transplant Patients and Healthy Volunteers
NCT00005908	Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer
NCT00005909	Study of Alkaptonuria
NCT00005910	Laparoscopy to Remove Pancreatic Tumors (Insulinomas)
NCT00005911	Magnetic Resonance Imaging to Study the Normal Eye
NCT00005912	Voriconazole to Prevent Systemic Fungal Infections in Children
NCT00005914	Genetics of Recurrent Early-Onset Depression
NCT00005915	A Comparison of Two Anti-HIV Treatment Plans
NCT00005916	PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer
NCT00005917	Study of Chediak-Higashi Syndrome
NCT00005918	Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients
NCT00005919	Cause of Pigment Dispersion Syndrome
NCT00005920	Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole
NCT00005921	A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis
NCT00005922	Conditioning, the Placebo Effect, and Psoriasis
NCT00005923	The Effect of Estrogen and Progesterone Levels on Knee and Ankle Joint Laxity
NCT00005924	Effects of Long-Term Treatment With Valaciclovir (Valtrex) on Epstein-Barr Virus
NCT00005925	Brain Infusion of Muscimol to Treat Epilepsy
NCT00005926	Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas
NCT00005927	Study of Adrenal Gland Tumors
NCT00005928	Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation
NCT00005931	SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment
NCT00005933	Learning and Behavior Problems in Children With Chronic Granulomatous Disease and Related Disorders
NCT00005934	5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia
NCT00005935	Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia
NCT00005936	Collection of Liver Tissue for Virologic Studies
